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ABSTRACT 
Human parthenotes have been proposed as a source of embryonic 
stem cells despite the high incidence of aneuploidy described in 
parthenotes of most mammalian species. Through a comparative 
analysis between parthenogenetic and bi-parental cells lines we found 
that parthenogenetic cells are affected by chromosomal instability and 
centrosome amplification. We provide evidence that both alterations 
are determined by the lack of paternal centriole, normally contributed 
by the sperm at the time of fertilization, but parthenogenetic cell lines 
activate a series of adaptive mechanisms that allow them to 
proliferate and differentiate. These include down-regulation of the 
p53/p21 pathway, massive increase of autophagic activity and 
formation of a wide network of intercellular bridges with the 
morphological and molecular characters of blocked cell abscissions. 
These processes are commonly observed in transformed cells 
therefore parthenogenesis may be used to explore the mechanisms 
regulating oncogenesis and their link with self-renewal and 
pluripotency in human cell lines. 
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1. INTRODUCTION 
1.1 Stem cells 
Stem cells are a special kind of cell that have the unique capability 
to make identical copies of themselves (this property is referred to 
as “self-renewal”) for the lifetime of the organism and, under 
appropriate conditions, to give rise to several specialized cell 
types 1,2 (Figure 1).  
 
 
 
 
Figure 1. Symmetric and asymmetric division of stem cells. 
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Although most cells of the body, such as heart cells or skin cells, 
are committed to conduct a specific function; stem cells are 
uncommitted and remain uncommitted, until they receive a signal 
to develop into a specialized cell. Their proliferative capacity 
combined with the ability to become specialized makes stem cells 
unique. Recently, stem cells have received much attention 
following their possible use in regenerative medicine. This is a 
new concept in contemporary medical science based on the 
possibility to produce new cells that may be utilized to repair or 
renovate degenerated and damaged tissues.  
 
Three different types of cells exist, based on their differentiation 
capability: 
1. Totipotent cells: zygote; 
2. Pluripotent cells: embryonic stem/germ/carcinoma cells; 
3. Multipotent/unipotent: adult stem cells. 
 
1.1.1 Totipotent cells 
Totipotent cell —from the Latin “totus”, meaning entire— has the 
potential to generate all the cells and tissues that make up an 
embryo and that support its development in utero (fetal 
membranes). Totipotent cells formed during sexual and asexual 
reproduction include spores and zygotes. In some organisms, cells 
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can dedifferentiate and regain totipotency 3. For example, a plant 
cutting or callus can be used to grow an entire plant. Mammalian 
development commences when an oocyte is fertilized by a sperm 
forming a single celled embryo, the zygote. Consistent with the 
definition, zygote is considered the only existing totipotent cell. 
This single cell has the potential to develop into an embryo with 
all the specialized cells that make up a living being, as well as into 
the placental support structure necessary for fetal development. 
Thus, each totipotent cell is a self-contained entity that can give 
rise to the whole organism. This is said to be true for the zygote 
and for early embryonic blastomeres up to at least the 4-cell stage 
embryo (Figure 2). Experimentally, totipotency can be 
demonstrated by the isolation of a single blastomere from a 
preimplantation embryo and subsequently monitoring its ability 
to support a pregnancy following transfer into a suitable 
recipient. This approach was pioneered in rats and has been 
realized in several mammalian species including non-human 
primates 4-6. The results obtained in rhesus monkey confirm the 
ability of isolated blastomeres from 2- and 4-cell stage IVF 
embryos to support pregnancies and to produce live animals, 
demonstrating the totipotency of these cells 7. As embryo 
development progresses to the 8-cell stage and beyond depending 
on the species, the individual blastomeres that comprise the 
embryo gradually lose their totipotency (Figure 2). It is generally 
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believed that this restriction in developmental potential indicates 
irreversible differentiation and specialization of early embryonic 
cells into the first two lineages, the inner cell mass (ICM) that 
includes cells that will give rise to the fetus and the 
trophectoderm (TE), an outer layer of cells that is destined to an 
extraembryonic fate. 
However it is important to note that totipotent cells are not stem 
cells because they lack the property of symmentric division, 
therefore they can indeed differentiate but are unable to self-
renewal. 
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Figure 2. Development. Ontogeny begins from a single cell, the 
zygote. The zygote and each blastomere of the early embryo are 
totipotent with the potential to develop into the whole 
organism. As development unfolds, the developmental 
potential of individual blastomeres gradually declines resulting 
subsequently in pluripotent, multipotent, unipotent and 
terminally differentiated somatic cells. (Modified from 
Mitalipov S. and Wolf D., 2009). 
 
 
1.1.2 Embryonic stem cells 
Embryonic stem cells (ESCs) are pluripotent cells — from the 
Latin “plures”, meaning several or many- derived from the inner 
cell mass (ICM) of preimplantation blastocysts. In vitro, these cells 
are capable of undergoing an unlimited number of symmetrical 
divisions without differentiating (long-term self-renewal) and, 
when exposed to specific conditions, can give rise to cells derived 
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from all three embryonic germ layers: ectoderm, endoderm and 
mesoderm (Table 1).  
 
 
Embryonic 
Germ Layer 
Differentiated Tissue 
Endoderm Thymus 
Thyroid, parathyroid glands 
Larynx, trachea, lung 
Urinary bladder, vagina, urethra 
Gastrointestinal (GI) organs (liver, pancreas) 
Lining of the GI tract 
Lining of the respiratory tract 
Mesoderm Bone marrow (blood) 
Adrenal cortex 
Lymphatic tissue 
Skeletal, smooth, and cardiac muscle 
Connective tissues (including bone, cartilage) 
Urogenital system 
Heart and blood vessels (vascular system 
Ectoderm Skin 
Neural tissue (neuroectoderm) 
Adrenal medulla 
Pituitary gland 
Connective tissue of the head and face 
Eyes, ears 
 
Table 1. Embryonic germ layers from which differentiated 
tissues develop 
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Pluripotent stem cells can give rise to any fetal or adult cell type. 
These include more than 200 kinds of cells, such as nerve cells 
(neurons), muscle cells (myocytes), skin (epithelial) cells, blood 
cells (erythrocytes, monocytes, lymphocytes, etc.), bone cells 
(osteocytes), and cartilage cells (chondrocytes) (Figure 3). 
Consequently ESCs are considered a potential unlimited source of 
transplantation materials for replacement cell therapy. 
 
 
Figure 3. Pluripotent stem cells can give rise to different kind of 
adult cells. 
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It is fundamental to remember that a formally correct deﬁnition of 
embryonic stem cells implies the satisfaction of several criteria 
including: derivation without transformation or immortalization; 
stable diploid karyotype, clonogenic ability, unlimited self-
renewal capacity, ability to generate all cell types in vitro and in 
teratomas, incorporation into embryonic development and 
contribution to all germ layers in chimera, germ-line colonization 
and transmission 8. These definitions have been used to qualify 
cell lines derived from ICM of all mammalian embryos as ESCs. 
Any cell line which fails to satisfy all these requirements should 
be deﬁned as stem cell-like or other dubitative descriptions.  
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Marker 
Name 
Mouse ECC/ 
ESC/EGCs 
Monkey 
ESCs 
Human 
ESCs 
Human 
EGCs 
Human ECCs 
SSEA-1 + – – + – 
SSEA-3 – + + + + 
SEA-4 – + + + + 
TRA-1–60 – + + + + 
TRA-1–81 – + + + + 
Alkaline 
phosphatase 
+ + + + + 
Oct-4 + + + Unknown + 
Telomerase 
activity 
+ ES, EC Unknown + Unknown + 
Feeder-cell 
dependent 
ES, EG, some 
EC 
Yes Yes Yes Some; 
relatively low 
clonal 
efficiency 
Factors which 
aid in stem 
cell self-
renewal 
LIF and other 
factors that act 
through gp130 
receptor and 
can substitute 
for feeder layer 
Co-culture 
with feeder 
cells; other 
promoting 
factors have 
not been 
identified 
Feeder cells + 
serum; feeder 
layer + serum-
free medium + 
bFGF 
LIF, bFGF, 
forskolin 
Unknown; low 
proliferative 
capacity 
Growth 
characteristics 
in vitro 
Form tight, 
rounded, 
multi-layer 
clumps; can 
form EBs 
Form flat, 
loose 
aggregates; can 
form EBs 
Form flat, 
loose 
aggregates; can 
form EBs 
Form rounded, 
multi-layer 
clumps; can 
form EBs 
Form flat, 
loose 
aggregates; can 
form EBs 
Teratoma 
formation in 
vivo 
+ + + – + 
Chimera 
formation 
+ Unknown + – + 
 
Table 2. Comparison of mouse, monkey and human pluripotent 
stem cells and their essential characteristics. 
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1.1.3 Adult stem cells 
Multi/unipotent stem cell - derived from the Latin “multi”, which 
means few and “unus” meaning one- is a term that is usually 
applied to a cell in adult organisms: the adult stem cells. These are 
undifferentiated cell that are present in a differentiated 
(specialized) adult tissue and are capable of differentiating along a 
few or only one lineage. Adult stem cells, in fact, can yield all 
specialized cell types of the tissue from which it originated (Figure 
4) and ensure tissue homeostasis and repair during the individual 
life. This characteristic is an advantage because it makes 
controlled differentiation easier than pluripotent cells. Moreover 
these kind of cells are also capable of self-renewal for the lifetime 
of the organism.  
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Figure 4. Hematopoietic stem cell differentiation. 
Representative picture of multipotent stem cells that are able to 
differentiate in  all specialized cell types of the tissue from 
which it originated. 
 
 
 
During the past decade, scientists discovered adult stem cells in 
tissues, such as in the bone marrow 9, brain, blood stream, cornea 
and retina of the eye 10,11, the dental pulp of the tooth, liver, skin 12, 
gastrointestinal tract and pancreas. Some of these cells are already 
being used for therapeutic applications, thanks to their easy 
isolation and progation in vitro. Unfortunately, not all adult stem 
cells, can be used for therapeutic application. Many of them, in 
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fact, are difficult to access (i.e. central nervous system cells) and/or 
show a limited proliferating ability (i.e. muscle cells) 13. 
 
 
1.2 Embryonic stem cells 
During the last decades the field of stem cell biology has received 
increasing amounts of attention from scientists, ethicists, 
industrialists, politicians and the general public. In particular, 
ESCs are considered of great interest because they are recognized 
as a potential renewable source of specialized cells that can be 
used for therapeutic purposes, replacing diseased or damaged 
cells. 
Here we describe in more detail their characteristics in some 
species relevant for the subjects reported in this thesis. 
 
 
1.2.1 Embryonic stem cells in mouse 
ESCs were first derived by Martin 14 and Evans and Kaufman in 
1981 15. They successfully isolated and characterized ICM-derived 
cells from in vivo-derived mouse blastocyst-stage embryos 
obtained from random bred ICR female mice with SWR/J males 14-
16. Undifferentiated cell colonies show a compact morphology 
with a high nucleus- cytoplasm ratio and prominent nucleoli 
(Figure 5).  
13 
 
 
 
Figure 5. Representative picture of ESCs colony.  
 
 
They express specific markers or characteristics similar but not 
identical to the transient pluripotent cells of an embryo. This 
includes stage specific embryonic antigens, enzymatic activities 
such as alkaline phosphatase and telomerase, and “stemness” 
genes that are rapidly down-regulated upon differentiation, 
including OCT4 and NANOG 17. Furthermore mouse ESCs 
showed their ability to proliferate indefinitely in an 
undifferentiated state 15, when cultured in specific conditions, 
suggesting that their transcriptional activity and epigenetic 
regulators were capable to support pluripotency also  in vitro 3. 
However, when released from the influence of these culture 
conditions or following their introduction back into a host 
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embryo, ESCs retain their ability to differentiate into any cell-
type, just like ICM cells. Alternatively, when injected in immune-
deficient mice, they can differentiate in vivo in teratomas 
containing cells representing the three major germ layers: 
endoderm, mesoderm and ectoderm 18 or they can be directed to 
differentiate in vitro into any of the 200 cell types present in the 
adult body 19-22. 
All these data obtained in mouse resulted in efforts aimed at 
establishing the same kind of cells in other species, including 
rabbit, hamster, cattle, sheep, goat, in no-human primate and 
human too. Actually human and mouse embryonic stem cell 
(ESC) lines have been the two predominant animal models 
investigated by researchers over the past one and two decades 
respectively.  
 
1.2.2 Embryonic stem cells in human 
In 1994 human ICMs, isolated from blastocysts created for 
reproductive purposes using IVF and donated by patients for 
research, were maintained in culture and generated aggregates 
with trophoblast-like cells at the periphery and ES-like cells in the 
center. These cells retained a complete set of chromosomes 
(normal karyotype) and showed a stem cell-like morphology, 
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although some ICM clumps differentiate into fibroblasts. These 
cultures were maintained only for two passages 23. 
The first research paper that reported ESCs maintenance in 
undifferentiated state for more than 4 or 5 months was published 
in 1998 by James Thomson and colleagues 18. They described 
methods for deriving and maintaining human ESCs and 
demonstrated differentiation their ability producing endoderm 
(gut epithelium), mesoderm (cartilage, bone, smooth muscle and 
striated muscle) and ectoderm (neural epithelium, embryonic 
ganglia, and stratified squamous epithelium) derived cells 18. 
 
 
 
 
Figure 6. Human blastocyst showing distinct ICM and 
trophectoderm. 
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To date, several laboratories have demonstrated pluripotent 
characteristics of human ESCs, like expression of pluripotency 
markers, high telomerase activity, in vitro differentiation ability 
and, when injected into immune-deficient mice, formation of 
teratomas 24,25.  
Obviously, two aspects of in vivo pluripotency typically tested in 
mouse have not been met by human cells: evidence that cells have 
the capacity to be injected into a human embryo and form an 
organism made up of cells from two genetic lineages; and 
evidence that they have the ability to generate germ cells, the 
precursors to eggs and sperm in a developing organism. 
Furthermore it is important to underline that differences are 
emerged comparing mouse and human ESCs. Despite the 
apparent common origin and the similar pluripotency 
characteristics of cell lines obtained from the two species, recent 
studies have revealed that the two cell types use different 
signalling pathways to maintain their pluripotent status. Indeed 
mouse ESCs depend on leukaemia inhibitory factor (LIF) and 
bone morphogenetic protein (BMP), whereas their human 
counterparts rely on activin (INHBA)/nodal (NODAL) and 
fibroblast growth factor (FGF). Moreover, despite having similar 
core transcription factor circuitry, human and mouse ESCs have 
substantially different target genes for Oct-4 and Nanog 17,26. Until 
the last few years these differences between the two cell types had 
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not explanation. Only recent studies carried out on mouse epiblast 
stem cells (EpiSCs) 27,28 explained that these divergences are 
developmental and represented two different stages of embryonic 
development with human ESCs recapitulating the epiblast state 29. 
Interestingly, EpiSCs share with human ESCs not only a 
dependence on activin/Nodal signaling, but also other key 
differences from mouse ESCs that have previously been attributed 
to species divergence. EpiSCs and human ESCs, in fact, grow in 
large, flat, epithelial colonies, they are not able to clonally 
propagated, show a limited capacity for colonising pre-
implantation embryos and directly respond to known gastrulation 
signals in vitro 30-33. Finally, EpiSCs (like human ESCs) have been 
shown to differentiate into trophectoderm in the presence of 
BMP4 34, whereas mouse ESCs have little or no capacity for 
contribution to either primitive endoderm or trophectoderm 
lineages in chimaeric embryos 35 and differentiate into 
trophectoderm only when their Oct-4 gene is mutated by 
homologous recombination 36.  
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Figure 7. Early development. Pluripotent cells from a 
developmental window in the pre-implantation embryo grow as 
mouse embryonic stem (ES) cells, and those from the post-
implantation epiblast grow as epiblast stem cells (EpiSCs). The 
ability to grow cells in vitro, and move between distinct 
pluripotent states will provide insight into the undefined 
molecular mechanisms (‘‘black boxes’’) that establish the early 
cell fates within the embryo. (From Chenoweth et al., 2010). 
 
 
1.2.3 Embryonic stem cells in ungulates 
Overall the ESC characteristics described above made them an 
invaluable genetic engineering tool for studying functional 
mammalian genetics, mammalian developmental biology and for 
producing animal models of human diseases. At present human 
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and mouse ESCs have been the two predominant animal models 
investigated by researchers. However, as described above, cells 
derived from mice and humans differ considerably. Furthermore 
because of legal/ethical problems tied to the use of blastocysts, the 
development of alternative, non-human embryonic stem cell lines 
is crucial for continued extension of research and for development 
of stem cell therapies.  
In this scenario the establishment of ESC lines in large mammal is 
of great interest for basic research (comparative embryology and 
the cell biology of ungulate stem cell maintenance and 
differentiation) and represent an advantage due to their 
physiological similarity to the human and perhaps more relevant 
for clinical translation studies compared with mouse ESCs. 
Over the past 20 years many reports of sheep 37, hamster 38, dog 39, 
cat 40, mink 41, rabbit 42, horse 43, cattle 44 and pig 45-47 ESC lines, or 
what are often presented as “ESC-like cell” lines, have been 
published. Despite this, the primary problem for ESCs in domestic 
animal is that no standard protocol for their isolation and culture 
currently exists. Indeed, based on previously definition of ESC, 
none of the ungulate cell cultures or cell lines described have been 
definitively proven to be ESCs, and none have been successfully 
used as biological reagents in a manner similar to that of human, 
monkey, or mouse ESCs, i.e., directed pluripotent in vitro 
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differentiation 48,49 or as a means of genetically engineering a 
mammal through embryonic chimera formation 50. 
 
1.2.4 Embryonic stem cells in pig 
The experiments described in this thesis were carried out in the 
pig. The choice of using the porcine model is based on the well 
known similarities in term of anatomy, physiology, metabolism 
and organ development with primates that make this large animal 
the ideal link between the classical rodent models and the human. 
Peer-reviewed reports of porcine ESCs, ES-like or ICM cell lines 
have been published all of which used in vivo-derived blastocysts 
as their primary culture material 37,45,51-54. This occurred because of 
the well known difficulties in the production of porcine embryos 
in vitro that is still challenging with low efficiency and quality. On 
the contrary, generally, primate ESC lines have been established 
from in vitro-fertilized (IVF) in vitro-cultured (IVC) blastocysts of 
humans 55,56. Furthermore given the high cost and the low 
efﬁciency of ESC derivation from in vivo-derived embryos 57, more 
researchers are working with domestic species to produce in vitro-
embryos and to use them for ESC isolation.  
Only in the last period few studies have described the isolation of 
putative pig ESCs using in vitro produced blastocysts 58-61. 
Furthermore putative porcine ESCs established by Notarianni et 
al. were poorly defined 45. In other studies no ESC-like cells 
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survived passage 10, while epithelial-like lines survived up to 
passage 42, but failed to differentiate 47. Talbot et al. reported that 
pluripotency was difficult to maintain in ESC-like and epithelial-
like cell cultures for more than a few passages 62. Further studies 
have been conducted by other authors 53,63, however, the general 
consensus is that none of these lines were truly ESCs and 
pluripotent 64,65 and a number of technical questions are still to be 
answered. The use of conventional protocols for culture of mouse 
and human ESC does not appear to sustain extended growth nor 
pluripotency of cultured porcine cells. Recently it has been 
demonstrated that medium components play a pivotal role in 
regulating intrinsic and extrinsic factors involved in the control of 
pluripotency and that specific pathways may be up-regulated, or 
down-regulated, in response to the addition of specific molecules 
66. It is evident that many important aspects need to be elucited in 
order to be able to establish homogeneous porcine outgrowths 
and ensure a favorable environment for porcine ESC 
maintenance67.  
 
1.2.5 Embryonic stem cells and ethical concern  
Isolation of embryonic stem cells cannot be obtained without 
destroying a viable embryo and for this reason, despite the 
potential therapeutic usefulness, their derivation in the human 
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raises substantial religious, ethical as well as legal and political 
concerns. In this scenario a number of scientific attempts that do 
not require the generation and subsequent destruction of human 
embryos have been proposed in order to fill the gap between 
ethical questions and potential scientific and  medical benefits 68. 
These different approaches involves obtaining stem cells from 
embryos that are clinically dead or developmentally arrested 69,70, 
or removing single blastomeres from less developed embryos 
(morulae), using an approach similar to that used for 
preimplantation genetic diagnosis during in vitro fertilization 
(IVF), in which a single cell is extracted from an embryo and 
tested for genetic disorders 71,72. The possibility to create 
genetically modified biological artifacts obtained through altered 
nuclear transfer (ANT) that create abnormal blastocysts unable to 
implant into the uterus but capable of generating customized 
ESCs has also been proposed as an alternative possibility to 
produce ethically acceptable cell lines 73-77. Epigenetic 
reprogramming of adult stem cells is a further and very promising 
approach for the derivation of stem cells 78-80. In particular, the 
recent identification of 4 factors that  seem to play a crucial role 
for the induction and maintenance of pluripotency, namely Oct-
3/4, Sox2, c-Myc and KLF4, have allowed for the establishment of 
new cell lines called induced pluripotent stem (iPS) cells that are 
similar to ESCs in morphology, proliferation and pluripotency 81-83 
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but derived from terminally differentiated cells. The use of 
artificial parthenogenesis in order to create entities, namely 
parthenotes, which may represent an alternative ethical source for 
pluripotent cell lines is also a promising possibility 84. Such 
embryos constitute a potential source of pluripotent cells that 
would be isogenic with the oocyte donor 85,86 and therefore 
suitable for use in cell or tissue replacement therapy.  
Since many features of parthenogenetic cells are actually 
unknown and several biological aspects need to be elucidated, it is 
not possible to consider this cells suitable for therapy. In this 
thesis different cell lines isolated from human and porcine 
parthenogenetic embryos and from sheep parthenogenetic fetuses 
will be studied and analyzed in detail. 
 
1.3 Parthenogenesis 
1.3.1 Parthenogenesis in mammals 
Parthenogenesis  is a form of asexual reproduction, by which an 
oocyte can develop without the intervention of the male 
counterpart. This process may routinely occur naturally in some 
lower species such as fish, ants, flies, honeybees, amphibians, 
lizards and snakes.  
By contrast, mammals are not spontaneously capable to use this 
form of reproduction.  However, mammalian oocytes can be 
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successfully activated in vitro, using a variety of stimulations, such 
as ethanol 87-93, electric shock 94-96, strontium chloride treatment 
97,98, and ionomycin 99,100, which mimic the intracellular calcium 
wave induced by sperm at normal fertilization 101,102. This 
phenomenon causes cleavage divisions and embryonic 
development. However, mammalian parthenotes are unable to 
develop to term due to genomic imprinting alteration that result 
in the repression of paternally expressed genes 103. The consequent 
developmental abnormalities cause an arrest of parthenote 
development at different stages after activation - depending on 
the species 104 - giving embryo-like structure unable to form a new 
individual.  
Parthenotes can be obtained in two different ways. The most 
common consists of combining the activation of metaphase-2 
oocytes with exposure to an actin polymerization inhibitor, 
usually cytochalasin D and B 89-91,105, cycloheximide 92,93 or 6-
dimethylaminopurine (DMAP) 99,100,106,107. Alternatively a diploid 
parthenote can be generated by preventing the extrusion of the 
first polar body. This protocol leads to the formation of tetraploid 
oocytes 89 and the diploid status is then re-established at the end 
of oocyte maturation with the extrusion of the second polar body. 
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 1.3.2 Parthenogenesis and zygosity 
An important aspect related to parthenogenesis is zygosity. It 
refers to the similarity of alleles for a trait in an organism and is 
used to describe the genotype of a diploid organism at a single 
locus on the DNA. If both alleles are the same, the organism is 
homozygous for the trait, while if alleles are different, the 
organism is heterozygous (Figure 8). 
 
 
 
 
Figure 8. Representative figure of homozygous (left) and 
heterozygous (right) chromosome for different alleles. 
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Using one or the other method described above to obtain 
parthenogenesis in mammals (paragraph 1.3.1) has important 
consequences for the genetic make-up of the parthenote in 
question 108. Performing oocyte activation before inhibition of the 
second polar body extrusion determines the formation of highly 
homozygous parthenotes, since diploid status of the parthenote is 
obtained after segregation of sister chromatids (Figure 6). In 
contrast, when the first polar body extrusion is inhibited, 
parthenotes are genetically identical to each other and have the 
same heterozygosity as their mother 89 (Figure 9).  
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Figure 9. Genetic composition of in vitro fertilized embryos (A) 
and parthenotes where extrusion of the II polar body (A) or I 
polar body(C) is inhibited. (From Brevini et al., 2008). 
 
 
The occurrence of a high degree of homozygosity in parthenotes 
has been evaluated in contrasting ways in the perspective of using 
these entities as a source of embryonic stem cells. Homozygosity 
can be seen as a potential benefit when reduction of 
immunogenicity of a stem cell derivative is considered. The 
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possibility of generating stem cells that are homozygous for all 
three sets of HLA (A, B and DR) would exponentially increase the 
number of phenotypes a graft fully matches. Furthermore, 
homozygosity has also been suggested to be an advantage to be 
exploited for selecting cell lines carrying drug response genes, or a 
disease gene or cancer gene correction, providing a useful 
research tool for drug testing and development 109. At the same 
time, it must be remembered that homozygosity can represent a 
severe risk. Loss of heterozygosity could amplify any negative 
genetic component potentially present in the genotype.  
 
1.3.3 Parthenogenesis and asymmetric imprinting 
The term ‘genomic imprinting’ is used to describe the functional 
differences between parental genomes during mammalian 
development, but was not described in animals, other than 
mammals 110. In particular, the imprinting can be consider an 
epigenetic mechanisms which regulates hereditary changes in 
gene expression not related to disturbed sequences of DNA 
nucleotides. It is involved in many processes of normal and 
pathological development of humans and animals 111. 
Interestingly, a number of studies demonstrated that various 
anomalies and mortality exhibited by mammalian clones may be 
due to genomic imprinting 112,113. In cloned mice and sheeps, for 
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example, uncontrolled growth of embryonic tissues and organs 
and an increase of 8 to 50% in embryo weight of embryos may 
reach 8 to 50% were observed 114. These problems seems to be 
caused by disturbed expression of imprinted genes due to 
manipulations of gametes and early embryos 115-117. 
This observation suggested that the parental genomes are 
complementary but functionally non-equivalent, despite the fact 
that they have equivalent genetic information 8. This explains why 
both genomes are needed in mammalian development. Indeed as 
described by Surani, although oocytes are potentially totipotent in 
many organisms, this is not so in mammals 103. This is because the 
maternal genome is epigenetically modified in the germ line to 
contain only maternal ‘imprints’, which normally results in 
repression of certain maternally inherited imprinted genes (Figure 
10). A paternal genome is therefore essential to ‘rescue’ the oocyte, 
as the maternal genes are imprinted reciprocally to paternal 
imprints. 
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Figure 10. Imprinted genes are 'marked' in a parental-specific 
way. Primordial germ cells enter the genital ridge of developing 
male and female embryos and all imprinting marks are erased 
(a). Male (top) and female (botton) germ cells grow and develop 
into sperm/oocytes and reintroduction of paternal and maternal-
specific imprints take plays (b). After fertilization, a zygote is 
formed with both genetic and epigenetic (imprinting) 
contributions from the parental genomes (c). (From Surani M.A., 
2002). 
 
 
Convincing evidence of parental imprinting was obtained in mice 
only in the 1980s, when two groups, Surani and his coworkers 
118,119 and McGrath and Solter 120, demonstrated that both 
chromosome sets, maternal and paternal, are essential for the 
normal development of mammals. This explains why in none of 
31 
 
more than 4500 known species of mammals, parthenogenesis has 
been described.  
However,  the possibility of artificial parthenogenetic activation of 
mammalian oocytes lead numerous investigations of genomic 
imprinting using parthenotes as model. These studies began in the 
1930s 121, but only in the 1980s effective methods were found for 
activation 122 and development of parthenogenetic embryos to the 
somite stages 123.  
At present it is well known that imprinting has two major effects 
on parthenotes. Firstly, imprinting alteration affects 
parthenogenetic cell growth in the fetus and post-natally 124. 
Secondly, it causes a restriction of cell lineages in which 
parthenogenetic cells can participate. During embryo 
development, in fact, the dramatic consequences of genomic 
imprinting have been clearly demonstrated by failure of 
parthenotes to give raise to their trophectoderm and primitive 
endoderm, which results in failure of the extra-embryonic tissues 
(especially placental tissue, 125) in parthenogenetic conceptuses 118. 
Indeed mammalian parthenogenetic embryos can develop 
normally up to the 40-somite stage 126,127, but they are unable to 
develop to term and die shortly after this stage, as showed in 
Table 3. In the mouse, for example, the most advanced 
parthenotes survive to the early limb bud stage, have little extra-
embryonic tissue and almost no trophoblast 128.  
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Species Maximum 
development (days) 
Pregnancy 
length (days) 
Reference 
Mouse 10 21 Surani et al. 1986 
Rabbit 10-11 31 Ozil 1990 
Pig 29 114 Kure-bayashi et al. 
2000 
Sheep 25 150 Loi et al. 1998 
Bovine 48 280 Fukui et al. 1992 
Marmoset 
monkey 
10-12 144 Marshall et al. 
1998 
 
Table 3. Summary of maximum development of mammalian 
pathenotes and length of normal pregnancy. 
 
 
At present, approximately 50–100 imprinted genes have been 
identified in the mouse and human genomes. These display a vast 
range of functions, ranging from splicing factors, such as Snrpn 129, 
to growth factors, such as insulin (Ins1 and Ins2 ), Igf-2 130,131, Igf2r 
132, to genes that are functional as RNAs, such as H-19 133 and Xist 
(reviewed by Bartolomei 134).  
Since both parental genomes are needed for generating a 
functional genome, it comes as a consequence that 
parthenogenetic blastocyst-like structures do not possess a 
functional genome that can be considered distinctive of a human 
embryo. Their genome is in reality constituted by a double set of 
an epigenetically imprinted female gamete genome and should be 
more correctly considered unfertilized eggs that have been 
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activated to initiate cell division. Since they are able to undergo a 
few cycles of cell division during the last years parthenogenetic 
blastocysts have been considered as a possible ethically acceptable 
source for human pluripotent cells. 
 
1.3.4 In vitro animal parthenogenesis 
The first paper describing the obtainment of a mammalian 
parthenote was published in 1936 by Gregory Goodwin Pincus, 
who successfully induced parthenogenesis in a rabbit 121. During 
the following years this approach was applied to other 
mammalian species such as rat 135, mouse 136, ferret 137,138 and 
hamster 139. A significant milestone in reproductive science has 
been achieved by Kono et al. with the birth of the first viable 
parthenogenetic mouse 140. Using gene targeting, they were able to 
manipulate two imprinted loci H19/IGF2 and DLK1/MEG3 to 
produce bi-maternal mice at high frequency 141. Pups were 
obtained at day 19.5 of gestation, showing that fatherless mice 
have enhanced longevity 142. This work further expands what is 
achievable in artificial reproduction and may have important 
implications for understanding aspects of embryonic development 
and gene regulation.  
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At present parthenogenetic activation in no-rodent species is used 
for the derivation of embryonic stem cell lines (Table 4) or for  
biological studies.   
 
 
Specie Refecences 
No-human 
primates 
Vrana KE et al., 2003; 
Wei Q et al., 2011. 
Pig Brevini TA et al., 2007; 
Brevini TA et al., 2010. 
Cow Talbot NC et al., 2004; 
Talbot NC et al., 2007; 
Pashaiasl M et al., 2010. 
Buffalo Sritanaudomchai H et al., 2007. 
Rabbit 
Fang ZF, et al., 2006; 
Wang S et al., 2007; 
Hsieh YC et al., 2011. 
 
Table 4. Parthenogenetic embryonic stem cell lines derived in 
non-rodent species. 
 
 
1.3.5 In vitro human parthenogenesis 
Data from the literature show that human oocytes can be 
successfully activated but often parthenogenetic development 
does not proceed beyond the eight-cell stage 143-148 149-152. 
Development of human parthenotes to the blastocyst stage has 
been reported only recently 109,153,154. This achievement, together 
with the establishment of parthenogenetic stem cells in non-
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human primates 155, stimulated new interest in human 
parthenogenesis because it could eliminate the requirement to 
produce or disaggregate normal competent human embryos for 
deriving pluripotent cell lines in vitro 153,156,157. 
Data reported in the literature showed that a combination of 
ionomycin and 6-DMAP constantly enabled the development of 
parthenotes to the blastocyst stage 108. This Ca2+ ionophore is able 
to induce one prolonged calcium peak that releases oocytes from 
metaphase arrest and then maturation-promoting factor quickly 
rises again and further development is arrested. The subsequent 
addition of 6-DMAP, which inhibits the reactivation of 
maturation-promoting factor following kinetics similar to those 
occurring after fertilization, leads to high in vitro development 
rates also in the human, confirming the results obtained in several 
other species including cattle 158, sheep 159, rhesus monkeys 160, 
rabbits 161 and pigs 162. 
 
1.3.6 Ploidy of parthenogenetic embryos 
Karyotype analysis has often been utilized to determine the 
normality of in vitro-produced embryos 163,164. This investigation 
was carried out on parthenogenetic embryos in order to verify 
their ploidy. First studies performed in mice demonstrated that 
most of parthenotes displayed diploid chromosomal phenotypes 
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87,105,123,165. This high frequency of diploid chromosomal 
complements may be related to the maternal inheritance of 
centrosomes in this specie (see below paragraphs 1.4.3 and 1.4.4). 
Indeed, when parthenogenesis were applied on other mammalian 
specie, many chromosomal alterations were identified.  
Winger et al. demonstrated that diploid bovine parthenotes 
arising from the application of standard procedures (ethanol or 
ionomycin activations following by cytochalasin D or 6-DMAP 
treatements) were a minority, while the majority of 
parthenogenetic embryo displayed polyploid and mixoploid 
chromosomal complements 166. These results are in agreement 
with other studies revealing a greater incidence of chromosomal 
abnormalities as assessed by haploidy, mixoploidy and 
polyploidy in in vitro 167-169 or in spontaneously activated cattle 
embryos 170. The same data were reported in porcine species 
activated by electric stimulation followed by cytochalasin B 
treatment 171 and in human puromycin or spontaneously activated 
oocytes 172-174.  
The events contributing to these abnormal chromosomal 
complements seems to occur as early as completion of the first cell 
cycle 166. As reported below (paragraphs 1.4.3 and 1.4.4), several 
studies demonstrated that the spermatozoa introduce the 
centrosome during fertilization in both bovine and human 99,175-177 
species as well as in porcine one 178. This complex mechanisms 
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may be the possible link between ploidy alterations and 
parthenogenesis. 
 
1.4 Centrosome 
One important aspect that may lead to abnormalities in 
parthenogenesis is the centrosome organization.  
 
1.4.1 Centrosome and its function 
The centrosome, approximately 1 µm in size, is a non membrane-
bound cytoplasmatic organelle composed by a protein complexes 
in animal cells. Its duplication occurs in a semi-conservative 
manner with each centrosome receiving one old preexisting 
“maternal” centrioles and one new. It is a no static structure, since 
it changes shape and components throughout the cell cycle 179 and 
has several functions summarized in Table 5. In particular, the 
main function of centrosome is the organization of both 
interphase microtubule arrays responsible for cell polarity and of 
the mitotic spindle, which mediates bipolar separation of 
chromosomes. Indeed centrosomes are closely associated with the 
nucleus during interphase and undergo cell cycle-specific 
reorganizations during mitosis. In addition it is also implicated in 
numerous other cellular functions such as reported in table 6 
(reviewed by Kimble M. and Kuriyama R. 180 and Rose M.D.181) 
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and impacts cellular processes such as entry into mitosis, 
cytokinesis, Gl/S transition and monitoring of DNA damage. 
 
 
 
Function Responsible element 
Intrinsic 
Reproducing element Unknown 
Microtubule organizer Unknown γ-tubulin binding 
protein 
Microtubule nucleation 
peripheral 
γ-tubulin 
Peripheral 
Nuclear association Gene products 
Configurational alterations Affected and effected by MTs and 
MFs 
Centrosome destruction Absence of duplication of 
reproducing elements 
Cell’s pacemaker: orchestrator of 
the cell cycle’s regulation 
Arrangement of kinase, cyclins 
and phosphatises 
Centriole assembly and axoneme 
excision 
Involves centrin and microtubule 
assembly 
Cell body organizer Perhaps derived from 
microtubules 
 
Table 5. Summary of centrosome functions. 
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Each mammalian somatic cell typically contains one centrosome, 
which must double at each cell cycle and divide between the two 
daughter cell at each cell division, like chromosomes and 
cytoplasm (Figure 11). The centrosome duplicate during 
interphase, at S phase, in coordination with maximum DNA 
decondensetion and subsequent replication (Figure 11). After 
duplication the two separated centrosomes undergo a maturation 
process and move to opposite sides of the nucleus.  During cell 
division, centrosomes form the poles of the bipolar mitotic 
spindle. After anaphase and telophase, centrosomes become 
separated into two daughter cells (Figure 11).  
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Figure 11. The centrosome cycle. At the beginning of G1 phase, 
cells contain a single centrosome with two perpendicularly 
aligned, closely associated centrioles. During G1 phase, the tight 
link (purple bar) between the centrioles is dissolved (centriole 
disengagement), but centrioles remain connected by a loose 
fibrous structure. In S phase, the centrosome duplicates 
simultaneously with DNA replication. Duplication involves the 
assembly of two new centrioles perpendicular to the existing 
centrioles. In late G2 phase, the two centrosomes undergo 
maturation by recruiting additional PCM (grey circle) 
components to prepare for their role as spindle poles. The 
centrosomes then separate and move to the opposite side of the 
nucleus. After chromosome segregation in anaphase and 
telophase, two new daughter cells are produced, each with one 
centrosome associated with the nucleus. (From Barr A.R. and 
Gergely F., 2007). 
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1.4.2 Centrosome molecular composition 
Centrosome  consists of a pair of orthogonally arranged cylinder-
shaped centrioles surrounded by an amorphous matrix of electron 
dense proteins referred to as pericentriolar material (PCM Figure 
12).  
 
 
Figure 12. Centrosome structure. The centrosome is composed of 
two centrioles surrounded by a protein matrix called the 
pericentriolar material (PCM). (From Sun Q.Y and Schatten H., 
2007). 
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Centrioles show the classic 9 + 0 pattern of nine triplet 
microtubule and no central pair of microtubule (Figure 13) and 
contains centrin, cenexin and tektin 182. "The centrosome in 
vertebrates: more than a microtubule-organizing center). In 
particular, centrin is a calcium-sensitive 20-kDa protein with 
contractile properties 183,184 that bind calcium ion transients and 
cause a centrosome shape changes. Centrioles duplication is semi-
conservative, with each daughter cell retaining one of the 
mother’s centrioles and a newly formed daughter centrioles 185.  
 
 
 
 
Figure 13. Centriole structure. Each centriole is made up of nine 
microtubule triplets, which lie evenly spaced in a ring. There 
are no microtubules in the center (9+0 arrangement). 
Transmission electron microscopy image of centrioles 
transverse section (right). 
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The PCM contains a complex meshwork of proteins responsible 
for microtubule nucleation and anchoring 186 including γ-tubulin 
187,188 189,190, pericentrin and ninein. Usually γ-tubulin and centrin 
are two classical markers of the centrosome with specific 
localizations, but the majority of these two proteins (80-90%) are 
not centrosome-associated, while matrix proteins are only 
concentrated at the centrosome with specific localizations 191. 
Pericentrin anchors γ-tubulin complexes at centrosomes in mitotic 
cells, which is required for proper spindle organization. Another 
essential cell cycle-dependent centrosome-associated proteins is 
the nuclear mitotic apparatus protein (NuMA) that is distributed 
to the separating centrosomes during early mitosis. This protein 
ensures the cross-linking of spindle microtubules on the 
centrosome side facing the chromosomes, which is essential for 
the organization and stabilization of spindle poles from early 
mitosis until at least the onset of anaphase. 
 
1.4.3 Centrosome reduction in gametes 
Originally spermatids and primary oocytes display a typical 
centrosome organization with a pair of centrioles surrounded by 
pericentriolar material, in common with somatic cells. This 
somatic cell-like centrosomes undergoes profound modification 
and/or degeneration during the final stages of gametogenesis to 
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meet the specific needs of gamete functions and fertilization. 
Indeed in mammals, with the exception of mouse, spermatozoa 
retain centrioles but lose most of the pericentriolar centrosomal 
proteins, whereas oocytes lose centrioles while retaining a 
stockpile of centrosomal proteins 192. This reciprocal reduction of 
centrosomal constituents makes sperm and oocyte 
complementary to each other and they became able to form a 
functional centrosome in the zygote only after fertilization. 
In rhesus monkey and human, centrosomes are reduced during 
spermiogenesis, but not as completely as in mice (see above). 
Their spermatozoa have proximal centrioles intact (Figure 14), 
whereas the distal centrioles are mostly disorganized or highly 
degenerated together with γ-tubulin and centrosomal proteins 
193,194 (Figure 15). 
 
 
 
 
Figure 14. Proximal and distal centrioles of the human 
spermatozoon. (From Palermo G.D. et al., 1997). 
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In agreement with data reported in primates, previous studies 
demonstrated that boar ejaculated spermatozoa show residual 
centrioles in sperm tail 178 as well as proximal centrioles were 
present in sheep mature male gametes 195,196.  
On the contrary, in mouse, gamete centrosome modifications and 
degenerations is completely different. Centrosome reduction takes 
place during spermatogenesis when it loses the microtubule 
nucleating function, then lose centrosomal proteins and finally 
lose centrioles (Figure 15). In particular, murine microtubule and 
centrosomal proteins are discarded during spermiation, and the 
distal centriole degenerates during the testicular stage of  
spermiogenesis, while the proximal centriole is lost during the 
epididymal stage 197,198.  
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Figure 15. Centrosome reduction during spermiogenesis. The 
male germ cells possess intact centrosomes containing centrioles 
and centrosomal proteins until the round spermatid stage (A). 
The microtubules of the distal centriole extend as axoneme of 
the spermatid tail (B). During spermiation, γ-tubulin and other 
centrosomal proteins are disjuncted from the centrioles and 
discarded with the residual bodies (B). The centrioles are 
degenerated to various extents in spermatozoa of different 
species. Rodent and snail spermatozoa lose both centrioles 
completely (C), whereas primate spermatozoa retain proximal 
centrioles intact but degenerate distal centrioles partially (D). 
Xenopus and Drosophila spermatozoa possess both centrioles 
intact (E). (From Manandhar G. et al., 2005). 
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Contrary to spermatogenesis, centrioles disappear from the oocyte 
during early oogenesis. In particular, oogonia and fetal oocytes 
display normal centrioles until pachytene stage, while these 
organelles are absent in the mature oocytes 199. This degenerative 
process has been demonstrated in rhesus monkeys 200, rabbits 201, 
sea urchins 202, Xenopus 203 and many other species 204 including 
sheep 195,196, cow 99,205 and pig 178, while there is no experimental 
evidence of centriole degeneration in mouse oogenesis 206 (Figure 
16). 
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Figure 16. Centrosome reduction during oogenesis. The oogonia 
possess standard centrosomes containing centrioles and 
centrosomal proteins (A). The centrioles are either retained or 
degenerated during meiotic arrest in different animal oocytes. 
Mammalian primary oocytes lose both centrioles completely (B) 
resulting in acentriolar and anastral poles during meiotic I and 
II divisions (E). The pericentriolar centrosomal proteins are 
dispersed in the oocyte cytoplasm during non-dividing stage (B) 
or distributed as concentric poles of the barrel-shaped spindles 
during dividing stages (E). In snail primary oocytes, the 
centrioles are retained, but they do not replicate during the 
meiotic arrest (C) and the mature eggs are without centriole (F). 
In starfish primary oocytes the centrioles duplicate only one 
time during the dictyate stage producing four centrioles before 
beginning the dividing stage (D) and at the end of meiosis the 
mature eggs retain one centriole from the inner pole (G). (From 
Manandhar G. et al., 2005). 
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1.4.4  Centrosome restoration after fertilization 
At fertilization, sperm and egg equally contribute haploid 
genomes as well as the relative centrosome components. Since in 
mammals, with the exception of mouse, centrosome of MII oocyte 
is greatly reduced/inactivated and centrioles are absent, early 
embryo development requires maternal and paternal contribution 
and, in particular, needs their elements to restore normal and 
functional centrosomal structure.  
In fact, while in mouse there is no evidence of a functional 
centrioles in the sperm and they are maternally inherited, in the 
human and other mammalian species, the spermatozoa contribute 
the proximal centriole during fertilization (Figure 17).   
In agreement with this, in mammalian species, whit the exception 
of mouse, sperm tail and its centriole-harboring connecting piece 
are incorporated into the ooplasm together with the sperm head. 
In the human after insemination, sperm head decondenses in the 
ooplasm and the proximal centriole remains intact forming the 
sperm aster sited around the male pronucleous subjacent to 
oocyte cortex. On the contrary, most sperm cytoplasmic structures 
including mitochondria, fibrous sheath, microtubule doublets, 
outer dense fibers and the striated columns of the connecting 
piece are discarded in a programmed order 207. Sperm aster 
enlarges as male pronucleous decondenses and moves in 
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cytoplasm, ensuring male and female pronuclei apposition and 
formation of a single mitotic metaphase plate with a bipolar 
spindle. The human sperm centriole duplicates during the 
pronuclear stage, and at syngamy, one or two centrioles are 
located at opposite poles of the first mitotic spindle 208,209 together 
with a surrounding halo of electron-dense PCM that nucleates 
microtubules 207. The mitotic spindle is fusiform and is generally 
almost centrally located 209,210, having never been identified in the 
cytocortex. In human embryos, centrioles were detected from the 
one-cell to the eight-cell stages of embryonic cleavage, and even in 
the hatching blastocyst 209. Thus, the zygote centrosomes are 
ancestors of centrosomes in embryonic, fetal and adult somatic 
cells 209,211. The same process were described in sheep, where 20 
hours after insemination are detectable one bipolar spindle 
displaying two centrioles at the opposite pole (first embryo 
mitosis) 195. 
On the contrary, recent study by Manandhar et al. revealed that in 
the pig sperm centrioles are lost in zygote after in vitro fertilization 
and they are not detectable until the late blastocysts stage. 
Accordingly, the early pre-implantation cleavages show broad 
and anastral spindle poles, while only blastomers of the hached 
blastocysts developed centrioles comparable with those of culture 
cells 178. 
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Figure 17. Centrosome inheritance in non-rodent mammalian 
specie. Meiotic spindle during the extrusion of the first polar 
body (a).  Meiotic spindle for the extrusion of the second polar 
body (b). Sperm before fertilization contains a proximal 
centriole, while  MII oocyte show a meiotic spindle with 
acentriolar centrosomes. Sperm proximal centriole–centrosome 
complex form the aster and, after pronuclear apposition, 
centriole replicate. At syngamy, duplicated centriole–
centrosome complex migrates around the zygote nucleus, it 
relocates to opposite poles to form the centers of the mitotic 
spindle poles and drives first embryo mitotis (b). (From Palermo 
G.D. et al., 1997). 
 
 
It is easy to understand that sperm centrosome has important 
implications in human infertility, and it has been demonstrated 
that sperm centrosomal dysfunctions lead to aberrant embryonic 
development 211,212. This has been also proven in a 
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globozoospermic patient, though an attempt to restore defective 
sperm centrosomal function has been performed, without 
success213,214. 
 
1.4.5 Centrosome and parthenogenesis 
As described above (paragraph 1.3) unfertilized oocytes can be 
activated by various physical or chemical stimuli and their female 
haploid genome can be diploidized, but the embryonic 
development does not proceed to term. To understand this 
process it is important to consider that centrosomal material of 
MII oocyte does not organize into unified foci and is not capable 
to generate astral microtubules nor a correctly oriented spindle in 
the absence of centrioles 215. Accordingly previous studies carried 
out in Xenopus showed that microinjected exogenous centrosomes 
can function as zygotic centrosomes and induce successful 
parthenogenesis. It was shown that the centrosomes from various 
cell types are capable of inducing parthenogenesis 216-218 in case 
they contain intact and replication-competent centrioles 219,220. 
These observations imply that the oocyte centrosome reduction 
has evolved as a control mechanism to suppress parthenogenetic 
development. Due to the loss of functional autonomy, the oocyte 
centrosome cannot initiate or successfully complete normal 
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embryonic cleavages without being supplemented by a fertilizing 
spermatozoon.  
Yet many insect species are obligatory or facultative parthenotes 
221. Indeed in lower specie successful parthenogenesis depends 
upon the oocyte’s ability to generate complete and functional 
centrosomes in the absence of male gamete. In sea urchin and 
insects, for instance, parthenogenetically activated eggs generate 
multiple cytoplasmic asters, containing centrosomal proteins and 
centriole, possibly due to the absence of a correct control along the 
process of spindle formation 222,223. Two of the multiple astral 
centrosomes become associated with the female pronucleus and 
form the mitotic spindle, whereas the others degenerate. 
Furthermore in some stick insect species, spermatozoa do not 
contribute centrioles, so eggs replenish all of the components of 
the zygotic centrosome.  
Currently there are only a few data in the literature about mitotic 
spindle organization and parthenogenesis in mammals. Mouse 
oocytes do not receive centrosomes from spermatozoa, yet they do 
not develop through parthenogenesis. Probably this block is due 
to another control strategy present in eutherian mammals linked 
to imprinting 179 (paragraph 1.3.3). All these processes suggest us 
to study centrosomal organization in parthenogenetic cells, 
comparing these with their bi-parental counterpart. 
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1.4.6 Centrosome alterations and chromosomal instability 
Recent studies have shown that several factors like abnormal 
kinetochore–spindle interactions, premature chromatid 
separation, centrosome amplification, multipolar spindles and 
abnormal cytokinesis can result in chromosomal segregation 
defects 224. 
Usually chromosomal alterations and karyotypic instability are in 
relation with tumors. Malignant formations were studied in depth 
the past century. In 1929 Theodor Boveri, in fact,  while studying 
chromosomal segregation in Ascaris worms and Paracentrotus sea 
urchins, suggested that malignant tumors arise from a single cell 
with an abnormal genetic constitution acquired as a result of 
defects in the mitotic spindle apparatus 225.  He was right, the best 
explanation today is that numerical chromosomal instability 
appears to arise as a result of chromosome segregational defects 
226-229, most frequently resulting from multipolar spindles. 
Structural chromosomal instability results from chromosome 
breakage and rearrangement due to defects in cell cycle 
checkpoints, the DNA damage response and/or loss of telomere 
integrity 230. Structural chromosomal instability frequently results 
from breakage-fusion-bridge (BFB) cycles, first described in maize 
by geneticist Barbara McClintock in 1938 231. In this process, a 
chromatid break occurs, exposing an unprotected chromosomal 
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end which, after replication, is thought to fuse with either another 
broken chromatid or its sister chromatid to produce a dicentric 
chromosome. During the anaphase stage of mitosis, the two 
centromeres are pulled to opposite poles, forming a bridge which 
breaks, resulting in more unprotected chromosomal ends, and 
thus the cycle continues 232. 
Since we hypothesized that parthenogenetic cells posses 
centrosome alterations and multipolar spindle formations (Figure 
18) we carried out a comparative analysis between 
parthenogenetic versus bi-parental cell line chromosomal 
assessment. 
 
 
 
Figure 18. Normal centrosome organization ensure timely and 
controlled switching between symmetric and asymmetric cell 
division, resulting in correct chromosome segregation (A). 
Supernumerary centrioles are sufficient to cause chromosome 
malsegregation (B). (From Brevini T.A.L. et al., 2011). 
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Multiple chromosome malsegregations have been previously 
described in human oocytes after parthenogenetic activation, 
either spontaneous or induced by puromycin 173. Consistent with 
this, a high incidence of polyploid and mixoploid chromosomal 
complements has been reported in parthenotes derived from 
bovine and porcine activated oocytes, with abnormal 
chromosomal complements occurring as early as completion of 
the first cell cycle 166,233. 
Generally in all mammalian parthenotes, with the exception of 
mouse, the lack of paternal contribution to the centrosome is 
considered the most likely cause of such a high rate of aneuploidy. 
Furthermore since mammalian parthenote are able to achieve the 
40-somite stage 126,127, it appears that centriole abnormalities does 
not limit cell proliferation, self-renewal and correct differentiation 
into a variety of tissues, indicating that the requirement of a 
paternal centrosome described in lower animals appears to be less 
stringent in mammalian cells. One explanation for this may be 
found in the hypothesis that genomic imprinting may represent 
the main mechanism that ensure bi-parental fertilization in higher 
mammals 179,234.  
On the other hand, the link between the high percentage of 
parthenogenetic cells showing chromosome number alteration 
and mono-parental cell ability to proliferate is puzling.  
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1.4.7 Mitotic spindle defects and protein alterations  
Several centrosomal proteins are closely related to centrosome 
organization and studies of their expression level alterations are 
often used to understand or confirm cell centrosome defects. In 
the studies described below in this thesis many protein related to 
spindle formation/organization and mitotic check point were also 
investigated in order to verify the alterations resulted by 
morphological or immunocitochemical analysis.  
One family of proteins analyzed and that plays an important role 
in regulating centrosome function, bipolar spindle assembly, 
chromosome segregation and cytokinesis is the Aurora kinases 
235,236 (Figure 19). The three members of the Aurora kinase family 
in mammals, Aurora kinases A/B/C (AURKA, AURKB and 
AURKC), are usually overexpressed in cancer cells and many 
studies were carried out on these cell type in order to characterize 
these kinases.  
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Figure 19. From G2 phase of the cell cycle to metaphase of 
mitosis polo-like kinase 1 (PLK1; green) and aurora kinase A 
(also known as STK6; purple) co-localize at the centrosomes, but 
in contrast to aurora kinase A, PLK1 also localizes to 
kinetochores in prometaphase and metaphase. Aurora kinase B 
(also known as STK12; red), however, is not present on 
centrosomes and is first detected on chromatin in late G2. In 
prophase, aurora kinase B localizes to the chromosome arms and 
inner centromere, and in prometaphase and metaphase it 
localizes only to the inner centromere. In anaphase and 
telophase aurora kinase B co-localizes with PLK1 on the central 
spindle, cortex and midbody to regulate cytokinesis. Although 
aurora kinase A is degraded in anaphase and telophase a small 
proportion of the kinase is also associated with the central 
spindle and midbody; however, the exact function of aurora 
kinase A at this location is unclear. Crosstalk between aurora 
kinases and PLK1 is described in the blue boxes. 
 
 
AURKA is localized in the centrosome from the time of  
duplication until the end of mitosis. Its overexpression has been 
associated with centrosome amplification and multipolar spindles. 
Indeed recent study by Anand et al. showed that AURKA 
overexpression, overrides the spindle assembly checkpoint, 
resulting in arrested mitosis with incomplete cytokinesis, leading 
to multinucleation 237.  
AURKB is associated with the proteins, survivin and the inner 
centromere protein (INCENP). It is located in heterochromatin in 
early mitosis, in central spindle during anaphase, in cell cortex 
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when the contractile ring forms and then in midbody during 
cytokinesis. Studies by Hauf and colleagues demonstrated that 
this protein is involved in destabilization of improper microtubule 
attachments and also plays a role in maintaining the spindle 
assembly checkpoint 238. Further RNA interference experiments 
showed that AURKB absence induces alterations of function and 
localization of the spindle checkpoint components, namely 
budding uninhibited by benzimidazoles 1 homolog beta 
(BUBR1/BUB1B), mitotic arrest deficient-like 2 (MAD2) and 
centrosome-linker motor protein (CENPE) 239 resulting in 
misaligned chromosomes, syntelic attachments of chromosomes 
to the spindle poles (in which both chromatids are attached to the 
same pole), cell division failure, and endoreduplication.  
The last Aurora kinase, not studied in the thesis, AURKC, 
localizes to the centrosome from anaphase to telophase. It is 
essential for mitosis, but little has been published about its exact 
function and its substrates.  
Another important protein family required for mitotic spindle 
assembly and function is polo -like kinase (PLK). 
The first polo kinase was originally identified in a Drosphila 
mutants that display abnormal mitotic spindle organization 240. 
Subsequently, potential homologues of Drosophila polo have been 
identified in yeasts and in mammals. Currently, the conserved 
family of PLKs consists of many members throughout various 
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species. Multiple PLKs are present in mammalian cells (PLK1, 
PLK2/SNK, PLK3/FNK/PRK, and PLK4/SAK) and the available 
data are consistent with the idea that these may also act earlier in 
the cell cycle, possibly during G1. If this hypothesis is correct, 
different members of the polo-like kinase family would act at 
several points during the cell cycle. 
In this thesis particular attention was given to PLK2. It display a 
broad tissue distribution 241 and plays important roles in 
regulating cell proliferation in G1 and early S phases (Figure 20), a 
time when both PLK2 mRNA and protein levels peak 242,243. 
Overexpression and depletion of PLK2 lead to an increase and 
decrease of centrosome numbers, respectively, indicating that it is 
fundamental for  controlled centriole duplication during S 
phase244.  
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Figure 20. PLK2 control the centriole cycle in a close association 
with the cell cycle. PLK2 phosphorylation is important for the 
function of CPAP in procentriole formation at G1/S transition 
phase. The phosphorylated CPAP (red dots) is located at the 
proximal end of the procentriole. CPAP is dephosphorylated by 
an unknown phosphatase once the cell enters anaphase (blank 
dots). (From Chang J et al., 2010). 
 
 
 
 
Other molecules analyzed in this thesis are TTK protein kinase 
(TTK), BUB1, CENPE 245 and mitotic arrest deficient-like 1 (MAD1) 
(Figure 21).  
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Figure 21. Proposed schematic diagram of the spindle 
checkpoint cascade. (From Vigneron S. et al., 2004). 
 
 
All these proteins are normally involved in kinetochore-
microtubule binding, correct chromosome congression and 
alignment as well as segregation during mitosis. In particular, 
studies by Abrieu showed that disruption of BUB1 and CENPE 
caused a reduction of tension across the centromere, an increase of 
incidence of spindle pole fragmentation and resulted in mono-
oriented chromosomes approaching abnormally close to the 
spindle pole, with a mixture of aligned and unaligned 
chromosomes 246. Moreover, usually the final result of CENPE 
inhibition is mitotic arrest, initiation of apoptosis and cell death 
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and this effect is more likely to affect rapidly dividing cancer cells. 
However redundant mechanisms have been described in 
mammalian cells to enable kinetochore microtubule binding and 
checkpoint monitoring in the absence of CENPE, although with 
poor positioning at the spindle poles and chronically 
monooriented chromosomes 247.  
Another central component of the spindle assembly checkpoint 
and recruitment of kinetochores is MAD1 248-250. Deregulation of its 
expression has been shown to affect cell cycle progression and, in 
particular, the increase of its levels causes a reduction in the 
expression of v-myc myelocytomatosis viral oncogene homolog 
(MYC) in human monoblasts where a decrement of cell 
proliferation with a protracted G1 phase was observed 251.  
A further molecule only recently identify as implicated in 
centrosome replication control and examined in this thesis is the 
Cyclin F (CCNF). Indeed, D'Angiolella et al. showed that siRNA 
mediated depletion of CCNF in HeLa cells induces centrosomal 
and mitotic abnormalities, including multipolar spindles and/or 
asymmetric bipolar spindles with lagging chromosomes 252 
(Figure 22). 
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Figure 22. Cells transfected with siRNAs to Cyclin F show 
centrosome alterations (a) and form multipolar spindle (b). 
(From D’Angiolella V. et al., 2010). 
 
 
1.5 Human parthenogenesis and parthenogenetic stem cells 
Since it is possible to derive parthenogenetic embryos from 
supernumerary human oocytes, as described above (paragraph 
1.3.5) recent studies also demonstrated that these embryo-like 
structures can be used in order to isolate pluripotent cells. First 
attempts at this have described low attachment of parthenogenetic 
embryos to feeder cells and arrest of proliferation after few cell 
divisions 109. Only in the last few years several paper reported the 
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obtainment of parthenogenetic stem cells, displaying 
characteristics in common with their bi-parental counterpart 253-257. 
In our laboratory we developed a protocol for isolation of ICMs 
from human parthenogenetic blastocyst-like structures. 
Parthenotes were subjected to enzymatic digestion with pronase 
in order to remove zonae pellucidae and ICM cells were separated 
from trophectoderm with microsurgical tecnique. These were 
plated of inactivated feeder layer and cultured as described by 
Brevini et al, 2009. Currently, these lines have been growing for 
over 4 years and possess most of the main features of bi-parental 
stem cells. In particular, as reported in our paper 257 (see Appendix 
A), these cells show the typical ESC morphology, express 
appropriate stem cell markers such as OCT4, NANOG, REX1, 
SOX2, alkaline phosphatise (AP), SSEA-4, TRA 1-81, and lack of 
the human ESC negative markers (e.g. SSEA-1). Furthermore our 
parthenogenetic cell lines also possess high levels of telomerase 
activity, which is turned down when cells are subjected to culture 
conditions that induce their differentiation, indicating that a 
physiologically normal control of telomerase activity is present. 
In vitro differentiation potential of these cells was assessed and the 
results obtained demonstrated the ability of these cells to 
differentiate and give rise to components belonging to the three 
embryonic germ layers, while no expression of trophectoderm-
related markers was detected, possibly reflecting parthenote 
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inability to generate adequate fetal membrane development and 
to implant correctly. Moreover, also driven differentiation, using 
controlled culture conditions, were tested on the cells. Data 
obtained in our laboratory demonstrate that parthenogenetic cells 
are able to differentiate and to form different cell subtypes 
belonging to the neural and hemopoietic lineage, not only giving 
rise to early cell population, but also generating more mature cell 
types expressing nestin, CNPase and MAP2 or showing 
lymphoid, erythroid and myeloid morphology, respectively. 
Altogether these findings  indicate that, outside the normal 
developmental paradigm, the differentiation potential of 
uniparental cells may be much less restricted than that of 
parthenogenetic cells in chimeras.  
However, injection of our human parthenogenetic cells in 
immunodeficient SCID mice gave rise to poor differentiation or in 
the formation of myofibrosarcomas. This suggests the possibility 
of an intrinsic deregulation of the mechanisms controlling the 
choice between proliferation and differentiation in embryonic 
stem cells obtained through parthenogenesis. Interestingly, this 
deregulated differentiation appears to be modulated by the 
microenvironment and, while undetectable, or repressed, when 
cells were differentiated in vitro, it became evident once cells were 
exposed to the less restrained in vivo milieu. Moreover we 
observed the presence of extranumerary centrioles and aberrant 
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ploidy. This is consistent with the high incidence of polyploid and 
mixoploid chromosomal complements reported in parthenotes 
derived from different species, including bovine, porcine and 
human, as described above (see paragraph 1.3.6). 
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2.AIM 
As described above human parthenogenetic ESCs possess most of 
the main features of their bi-parental counterpart, including 
indefinite proliferation and in vitro differentiation abilities (see 
Introduction 1.5 paragraph and Appendix A). At the same time 
we also observed the presence of severe chromosomes 
abnormalities and extranumerary centrosomes.  
We considered to be of biological interest to elucidate the origin of 
these discrepancies. To this purpose we performed a detailed 
characterization of parthenogenetic cell line specific properties 
and their differences with bi-parental ESCs.  
 
Specific aims of this thesis were: 
1. to investigate the mechanisms responsible for the severe 
anomalies observed in parthenogenetic cell lines; 
2. to understand which adaptive mechanisms are active in 
parthenogenetic cells, allowing them to normally proliferate 
and differentiate despite the abnormalities.  
 
To these purposes direct comparative studies were carried out on 
parthenogenetic and bi-parental human cell lines as well as on 
those obtained from animal models.  
In particular we used pig and sheep because their parthenogenetic 
mechanisms are more similar to those of the human than mouse. 
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As described above (see paragraph 1.4.4), in fact, in the human 
and other mammalian species, the spermatozoa contribute the 
proximal centriole during fertilization, while in murine species 
functional centrioles are maternally inherited. 
In the first set of the experiments we analysed if chromosome 
alterations are related to the use of human oocytes and the 
relatively old age of donors. It is well known, in fact, that 
advanced maternal age,  as well as the interference of ovarian 
hyperstimulation with the natural selection of good-quality 258,259, 
are clear risk factors for chromosomal aneuploidy and mosaicism 
in the human embryo 260-264. In this case we used the pig because 
oocytes can be retrieved from individual just after puberty, the 
age of maximal reproductive fitness in this species. 
Furthermore we examined if the sever anomalies found in human 
parthenogenetic cells are caused by the derivation protocol and/or 
the culture conditions used in the experiments. To this end we 
transferred sheep parthenotes into synchronized recipients shortly 
after oocyte activation. Embryos were allowed to grow for 21 days 
and fibroblast cell lines were established and analysed. 
In the second set of experiments reported in this thesis we 
investigated how such abnormal cells could survive, proliferate 
and correctly differentiate in vitro, instead of undergoing 
apoptosis as expected. 
71 
 
To this purpose we investigated the apoptotic mechanisms, the 
incidence of autophagy and the occurrence of special form of 
intercellular comunications. 
72 
 
3. MATERIALS AND METHODS  
Unless otherwise indicated, chemicals were purchased from 
Sigma- Aldrich (Italy). 
 
3.1 Human cell lines 
The experiments performed in the human species were carried out 
on two parthenogenetic pluripotent cell lines previously obtained 
in our laboratory 257 (Appendix A). The bi-parental cell lines used 
as bi-parental counterpart were: HUES13 (generated in the Melton 
lab and used with permission),  HES 7, HES I-3 and HES I-6 
thanks to a collaboration with the group of Prof. Benvenisty N. of 
The Alexander Silberman Institute of Life Sciences of The Hebrew 
University of Jerusalem.   
 
3.1.1 Human parthenogenetic cell line culture 
Human isolated ICMs were cultured on feeder cells in human 
embryonic stem cell medium composed by Dulbecco's modified 
Eagle's medium, without pyruvate, high glucose formulation 
(Gibco, Italy) and supplemented with 10% Knock-out serum 
replacer (Gibco, Italy), 5% FBS (Gibco, Italy), 1 mM glutamine, 
0.1 mM β-mercaptoethanol, 5 ng/ml human recombinant basic 
Fibroblast Growth Factor (bFGF; R&D System, USA) and 1% 
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nonessential amino acid stock (Gibco, Italy) as described by 
Brevini et al. 257.  
 
3.2 Parthenogenetic activation 
3.2.1 Porcine oocytes collection, in vitro maturation, activation 
and culture 
Porcine ovaries were collected from gilts of approximately 120 Kg 
at the local abattoir and transported to the laboratory in 
physiological saline (9g/l NaCl) at 30-34°C. Cumulus-oocyte 
complexes (COCs) were aspirated from antral follicles with an 18-
gauge needle and vacuum pressure of 50 ml/min. The follicle 
aspirate was collected in 15 ml tubes (Terumo, VenoSafeTM) and 
only COCs with a large, compact cumulus and homogeneous 
oocyte cytoplasm were selected for the in vitro maturation (IVM).  
For parthenogenetic activation studies, IVM was performed on a 
total of 1221 oocytes as previously described by Grupen et al. 265 
with minor modifications. COCs were cultured for 22 hours at 
38.5°C in an atmosphere of 5% CO2 in TCM-199 supplemented 
with 25% porcine follicular fluid, 1.1 mg/ml sodium bicarbonate, 
0.1 mg/ml sodium pyruvate, 0.5 mM cysteamin, 8.2 μg/ml insulin, 
10 ng/ml epidermal growth factor, 1 mM dibutryl cAMP, 0.5 
IU/ml porcine FSH:LH (Pluset; Serono, Rome, Italy), 1.0 μg/ml 17 
β-estradiol, 75 μg/ml penicillin and 50 μg/ml streptomycin (199-
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IVM). After 22 hours COCs were washed in fresh medium and 
matured for an additional 24 hours in the same medium without 
dibutryl cAMP.  
At the end of IVM (46 hours), oocytes were denuded by gently 
pipetting in TCM-199 HEPES buffered medium, containing 0.1% 
hyaluronidase at 38.5°C, washed for 10 min in the same medium 
supplemented with 20% (v/v) fetal calf serum (FCS, Gibco, Italy) 
and incubated in Tyrode’s albumin lactate pyruvate medium 
(TALP for activation, see Table 6) for 30 min at 38.5°C. 
Parthenogenetic activation was performed according to the 
method described by Brevini et al. by sequentially exposing the 
oocytes to 5 mM ionomycin in TALP for 5 min at 38.5°C in the 
dark and to 2 mM 6-DMAP in medium NCSU-23 (see Table 7) for 
3 h at 38.5°C in an atmosphere of 5% CO2, 5% O2, and 90% N2 266. 
Presumptive parthenotes were washed thoroughly in NCSU-23 
and cultured in groups of 25–35 in 50 µl NCSU-23 drops under 
mineral oil at 38.5°C in 5% O2, 5% CO2 and 90% N2 atmosphere. 
On day 5 post-activation, half of the medium was replaced with 
fresh NCSU-23 containing 20% (v/v) FCS to reach a final FCS 
concentration of 10% (v/v) in the in vitro culture drop. On day 6/7 
IVF blastocysts were obtained and ICMs were islated for culture. 
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TALP medium for activation 
Penicillin G 0,21 mM 
Streptomycin 0,07 mM 
Red Phenol 0,027 mM 
D-Glucose 5,00 mM 
NaCl 114,00 mM 
KCl 3,16 mM 
MgCl2.6H2O 0,50 mM 
NaH2PO4 anhydrous 0,35 mM 
NaHCO3 25,00 mM 
CaCl2.2H2O 4,72 mM 
Na- lactate syrup 10 mM 
Na-pyruvate 0,10 mM 
Ca-lactate 3,00 mM 
Caffeine Na-benzoate 50:50 2,00 mM 
Bovine Serum Albumin (BSA) 4 mg/ml 
pH: 7.6   OSM: 309 
 
Table 6. Composition of TALP medium used for parthenogenetic 
activation. 
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NCSU-23 medium 
NaCl 108,73 mM 
KCl 4,78 mM 
NaHCO3 25,07 mM 
KH2PO4 1,19 mM 
MgSO4.7H2O 1,19 mM 
D-Glucose 5,55 mM 
Sorbitol 50 mM 
Red Phenol 0,027 mM 
Penicillin G 0,21 mM 
Streptomycin 0,07 mM 
CaCl2.2H2O 1,7 mM 
BSA 4 mg/ml 
L-Glutamine 1mM 
pH: 7.6   OSM: 280 
 
Table 7. NCSU-23 medium composition. 
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3.2.2 Sheep oocytes collection, activation and transfer in uterus 
The experiments carried out in sheep were performed in 
collaboration with the group of Prof. Ledda S. of the Department 
of Veterinary Pathology and Clinic of the Università degli Studi di 
Sassari.   
Estrous cycles of adult Sarda-breed ewes were synchronized by 
the standard insertion of intravaginal sponges (40 mg FGA; 
Intervet). Multiple ovulations were induced by the administration 
of Follicular Stimulating Hormone (FSH-P; 20 mg pituitary extract 
kindly donated by FATRO, Italy) administered intramuscular 
every 12 hours for 48 hours. Recently ovulated oocytes were 
surgically removed from the oviducts of ewes, anesthetized with 
pentobarbital sodium, by flushing with 10 ml PBS supplemented 
with 4 mg/ml BSA fraction V. Oocytes were held in TCM 199-
HEPES plus 10% FBS (Boehringer Mannheim, Italy) and 
antibiotics (penicillin-streptomycin) at room temperature. 
Cumulus cells were removed with 300 UI/ml hyaluronidase in 
Ca2+-, Mg2 +-free PBS and repeated pipetting. 
In vivo matured oocytes were activated with 5 µM ionomycin for 5 
minutes and incubated for 3 h with 2 mM 6-DMAP in TCM-199 
with 10% Fetal Bovine Serum (FBS, Gibco, Italy) in standard 
culture conditions as previously described by Loi et al. 159. At the 
end of incubation 6-DMAP was washed off and the oocytes were 
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cultured. A well-developed blastocysts (> 100 cells and a clear 
ICM) were transferred to the uteri of foster-ewes (2 blastocysts per 
animal) that had ovulated 6 days previously. Fetal development 
was monitored and foetuses were collected at 21-day of 
pregnancy (the maximum length of time of sheep parthenogenetic 
development 159) in order to isolate their fibroblasts.  
 
3.3 In vitro fertilization 
3.3.1 Pig oocytes in vitro fertilization and culture 
For in vitro fertilization (IVF) studies, IVM was performed on a 
total of 1130 oocytes as previously described (please see 3.2.1 
paragraph).  
Frozen-thawed spermatozoa were purified by centrifugation 
through two-layer Percoll gradients. Live sperm cells were 
washed in TALP medium for IVF (see Table 8) and then were 
diluted in IVF medium (see Table 9). Oocytes were divided in 
groups of 45-50 and co-cultured  with 120000 spermatozoa/ml in 
IVF medium at 38.5°C in 5% CO2 atmosphere. After 24 h, oocytes 
were gently washed to eliminate cumulus cells and sperm 
adhering to the zona pellucida. Finally, embryos were cultured in 
groups of 25–35 in 50 µl NCSU-23 (see Table 7) drops under 
mineral oil at 38.5°C in 5% O2, 5% CO2 and 90% N2 atmosphere. 
On day 5 post-activation, half of the medium was replaced with 
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fresh NCSU-23 containing 20% (v/v) FCS to reach a final FCS 
concentration of 10% (v/v) in the in vitro culture drop. On day 7/8 
IVF blastocysts were obtained and ICMs were isolated for culture. 
 
 
 
TALP 10X medium for IVF 
MgCl2.6H2O 1.25 mM 
NaCl 102,7 mM 
KCl 3 mM 
NaH2PO4 0,28 mM 
NaHCO3 5 mM 
Na- lactate syrup 3,7 ml/l 
Na-pyruvate 1 mM 
HEPES 20 mM 
Polyvinyl alcohol (PVA) 1 mg/ml 
Kanamycin 1,3 mM 
pH: 7.4   OSM: 266 
 
Table 8. Composition of TALP medium used for IVF 
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IVF medium 
CaCl2.2H2O 2,65 mM 
MgCl2.6H2O 0,4 mM 
NaCl 106,1 mM 
KCl 3,08 mM 
NaHCO3 26 mM 
NaH2PO4 0,33 mM 
Na-pyruvate 1 mM 
Na- lactate syrup 1,86 ml/l 
BSA FAF 6 g/l 
Kanamycin 0,13 mM 
pH: 7.4   OSM: 280 
 
Table 9. IVF medium composition 
 
 
3.3.2 Sheep oocytes in vitro fertilization and transfer in uterus 
These experiments were performed in collaboration with the 
group of Prof. Ledda S. of the Department of Veterinary 
Pathology and Clinic of the Università degli Studi di Sassari.   
In vivo matured oocytes were collected from adult Sarda-breed 
after ovarian hyperstimulation (see 3.2.2 paragraph). Oocytes 
were partially denuded of granulosa cells by gentle pipetting in 
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TCM-199 HEPES buffered medium supplemented with 300 IU/ml 
hyaluronidase. Frozen-thawed spermatozoa from a Sarda breed 
were used in this experiment. The IVF system was composed by 
synthetic oviductal ﬂuid (SOF) medium, originally described by 
Tervit et al. 267, enriched with 20% heat inactivated estrous sheep 
serum, 2,9 mM Ca lactate and 16 nM isoproterenol 268. Fertilization 
was conducted in 50 µl drops with 1 x 106 spermatozoa/ml swim-
up derived motile spermatozoa and maximum 15 oocytes per 
drop. After 20/26 hours cleaved oocytes were washed three times 
and cultured in SOF medium supplemented with 2% BME-
essential amino acids, 1% MEM-nonessential amino acids (Gibco, 
Italy), 1 mM glutamine and 8 mg/mL fatty acid free BSA at 39°C in 
5% O2, 5% CO2 atmosphere. Culture was continued until 6 to 7 
days post fertilization, when embryos developed at least to 
expanded blastocysts were transferred to the uteri of foster-ewes 
(2 blastocysts per animal). Fetal development was monitored and 
foetuses were collected at 21-day of pregnancy (the same day used 
for parthenogenetic foetuses) in order to obtain fibrostast primary 
cultures.  
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3.4 Porcine sperm tail microinjection in matured oocyte  
These experiments were carried out in collaboration with the 
group of Prof. Galli C. of Avantea, Laboratory of Reproductive 
Technologies, Cremona. 
 
3.4.1 Porcine oocytes maturation 
Ovaries were collected from the local slaughtered. Oocytes were 
aspirated with the aid of a vacuum pump and transferred to a 
TCM199-based maturation medium supplemented with 10% of 
FBS (Gibco, Italy), 1 μl/ml ITS media supplement, 1 mM sodium 
pyruvate, 0.5 mM L-cystein and gonadotropins (0.05 IU/ml FSH 
and 0.05 IU/ml LH; Pergovet 75, Serono, Italy). Oocytes were 
cultured at 38.5°C in 5% CO2 for 44 h. After maturation oocytes 
were denuded of granulosa cells and MII oocytes were selected 
for polar body extrusion.  
 
3.4.2 Boar sperm preparation 
Frozen-thawed pig semen was washed through a discontinous 
Redigrad density gradient (45%-90%) at 750 g for 30 min. The 
viable spermatozoa recovered from the bottom of the tube were 
rinsed in Ca2+ free TALP and centrifuged at 400 g for 10 min. The 
sperm pellet was suspended at a concentration of 4 million 
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sperm/ml in Hepes buffered SOF medium supplemented with 6 
mg/mlfatty acid free BSA, MEM amino acids (Gibco, Italy), 1 
μg/ml heparin, 20 μM penicillamine, 1 μM epinephrine and 100 
μM hypotaurine (SOF-IVF). Just before ICSI, the sperm 
suspension was diluted 1:1 with a 12% solution of 
polyvinylpyrrolidone in SOF IVF medium. 
 
3.4.3 Intact sperm and tail microinjection 
Intact sperm and sperm tail microinjection was performed as 
described by Kimura and Yanagimachi 269 using a Piezo 
micropipette driving unit (Prime Tech, Japan). For ICSI of intact 
sperm, a motile sperm was aspirated into an injection pipette of 
approximately 7 µm, immobilized by two or three piezo-pulses to 
the tail-midpiece junction and injected. For sperm tail injection, 
just before the injection, sperm tails were detached mechanically 
from sperm heads with very strong piezo-pulses at the tail-sperm 
head junction. Then a single tail was aspirated into an injection 
pipette of approximately 2 µm and injected. The oocytes were 
held on the holding pipette by suction, with the polar body 
orientated to the 6 or 12 o’ clock position, and the injection pipette 
was advanced through the zona pellucida using the piezo drill 
motion. 
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3.4.4 Activation of tail injected oocytes and embryo culture  
Matured oocytes with or without injected sperm tails were 
activated at 48-50 h of maturation by double DC pulses of 1.2 
Kv/cm for 30 sec applied in 0.3 M mannitol solution, containing 1 
mM Ca 270 and 100 M Mg, followed by 3 hr culture in maturation 
medium with 5 g/ml cytochalasin B.  
Activated and intact sperm injected oocytes (day 0) were cultured 
in SOF medium supplemented with FAF BSA and MEM amino 
acids (SOF-BSA-AA 271) at 38.5°C in an atmosphere of 5% CO2 and 
5% O2. On day 2 the cleavage rate was assessed and not cleaved 
oocytes were removed. Culture medium was changed at 50% at 
day 4 and day 6. Embryos were fixed at different time point in 
order to analyzed their centriole assessment (see 3.7.1. paragraph). 
 
3.5 ICM isolation and culture 
3.5.1 STO feeder cell preparation 
STO fibroblasts (LGC Promochem-ATCC, Italy) were routinely 
cultured in high glucose DMEM (Gibco, Italy), supplemented with 
2mM glutamine and 10% FBS (Gibco, Italy). For growth 
inactivation, sub-confluent mono-layers were exposed to the 
medium above containing 10 μg/ml mitomycin-C (Gibco, Italy) for 
3 hours. They were re-suspended in culture medium and seeded 
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at a density of 25 x 104 cell/well in 4-well dishes, pre-coated with 
0.1% gelatin. Inactivation was carried-out 24 hours before plating 
of ICMs or passaging of pluripotent cell lines. Two hours before 
use, the medium was changed and replaced with embryonic stem 
cell medium (see 3.1.1 and 3.5.3 paragraphs). 
 
3.5.2 Porcine ICM isolation 
Porcine parthenotes and IVF embryos were cultured up to the 
early blastocyst stage. Blastocysts were incubated in pronase 0.5% 
(w/v) in medium TCM199 (Gibco, Italy), supplemented with 6.5 
mg/ml HEPES, 1.1 mg/ml sodium bicarbonate and 4 mg/ml 
bovine serum albumin (BSA). Incubation was carried out for 8 
minutes to eliminate zona pellucida. Subsequently, blastocysts 
were incubated in low glucose DMEM medium (Gibco, Italy) 
supplemented with 10% PVA and 10% monkey anti-porcine 
serum (supplied by Istituto Zooprofilattico Sperimentale 
Lombardia ed Emilia-Romagna, Brescia) for 15 minutes. A 30 
minutes incubation in DMEM medium (Gibco, Italy) containing 10 
% PVA and 10% Guinea pig complement was then performed. 
ICMs were isolated from lysed trophoblast cells by pipetting, 
washed through several DMEM drops to avoid culture oil carry-
overs and encourage better attachment and singly plated on 
feeder cells.  
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3.5.3 Porcine ICM culture 
Porcine embryonic stem cells were culture in DMEM-low glucose : 
HAM’SF10 (1:1; Gibco, Italy) supplemented with 10% K.O. 
SERUM (Gibco, Italy), 5% FBS (Gibco, Italy), 2 mM glutamine, 0.1 
mM β-mercaptoethanol, nucleoside mix, 1% non-essential 
aminoacid (Gibco, Italy), 1000IU/ml ES GROWTH (LIF; Chemicon, 
USA) and 5ng/ml bFGF (R&D System, USA) 67. 
Within 3 days, circular colonies with distinct margins of small, 
round cells were observed and media were refreshed. When a 
colony enlarged enough to cover half or more of the well surface, 
cells were mechanically removed using a sterile microloop (Nunc, 
DK), they were transferred to a 50 μl drop of fresh medium and 
pipetted to small cell clumps of an average of  500–600 cells, 
avoiding to obtain single cell suspension. Cells were then 
passaged on freshly prepared feeder-layers. Culture medium was 
changed every day.  
 
3.6 Fetal fibroblast isolation and culture 
This part of experiments was performed in collaboration with the 
group of Prof. Ledda S. of the Department of Veterinary 
Pathology and Clinic of the Università degli Studi di Sassari.   
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Primary cultures of foetal fibroblasts were obtained from 21 day-
old sheep fetuses generated by the transfer of IVF or 
parthenogenetic blastocysts into the uterus of synchronized 
recipients. The isolation of fibroblasts was carried out as previous 
described by Denning et al. 272. Explanted sheep fetuses were 
dissociated manually and then treated with 0.25% trypsin-EDTA. 
Primary cultures were grown on 0.1% gelatin pre-coated Petri 
dishes (Sarstedt, Italy) until the first passage, after which no 
treated Petri dishes (Sarstedt, Italy) were used. Cells were 
cultured in DMEM High Glucose (Gibco, Italy) supplemented 
with 20% FBS, 200 mM glutamine and antibiotic-antimicotic at 
37°C in a humidified environment with 5% CO2 in air. 
 
3.7 Centrosome characterization  
3.7.1 Centriole immunocytochemical localization 
Number of centrioles was assessed in all cell lines as well as in pig 
parthenotes and IVF embryos. 
Human and porcine undifferentiated cells from bi- and mono-
parental origin and sheep fibroblast derived from parthenogenetic 
and IVF fetuses were plated directly on CultureWell Chambered 
Coverglass 16-well dishes (Molecular Probes, Invitrogen, Italy) 
and cultured for 24 hours. Sample were fixed in 100% methanol 
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for 10 minutes at -20°C and permeabilized with 0.1% Triton X-100 
for 15 minutes at room temperature. Aspecific sites were blocked 
with PBS containing 10% BSA. Incubation with primary antibody 
specific for Centrin-1 (1:100, Abcam, UK) was then carried out for 
1 hour at room temperature. Microtubules were also labelled with 
anti-beta tubulin antibody (1:50, Abcam, UK). Incubation with 
suitable secondary antibodies (Alexafluor, Invitrogen, Italy) was 
performed for 30 minutes and nuclei were stained with 4’,6-
diamidino-2-phenylindole (DAPI). Samples were observed under 
an Eclipse E600 microscope (Nikon, Japan) at 100x magnification.  
Porcine parthenotes and embryos at 2-cell, 4-cell, 8-cell, 16-cell 
and blastocyst stage were fixed and stained as previously 
described in small drops and mounted on slides at the end of the 
procedure. Samples were observed under a TCS-NT laser confocal 
microscope (Leica Microsystems, Germany).  
 
3.7.2 Centriole localization with transmission electron 
microscopy (TEM) 
This analysis was performed in collaboration with the group of 
Prof. deEguileor M. of the Department of Biotechnology and 
Molecular Sciences of the Università dell’Insubria, Varese. 
Cells from all different origin were analyzed with transmission 
electron microscopy in order to assess their centriole number. 
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Samples were fixed for 2 hours in 0.1 M cacodylate buffer pH 7.2, 
containing 2% glutaraldehyde. Specimens were then washed in 
the same buffer and post-fixed for 2 hours at +4°C with 1% osmic 
acid in cacodylate buffer. After standard serial ethanol 
dehydration, specimens were embedded in an Epon-Araldite 812 
mixture. Sections were obtained with a Reichert Ultracut S 
ultratome (Leica, Austria). Semi-thin sections were stained by 
conventional methods (crystal violet and basic fuchsin) and 
subsequently observed under a light microscope (Olympus, 
Japan). Thin sections were stained by uranyl acetate and lead 
citrate and observed with a Jeol 1010 EX electron microscope (Jeol, 
Japan). 
 
3.7.3 Mitotic spindle check-point molecule analysis by Real 
Time PCR 
Total RNA was extracted from bi-parental and parthenogenetic 
human, porcine and ovine cell lines. We used cDNA of three bi-
parental embryonic stem cell lines, HES 7, HES I-3 and HES I-6 
thanks to a collaboration with the group of Prof. Benvenisty N. of 
The Alexander Silberman Institute of Life Sciences of The Hebrew 
University of Jerusalem. RNA was extracted with the 
TaqMan®Gene Expression Cells to Ct kit (Applied Biosystem, 
USA). Expression of target genes was evaluated using an ABI- 
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Prism 7000 Sequence Detecting System (Applied Biosystem, USA). 
Pre-designed gene-specific primer and probe sets from 
TaqMan®Gene Expression Assays (Applied Biosystem, USA) 
were used for the following transcripts: Aurora kinase A 
(AURKA; RP5-1167H4.6; AIK; ARK1; AURA; AURORA2; BTAK; 
MGC34538; PPP1R47; STK15; STK6; STK7); Aurora kinase B 
(AURKB; AIK2; AIM1; ARK2; AurB; IPL1; STK5; AIM-1; STK12; 
aurkb-sv1; aurkb-sv2); Autophagy related 5 homolog (ATG5; ASP; 
APG5; APG5L; hAPG5; APG5-LIKE); Budding uninhibited by 
benzimidazoles 1 homolog (BUB1; BUB1A; BUB1L; hBUB1); 
Cyclin-dependent kinase inhibitor 1A (CDKN1A; P21; CIP1; SDI1; 
WAF1; CAP20; CDKN1; MDA-6; p21CIP1; CDKN1A); 
Centromere protein E (CENPE; CENP-E; KIF10; PPP1R61); Cyclin 
F (CCNF; FBX1; FBXO1); E1A binding protein p300 (EP300; p300; 
KAT3B); E2F transcription factor 1(E2F1; RBP3; E2F-1; RBAP1; 
RBBP3); Kelch-like 3 (KLHL3; FLJ40871; KIAA1129; MGC44594); 
Mechanistic target of rapamycin (serine/threonine kinase) (MTOR; 
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; FLJ44809); Microtubule-
associated protein 1 light chain 3 alpha (MAP1LC3A; LC3; LC3A; 
MAP1ALC3; MAP1BLC3); Mitotic arrest deficient 1 (MAD1; 
MAD1L1; PIG9; TP53I9; TXBP181); Mitotic arrest deficient 2 
(MAD2; HSMAD2; MAD2L1); MYC associated factor X (MAX; 
MGC10775; MGC11225; MGC18164; MGC34679; MGC36767; 
bHLHd4; bHLHd5; bHLHd6; bHLHd7; bHLHd8, orf1); Polo-like 
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kinase 2 (PLK2; SNK); Sirtuin (silent mating type information 
regulation 2 homolog) 1 (SIRT1; SIR2L1); Translin (TSN; RCHF1; 
TBRBP; TRSLN; BCLF-1; REHF-1); TTK protein kinase (TTK; RP3-
357D13.2; CT96; ESK; FLJ38280; MPS1; MPS1L1; PYT); Tumor 
protein p53 (TP53; p53; LFS1; TRP53; FLJ92943) and v-mos 
Moloney murine sarcoma viral oncogene homolog (MOS; MSV; 
MGC119962; MGC119963) (Table 10).  
When not available, gene-specific primer and probe sets were 
custom designed. Gene expression level was reported as ΔCt 
value. For each individual gene the number of amplification 
cycles for the fluorescent reporter signal to reach a common 
threshold value (Ct) was estimated and then normalized by 
subtracting the Ct value obtained for the same sample for a 
positive control transcript (Δ-actin), to give ΔCt value. 
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Human Genes Catalog number 
Aurora kinase A (AURKA; RP5-1167H4.6; AIK; ARK1; AURA; 
AURORA2; BTAK; MGC34538; PPP1R47; STK15; STK6; STK7) 
Hs01582072_m1 
Aurora kinase B (AURKB; AIK2; AIM1; ARK2; AurB; IPL1; STK5; 
AIM-1; STK12; aurkb-sv1; aurkb-sv2) 
Hs00945858_g1 
Autophagy related 5 homolog (ATG5; ASP; APG5; APG5L; hAPG5; 
APG5-LIKE) 
Hs00355494_m1 
Budding uninhibited by benzimidazoles 1 homolog (BUB1; BUB1A; 
BUB1L; hBUB1) 
Hs00177821_m1 
Centromere protein E (CENPE; CENP-E; KIF10; PPP1R61) Hs01068241_m1 
Cyclin-dependent kinase inhibitor 1A (CDKN1A; P21; CIP1; SDI1; 
WAF1; CAP20; CDKN1; MDA-6; p21CIP1; CDKN1A) 
Hs99999142_m1 
Cyclin F (CCNF; FBX1; FBXO1) Hs00171049_m1 
E1A binding protein p300 (EP300; p300; KAT3B) Hs00914221_m1 
E2F transcription factor 1(E2F1; RBP3; E2F-1; RBAP1; RBBP3) Hs01566609_g1 
Kelch-like 3 (KLHL3; FLJ40871; KIAA1129; MGC44594) Hs00213589_m1 
Mechanistic target of rapamycin (serine/threonine kinase) (MTOR; FRAP; 
FRAP1; FRAP2; RAFT1; RAPT1; FLJ44809) 
Hs01042405_m1 
Microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A; LC3; 
LC3A; MAP1ALC3; MAP1BLC3) 
Hs00261291_m1 
Mitotic arrest deficient 1 (MAD1; MAD1L1; PIG9; TP53I9; TXBP181) Hs00269119_m1 
Mitotic arrest deficient 2 (MAD2; HSMAD2; MAD2L1) Hs01554515_g1 
MYC associated factor X (MAX; MGC10775; MGC11225; MGC18164; 
MGC34679; MGC36767; bHLHd4; bHLHd5; bHLHd6; bHLHd7; 
bHLHd8, orf1) 
Hs00811068_m1 
Polo-like kinase 2 (PLK2; SNK) Hs01573408_g1 
SIN3 homolog A, transcription regulator (SIN3; DKFZp434K2235; 
FLJ90319; KIAA0700) 
Hs00411592_m1 
Sirtuin (silent mating type information regulation 2 homolog) 1(SIRT1; 
SIR2L1) 
Hs01009003_m1 
Translin (TSN; RCHF1; TBRBP; TRSLN; BCLF-1; REHF-1) Hs00935849_m1 
TTK protein kinase (TTK; RP3-357D13.2; CT96; ESK; FLJ38280; MPS1; 
MPS1L1; PYT) 
Hs01009887_m1 
Tumor protein p53 (TP53; p53; LFS1; TRP53; FLJ92943) Hs99999147_m1 
v-mos Moloney murine sarcoma viral oncogene homolog (MOS; MSV; 
MGC119962; MGC119963) 
Hs01114731_s1 
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Porcine Genes Catalog number 
Cyclin-dependent kinase inhibitor 1A (CDKN1A; P21) Custom  made 
Polo-like kinase 2 (PLK2) Ss03375595_u1 
Tumor protein p53 (TP53; P53) Custom  made 
Ovine Genes Catalog number 
Cyclin-dependent kinase inhibitor 1A (CDKN1A; P21) Bt03262188_m1 
Polo-like kinase 2 (PLK2) Custom  made 
Tumor protein p53 (TP53; P53) Bt03223221_g1 
 
Table 10. List of all the genes analyzed and probe catalogue 
numbers (TaqMan®Gene Expression Assays, Applied Biosystem, 
USA). 
 
 
3.8 Karyotype assesment  
Chrosomome number was assessed in human, porcine and sheep 
parthenogenetic and bi-parental cells. Mitotically active cells in 
log phase were incubated in 10µg/ml colcemid (Gibco, Italy) for 
40-60 minutes. Cells were dislodged with 0.25% trypsin and 
centrifuged at 200g for 8 minutes. The cell pellet was gently 
resuspended in 0.075 M KCl solution and incubated for 20 
minutes at 37°C followed by fixation with methanol/glacial acetic 
acid (3:1) solution. Fixed cells were dropped on wet slides and air 
dried. Giemsa staining was carried out as indicated by 
manufacturer (Cariomax Giemsa, Gibco, Italy). Metaphases were 
fully karyotyped under a Leica HC microscope. Images were then 
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captured with digital camera Leica DC250 using a Leica CW4000 
Karyo software. 
 
3.9 TUNEL assay 
Apoptotic index were tested in parthenogenetic and bi-parental 
human, porcine and sheep cell lines. Cells were plated directly on 
CultureWell Chambered Coverglass 16-well dishes (Molecular 
Probes, Invitrogen, Italy) and cultured for 24 hours. They were 
then fixed in 4% formaldehyde in PBS for 25 minutes at 4°C, 
washed twice in PBS and permeabilized with 0.25% Triton X-100 
in PBS for 5 minutes. Samples were incubated in 100 µl of 
Equilibration Buffer (Roche, Italy) for 10 minutes at room 
temperature and then 50 µl of TdT Reaction Mix (Roche, Italy) 
were added for an incubation of 60 minutes at 37°C. Cells were 
washed in SSC (Roche, Italy) for 15 minutes and their nuclei were 
counterstained with DAPI. At the end of the assay, slides were 
washed, mounted with Vectashield® Mounting Medium (Vector 
Laboratories, Italy) and examined under an Eclipse E600 
microscope (Nikon, Japan). 
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3.10 Autophagic activity detection 
3.10.1 Lysotracker Red staining 
To determ lysosome formation parthenogenetic and bi-parental 
embryonic stem cells were stained with Lysotracker Red, a red-
fluorescent dye for labeling and tracking acidic organelles. It is 
well known that lysosomes are cellular organelles that contain 
acid hydrolase enzymes (4.5 pH).  
In these experiments live cells were incubated with a 1 µM 
solution of Lysotracker Red DND-99 (Molecular Probes, 
Invitrogen, Italy) in complete medium for 30 minutes at 37°C. 
After extensive wash in PBS and distilled water, cells were 
mounted in Citifluor (Citifluor, UK), covered with a coverslip, and 
examined with an Olympus BH2 microscope. Negative control 
was performed by omitting Lysotracker in the medium.  
 
3.10.2 LC3 immunostaining 
Autophagic activity was evaluated using a specific 
autophagosome marker LC3. 
Parthenogenetic and bi-parental embryonic stem cells were fixed 
in 4% paraformaldehyde for 15 minutes at room temperature and 
permeabilized with 0.1% Triton X-100 in PBS for 5 minutes. 
Incubation with anti-LC3 antibody (Novus Biologicals, USA) 
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diluted 1:200 in 2% BSA was performed for 1 hour in a dark moist 
chamber. After incubation with the primary antibody, cells were 
washed and incubated with an appropriate Cy3-conjugated 
antibody (dilution 1:100; Jackson ImmunoResearch, UK) for one 
hour. Samples were mounted and observed with an Olympus 
BH2 microscope (Olympus, Italy). Negative control was 
performed by omitting primary antibody. 
 
3.10.3 TEM analysis 
The presence of autophagosome was also assessed though TEM in 
collaboration with the group of Prof. deEguileor M. of the 
Department of Biotechnology and Molecular Sciences of the 
Università dell’Insubria, Varese. 
Cells were processed and observed as described in 3.7.2 
paragraph. 
 
3.11 Inter-cellular bridge detection 
3.11.1 TEM analysis 
The occurency of inter-cellular bridges was assessed though TEM 
in collaboration with the group of Prof. deEguileor M. of the 
Department of Biotechnology and Molecular Sciences of the 
Università dell’Insubria, Varese. 
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Cells were processed and observed as described in 3.7.2 
paragraph. 
 
3.11.2 Scanning electron microscopy (SEM) 
The experiments here described were performed in collaboration 
with the group of Prof. deEguileor M. of the Department of 
Biotechnology and Molecular Sciences of the Università 
dell’Insubria, Varese. 
Inter-cellular bridge formation was investigated in human, 
porcine and sheep cell lines using scanning electron microscopy 
(SEM). Cells were fixed and dehydrated as previously described 
for TEM (3.7.2 paragraph). Samples were then treated with 
hexamethildisilazane and mounted on polylysinated slides, air 
dried and subsequently covered with a 9 nm gold film by flash 
evaporation of carbon in an Emitech K 250 sputter coater 
(Emitech, USA). Specimens were examined with a SEM-FEG 
Philips XL-30 microscope (Philips,  Netherlands). 
 
3.11.3 Dextran single cell injection  
Functional trafficking activity through inter-cellular canals were 
investigated in porcine and ovine bi-parental and parthenogenetic 
cells. Solution of 50mg/ml of Rhodamine-conjugated 10-kDa 
dextran (Molecular Probes, Invitrogen, Italy) was introduced into 
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the cytoplasm of a single cell. Eppendorf FemtoJet® Microinjector 
(Eppendorf, Italy) was used in order to inject a small quantity of 
dextran in cell cytoplasm. Movement of the molecule from the 
injected cell to others was observed with a Nikon Eclipse E600 
microscope (Nikon, Japan). 
 
3.12 Statistical analysis 
Statistical analysis was performed using the unpaired t-test or the 
Mann–Whitney rank sum test, as appropriate, using the Sigma 
Stat statistical package (Systat Software Inc., USA). Data are 
presented as mean percentages (± SEM) of a minimum of three 
independent replicates. In all cases, differences of P≤0.01 were 
considered significant. 
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4. RESULTS 
DERIVATION OF PIG AND SHEEP CELL LINES 
Isolation and characterization of porcine parthenogenetic and bi-
parental embryonic stem cells 
ICMs were isolated from 282 parthenotes and 101 IVF blastocysts 
using immunosurgery technique. They were plated on inactived 
feeder cells and 3 out of 6 and 30 out of 41 outgrowths, derived 
respectively from IVF and parthenogenetic embryos, were able to 
give rise a stable pluripotent cell lines that could be propagated 
extensively in vitro (more than 50 passages) (Table 11).  
 
 IVF 
embryos 
Parthenotes 
Oocytes 1388 1221 
Blastocysts 124 (8.93%) 282 (23.1%) 
Outgrowths 6 (4.84%) 41 (22.16%)* 
ESC lines 3 (2.42%) 30 (16.22%)* 
 
Table 11. Derivation of  porcine ESC lines from IVF embryos 
and parthenotes. Oocyte and blastocyst number used, total 
number (% rate) of outgrowths and cell lines obtained. *p<0.05. 
 
We obtained homogeneous outgrowths, consisting entirely of cells 
which resembled ESCs in their morphology (Figure 23 panel A 
and Figure 24 panel A), both using parthenogenetic and IVF 
ICMs.  
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The outgrowths grew in size and, after 7-8 days of culture, formed 
circular colonies of 3-5 mm in diameter, with distinct margins 
(Figure 23 panel A and Figure 24 panel A). At this stage they were 
passaged onto a fresh feeder layer to establish cell lines or were 
subjected to further characterization. Cells obtained from both 
origin showed many pluripotency aspects common to mouse and 
human ESCs. They expressed many of the known pluripotency 
related transcription factors and surface markers. More in detail 
molecular analysis demonstrated that both IVF and 
parthenogenetic derived cells transcribed for gene like OCT4, 
NANOG, SOX2 and REX1 (Figure 23 panel C and Figure 24 panel 
C). Moreover immunocytochemical studies confirmed the 
presence of Oct4, Nanog and SSEA4 in our porcine cells (Figure 23 
panel B and Figure 24 panel B).  
Three cell lines for each origin were analyzed in the experiments 
described below. 
For more detailed information see Appendix B titled: “Culture 
conditions and signalling networks promoting the establishment 
of cell lines from parthenogenetic and bi-parental pig embryos” 
by Brevini et al. 67. 
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Figure 23. Porcine ESCs derived from parthenotes. 
Parthenogenetic ESCs formed circular colonies with distinct 
margins (panel A). They were positive for several known 
pluripotency-related markers. The figure is representative of all 
passages (more than 50 passages at present). Immuno-
cytochemical analysis with specific antibodies demonstrated 
positivity of parthenogenetic cells for Oct-4, Nanog and SSEA-4. 
Cell nuclei, stained with DAPI, are coloured in blue (panel B). 
Molecular studies confirm the expression of OCT4, NANOG, 
REX1, SOX2 (panel C). Genomic DNA was used as a positive 
control; negative control was represented by differentiated 
parthenogenetic ESCs. 
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Figure 24. Porcine ESCs derived from IVF blastocysts. Bi-
parental ESCs formed circular colonies with distinct margins 
(panel A). They were positive for several known pluripotency-
related markers. The figure is representative of all passages 
(more than 50 passages at present). Immuno-cytochemical 
analysis with specific antibodies demonstrated positivity of 
porcine ESCs for Oct-4, Nanog and SSEA-4. Cell nuclei, stained 
with DAPI, are coloured in blue (panel B). Molecular studies 
confirm the expression of OCT4, NANOG, REX1, SOX2 (panel 
C). Genomic DNA was used as a positive control; negative 
control was represented by differentiated bi-parental ESCs. 
 
 
Isolation of sheep fibroblasts from IVF and parthenognetic fetuses  
In collaboration with the group of Prof. Ledda S. of the 
Department of Veterinary Pathology and Clinic of the Università 
degli Studi di Sassari, 2 IVF embryos and 2 parthenotes were 
transferred to the uteri of each of 4 recipients. Fetuses were 
constantly monitored and the sizes of the conceptuses after 
parthenogenic activation were compared with those of 
conceptuses obtained from normally fertilized oocytes. No 
difference in fetal sac size between parthenogenetic emrbyos and 
controls was detected. On day 21 fetuses were recovered from 
recipient ewes and fibroblasts were isolated as described above 
(paragraph 3.6). 6 cell lines, 3 from parthenogenetic and 3 from bi-
parental fetuses,  were established and analyzed in the following 
experiments. 
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PART 1: ORIGIN OF CHROMOSOME ABNORMALITIES  
Katyotype assessment in parthenogenetic and bi-parental cells 
We looked at the incidence of chromosomal abnormalities in 
parthenogenetic cell lines and compared it with their bi-parental 
counterparts. A total of 192, 172, 237 parthenogenetic and 200, 165, 
172 bi-parental human, pig and sheep cells were analysed 
respectively. The diploid configuration represented the modal 
value in the bi-parental cell lines of all species, whereas hypo-
haploid and hypo-diploid configurations where the most frequent 
in all parthenogenetic cell lines, irrespective of the species and of 
their origin: cell line or primary culture (Figure 28).  
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Figure 25.Representative pictures of human parthenogenetic 
(panel A) and bi-parental (panel B) cell karyotype. 
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Figure 26.Representative pictures of porcine parthenogenetic 
(panel A) and bi-parental (panel B) cell karyotype. 
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Figure 27.Representative pictures of sheep parthenogenetic 
(panel A) and bi-parental (panel B) cell karyotype. 
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Figure 28. Chromosome counting in parthenogenetic and bi-
parental cell lines highlights the higher incidence of 
chromosomal abnormalities in monoparental cells of all 
examined species. Hypodiploid and hypoaploid configurations 
were the most common ones and indicate the occurrence of 
multipolar mitosis. 
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Comparative studies of centrosome organization in 
parthenogenetic and bi-parental cell lines 
A systematic comparison of the incidence of multiple centrosomes 
after IVF or parthenogenetic activation was performed. To this 
purpose we analyzed human and porcine pluripotent cell lines as 
well as sheep foetal fibroblasts. Centriole number was analyzed 
after immune-localization of centrin, a centriole-associated 
calcium-binding protein that plays a fundamental role in 
centrosome duplication. Punctuate centrin localization were 
counted on 343, 237, 267 parthenogenetic and 150, 224, 416 bi-
parental human, pig and sheep cells respectively. A high and 
significantly different incidence of supernumerary pairs of 
centrioles was observed in parthenogenetic cell lines of all species, 
whereas only 20 of 847 bi-parental cells showed an abnormal 
number of centrioles (Figure 30).  
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Figure 29.Representative pictures of cells showing 1, 2 (normal 
centriole number) and 3 centriole pairs (abnormal centriole 
number), localized with centrin-specific antibody. 
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Figure 30. A significant increase of abnormal number of 
centriole pairs (more than 2) is observed in cell lines derived 
from human. pig and sheep parthenotes as established by a 
direct comparison with the respective bi-parental counterparts. 
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Furtheremore, the presence of multipolar asters (Figure 31) 
confirms that extranumerary centrosomes are functional and able 
to form multipolar spindles. 
 
 
 
Figure 31. Multipolar asters in human parthenogenetic 
pluripotent cells confirms that extranumerary centrosomes are 
functional and able to form multipolar spindles. 
 
 
To further confirm these results we also analysed the expression 
levels of PLK2, a molecule required for centriole duplication 244, 
and CCNF, depletion of which cause centrosomal and mitotic 
abnormalities, including multipolar spindles and asymmetric, 
bipolar spindles with lagging chromosomes 252. In our studies we 
detected up regulation of PLK2 in human (15,9-fold) pig (15,7-
fold) and sheep (13,9-fold) parthenogenetic cell lines and, in 
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parallel, we could observe a down-regulation (6,5 folds) of CCNF 
expression in human mono-parental cells (Figure 32). 
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Figure 32. A significant increase of PLK2 expression in human, 
pig and sheep parthenogenetic cell lines that confirms at the 
molecular level the centrosome amplification detected by 
morphological analysis. In parallel, down-regulation of CCNF 
further support the presence of centrosomal and mitotic 
abnormalities. *p<0.05. 
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Quantitative PCR experiments also demonstrated aberrant levels 
of molecules related to spindle formation in human 
parthenogenetic cells, when compared to those of three bi-
parental embryonic stem cell lines. In particular higher levels of 
MAD1, MAX and SIN3 were detected, pointing to the possibility 
of a deregulation in the MAD1 dependent pathway. Furthermore, 
negligible transcription levels of CENPE, TTK and Aurora A 
kinase, indicated abnormalities at different spindle check points in 
parthenogenetic cell lines (Figure 33). 
 
 
 
Figure 33. Expression level of molecules related to spindle 
formation and chromosome segregation in human 
parthenogenetic and bi-parental cell lines. Bars represent the 
average ΔCt of HP cells (solid bars) and bi-parental cells 
(striped bars) related to the genes examined. *p<0.05. 
* * 
* 
* 
* 
* 
* 
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Centriole number assessment in porcine IVF and parthenogenetic 
embryos 
In order to determine when centriole number alterations take 
place, we analyzed the number of centrioles present in IVF and 
parthenogenetic pig embryos. The evaluation was carried out on 
48 IVF embryos and 56 parthenotes at different developmental 
stages (2-, 4-, 8-, 16-cell and blastocyst) for a total of 364 and 376 
blastomers respectively. An abnormal centriole number was 
observed in 59.6% (224/376) of parthenote blastomers, while only 
2.7% (10/364) of the IVF blastomers examined, showed 
supernumerary centrioles (Table 12). In particular centrioles were 
detectable in parthenotes before  4-cell stage and a high incidence 
of abnormalities was immediately observed, while no centriole 
anomalies were visible in IVF embryos. In the latter case centrioles 
appeared at morula/blastocysts stage, as previous demonstrated 
for porcine species 178.  
 
 
 
 
 
 
117 
 
 IVF Parthenotes 
Embryos 
analyzed 
48 56 
Blastomer 
analyzed 
364 376 
Blastomers 
with >2 
centrioles 
10/364  
(2.7%) 
224/376  
(59.6%)* 
 
Table 12. Comparative analysis between IVF embryos and 
parthenotes. Centriole number alteration is significantly higher 
in parthenotes. *p<0.05. 
 
 
 
Sperm tail microinjection in porcine matured oocytes 
To confirm the hypothesis about the link between the absence of 
paternal centrioles contribution in parthenogenetic cells and the 
chromosome/centriole number alterations described above, we 
carried out specific experiment in collaboration with the group of 
Prof. Galli C. (Avantea, Laboratory of Reproductive Technologies, 
Cremona), injecting sperm tail in porcine mature oocytes. 
In this species, in fact, as well as in human and sheep, paternal 
centrioles were localized in the proximal end of the sperm tail 178. 
We separated head from tail spermatozoa and only tail, 
containing the proximal centrioles, was injected into MII oocytes. 
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After this, activation was performed in order to stimulate oocytes 
and to trigger parthenogenetic development. 
In the first set of experiment we compared 16-cells and morulas 
obtained from ICSI embryos, parthenotes and parthenotes in 
which sperm tail were injected. 
The results obtained showed that only partenothes display 
balstomers with more than 2 centrioles, while no centrioles were 
detected in ICSI embryos or parthenotes in which sperm tail was 
injected (Table 13). These results are in agreement with a previous 
study revealing that in the pig sperm centrioles are lost in zygote 
after in vitro fertilization and they are not detectable until the late 
blastocysts stage 178. Furthermore these data demonstrated that in 
parthenotes centriole alterations take place at the very early stage 
of parthenote development. 
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 ICSI Parthenogesis 
Tail injection 
plus activation 
Oocytes 56 30 53 
48h 43 25 42 
96h 19 25 17 
Blastomer 
analyzed 
225 376 79 
Blastomers 
with >2 
centrioles 
no 
centrioles 
224 (59.57%)* 
no 
centrioles 
 
Table 13. Centriole number in blastomers of 96h ICSI embryos, 
parthenotes without or with sperm tail. Centriole number 
alteration (more than 2 pair of centrioles) was observed only in 
parthenogenetic blastomers, while no centrioles were detected 
in ICSI embryos or parthenotes with injected sperm tail. *p<0.05. 
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In the second set of experiment we compared blastocysts obtained 
from ICSI embryos and parthenotes with injected sperm tail. The 
number of blastomers with an altered number of centrioles were 
not statistically different between the two groups (Table 14). This 
results validated our hypothesis demonstrating that the injection 
of centriole is sufficient to regulate and control de novo centriole 
formation. 
 
 
 ICSI 
Tail injection 
plus activation 
Oocytes 34 30 
48h 24 25 
144h 4 10 
Blastomer 
analyzed 
139 79 
Blastomers 
with >2 
centrioles 
10 (7.2%) 5 (6.3%) 
 
Table 14. Centriole number in blastomers of 144h ICSI embryos 
and parthenotes with sperm tail. Centriole number alteration is 
not statistical different between ICSI embryos and parthenotes 
in which sperm tail was injected. 
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These results indicate that chromosomal instability in 
parthenogenetic cells is caused by the presence of functionally 
active extranumerary centrioles. These centriole abnormalities are 
present in all cell types analyzed (ESCs and foetal fibroblasts), 
independently from the species (human, pig and sheep). These 
alterations are already present in embryos since the first mitotic 
divisions  and, consequently, before the derivation of cell lines, 
demonstrating that are not caused by the isolation protocol or 
culture conditions used for ESCs. Furthermore, data obtained 
after sperm tail injection demonstrated that all these alterations 
are cause by the absence of male proximal centrioles contribution.  
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PART 2: ADAPTIVE MECHANISMS ACTIVE IN 
PARTHENOGENETIC CELLS 
The high rate of aneuploidy together with multipolar centrosome 
should lead to the inhibition of cell proliferation and to a rapid 
cell death through the activation of the mitotic checkpoint 273. 
However we observed that both human and porcine 
parthenogenetic cells undergo unlimited cell divisions and 
maintain the ability to differentiate in vitro  into normal cell types 
if cultured in the appropriate conditions, as described above257,274. 
Furthermore, the capacity of cell proliferation and differentiation 
was certainly maintained also in sheep parthenotes developed in 
utero since they showed a normal morphology (Figure 34) with a 
beating heart as previously described by Loi et al. 159. 
 
 
 
Figure 34. Sheep parthenote after 21 days of gestation in utero 
shows normal morphological features and a beating heart. 
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Apoptotic index and expression levels of apoptosis-related genes 
In agreement with our observation TUNEL assay showed a low 
apoptotic index of parthenogenetic cells, that was not significantly 
different from their bi-parental counterpart (Figure 35). 
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Figure 35.Quantification of apoptotic index in human, pig and 
sheep bi-parental and parthenogenetic cell lines. TUNEL-
positive cells were scored randomly choosing five microscopic 
fields to reach a total of at least 900 cells and averaged. Error 
bars represent SD. The high rate of aneuploidy and multipolar 
centrosome does not increase TUNEL-positive cell number and 
the apoptotic index in parthenogenetic is not significantly 
different from that of corrisponding bi-parental counterpart. 
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To confirm this observation we also examined by Real Time-PCR 
the expression levels of TP53 and TP21, the two genes mainly 
involved in apoptosis mechanism activation. Results obtained 
clearly showed that both transcripts are significantly down 
regulated in parthenogenetic lines of all species, suggesting this as 
a possible way used by these kind of cells to continue their 
proliferation and to prevent apoptotic process activation even in 
the presence of high levels of aneuploidy (Figure 36). 
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Figure 36. Aneuploidy-related stress limits cell proliferation 
through a p53- and p21- dependent mechanism. On the contrary, 
we observed a down-regulation of p53/p21 pathway in all 
parthenogenetic cell lines. *p<0.05. 
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Characterization of autophagic activity 
Aneuploidy in yeast and mammalian cells leads to a stress 
response caused by the unbalance in cellular protein composition 
275. For this reasons we also investigated for the presence of 
autophagic degradation in parthenogenetic cell lines. This 
mechanism may help them to eliminate extranumerary centrioles 
and probably may represent an alternative way to re-establish a 
correct centrosome complement and to preserve the diploid 
status. 
This phenomena, in fact, is known as an evolutionary conserved 
and strictly regulated lysosomal pathway utilized in cells in order 
to eliminate aberrant and dysfunctional organelles 276. Results 
obtained using TEM and immunostaining analysis showed that 
parthenogenetic cells contained fagosome structures and 
exhibited a strong punctuate signal following the incubation with 
a lysosome-specific probe (LysoTracker Red DND-99) as well as  
with an anti-LC3 antibody, both of which indicate the presence of 
high amounts of lysosomes and autophagosomes in the cytoplasm 
(Figure 37).  
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Figure 37. Autophagic activity in parthenogenetic cells. The 
punctuate positivity in cells after Lysotracker Red staining 
(panel A) and immunocytochemical localization of LC3 (panel 
B) indicate the presence of numerous lysosomes and 
autophagosomes. Panels A’,B’: negative controls. Bar: 10 m. 
 
 
Consistent with morphological observations, LC3 expression was 
nearly 8 times higher in  mono-parental cell lines than in bi-
parental (Figure 38). We also observed a significant increase in the 
expression levels of other specific genes that correlate with the 
activation of the autophagic program, such as Autophagy related 
5 homolog (ATG5), Sirtuin1 (SIRT1), E1A binding protein p300  
(EP300) and E2F transcription factor (E2F1) (Figure 38). At the 
same time the analysis of Mechanistic target of rapamycin 
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(MTOR), a well characterized autophagy inhibitor 277, showed 
specific mRNA levels 10 times lower in parthenogenetic than in 
bi-parental cells (Figure 38).  
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Figure 38. The significant difference of autophagy levels 
between human parthenogenetic and bi-parental cell lines can 
be appreciated through the several fold difference in the 
expression levels of autophagy-related genes. *p<0.05. 
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The presence of inter-cellular bridges 
The high rate of supernumerary centrosomes and of severe 
aneuploidy of parthenogenetic cells, is inconsistent with the in 
continuous proliferation and ordinate in vitro differentiation as yet 
described. We hypothesized that this could be also possible 
through a wide communication between cells that provides 
mutual exchange of missing cell products and, at the same time, 
alleviates the unbalance in cellular protein composition that 
would hamper normal cell functions. Ultrastructural analysis 
clearly showed the existence of intercellular bridges variable in 
size that are compatible with the notion of reciprocal cell support, 
similarly to what occurs among germ cells (Figure 39). In addition 
in parthenogenetic cell lines and sheep post-implantation 
parthenote cells displayed the presence of communications 
besides the wide cytoplasmic characterized by actin bundles, 
unbalanced chromatid separation and chromosomal bridges 
(Figure 39). 
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Figure 39. Electron microscopy of human and sheep 
parthenogenetic cells demonstrate intercellular bridges, 
allowing a cytoplasmic continuity between the cells:  SEM 
(encircled areas), TEM (white arrows). In utero sheep parthenote 
(21 days of gestation) (panel E) and semithin sagittal section 
counterpart (panel F). Light microscopy of sheep post-
implantation parthenote cells shows cytoplasmic bridges 
(panels G-H white arrows) and unbalanced chromatid 
separation (panels G-Jarrowheads). Tripolar metaphase cell as a 
result of the presence of multiple centrioles (panel M, 
arrowhead). Anaphase cell with one intact chromatin bridge 
(panel J, arrowhead). TEM ultrastructure of sheep parthenote 
cells show the presence of intercellular bridges (panels I and N-
white arrows), wide open cytoplasmic communication, and in 
detail (panels K and N) actin patches (black arrows) at the level 
of the intercellular canal. Bars (panel A)10 μm; (panel B) 6 μm; 
(panel C) 1.25 μm; (panel D) 1 μm; (panel I) 1 μm; (panel L) 1.5 
μm; (panel K) 800nm; (panel N) 800nm. 
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Consistent with the morphological observations, human 
parthenogenetic cells showed up regulation of both AURKB (9-
fold) and KLHL3 (5-fold), compared with their bi-parental 
counterpart. These two molecules are known to actively stabilize 
intercellular canals 278. Furthemore, 5-fold increase of TSN 
expression level was detected in mono-parental cells (Figure 40). 
This up regulation is compatible with an active mRNA 
distribution between connected cells (Figure 40). 
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Figure 40. Up regulation of TNS (a well known RNA-binding 
protein that transports mRNA molecules between cells, through 
intercellular canals), of AURKB and of KLHL3 (recently 
described as an essential stabilizer of intercellular bridges) 
validate the morphological features. *p<0.05. 
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Functional intercellular trafficking activity through intercellular 
canals identified with ultra-structural analysis was demonstrated 
by an extensive migration among cells of fluroscent 10-kDa 
dextran that was injected into the cytoplasm of a single cell. This 
molecule in fact moved from the cell injected to others (Figure 41) 
suggesting their use for transfer of mRNAs, proteins and cell 
products among cells. 
 
 
*
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Figure 41. Cells injected with 10-kDa dextran. Functional 
activity of intercellular bridges in parthenogenetic cells (panel 
A) is demonstrated by migration of dextran molecules from the 
injected cell (panel B) to adjacent cells (panels C and D). 
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All the results obtained in this second part of thesis demonstrate 
that, despite ploidy alteration, parthenogenetic cell lines continue 
to proliferate without active apoptosis mechanism. This is possible 
thanks to significant down regulation of p53 and p21 genes 
observed in our uni-parental cells when compared with their bi-
parental counterpart.  
Furthermore parthenogenetic cells show a dramatic increase of 
autophagic activity which helps them to eliminate extranumerary 
centrioles and probably may represent an alternative way to re-
establish a correct centrosome complement and to preserve the 
diploid status. 
Since this mechanism was insufficient to prevent an incidence of 
chromosome number alterations, but cell proliferation and 
differentiation was not compromised, the extensive network of 
intercellular bridges identified among parthenogenetic cells may 
have a crucial role. 
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5. DISCUSSION 
The development of parthenotes to the blastocyst stage was 
reported for several species 109,153,158-162,279, but limited data related 
to the potential plasticity of the cell lines derived from them and 
their biological characteristics, with specific regards to the 
potential abnormalities associated with their origin, are available.  
Since our previous studies demonstrated the presence of 
abnormal karyotype in human parthenogenetic cell lines 257, in the 
experiments reported in this thesis we looked at the incidence of 
chromosomal abnormalities in human, porcine and sheep 
parthenogenetic cell lines and compared it with their bi-parental 
counterparts.  
The results described in this thesis showed that hypo-haploid and 
hypo-diploid configurations were the most frequent in all 
parthenogenetic cell lines, irrespective of the species and of their 
origin: pluripotent cell line or primary culture (Figure 28), while 
the diploid configuration represented the modal value in the bi-
parental cell lines of all species. In particular, we were able to 
identified not only chromosome number alteration in human 
parthenogenetic ESC lines, where the donor age is relative old, but 
also in parthenogenetic porcine ESCs. In the latter case oocytes 
were retrieved from young animals just after puberty (the age of 
high reproductive fitness in this species), suggesting that 
chromosome alterations are independent from the donor age. 
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Consistent with our results, a similar incidence of aneuploidy was 
recently described also in cell lines obtained from bovine 
parthenotes 280, which were derived from oocytes isolated from 
animals in their full reproductive fitness.   
Moreover we detected hypo-haploid and hypo-diploid 
configurations in primary cultures of fibroblasts obtained from 
parthenotes transferred into the uterus of synchronized recipients 
and allowed to develop in vivo for 21 days, the maximum length 
of time of sheep parthenogenetic development 159. These results 
give us the possibility to rule out the experimental protocols used 
in our laboratory for establishing and maintaining of embryonic 
stem cell lines as possible causes of aneuploidy. 
In agreement with these data, the presence of frequent 
chromosomal abnormalities in pre-implantation mammalian 
parthenotes has been previously described both in human 281-283 
and animal species 284-286. 
Furthermore the results obtained in the experiment carried out in 
this thesis demonstrated that parthenogenetic cell lines of all 
species showed a high and significantly different incidence of 
supernumerary pairs of centrioles (Figure 30). Furthermore the 
presence of multipolar asters in parthenogenetic cell lines (Figure 
31) confirms that extranumerary centrosomes are functional and 
able to form multipolar spindles similar to that of tumour cell 
lines 287. 
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We also observed a significant high rate of parthenote blastomers 
(59,57%) showing an abnormal centriole number. In particular our 
results showed that centriole formation were evident in 
parthenotes from the 4-cell stage and a high incidence of 
abnormalities was immediately visible. This is the first description 
of centriole dynamics during parthenote pre-implantation 
development in a non-rodent species and indicates that centriole 
abnormalities are not linked to a prolonged culture, but are 
already present at the blastocyst stage, when embryonic cell line 
derivation takes place. 
Similar abnormalities have been previously described in human 
parthenogenetic embryos, that were obtained from oocytes 
spontaneously activated and/or induced with puromycin 282,283. 
Furthermore they do not seem to be confined to human 
parthenotes and appear to be common to other mammalian 
species. Indeed a high incidence of abnormal spindle has been 
reported in parthenotes derived from bovine activated oocytes, 
with abnormalities occurring as early as completion of the first 
cell cycle 166.  
All these observations are in agreement with the recent 
observations that centriole de novo assembly is normally turned off 
when one centriole, acting as template, is present 288. The absence 
of sperm centriole in parthenotes may therefore lead to the lack of 
a negative regulatory mechanism that suppress de novo centriole 
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assembly and may explain the presence of multicentriolar 
structures as the ones detect in these cell lines. 
The relationship between parthenogenesis and centrosome, in 
fact, is complex. It is important to point out that in mammals, with 
the notable exception of mice 206, centrosome of the male and 
female gametes undergo a reciprocal reduction. In fact, centrioles 
degenerate and are lost during oogenesis and while oogonia and 
growing oocytes display normal centrioles until pachytene stage, 
they are absent in the mature oocytes 199. At the time of 
fertilization, the distal centriole is carried into the ooplasm by the 
sperm, where it mixes with a stockpile of centrosomal proteins 
and generates a functional zygotic centrosome 179,204,208,209. This 
process has been described in rhesus monkeys 200, rabbits 201, cows 
99, sea urchins 202, Xenopus 203 and several other species 204. 
Indeed in mammalian parthenotes, due to the absence of 
centrioles, the oocyte centrosomal material does not aggregate 
into unified foci and is unable to form astral microtubules and a 
correctly oriented  spindle, unless rescued by a spermatozoon. 
However, in many insects where parthenogenetic development is 
an obligatory or facultative form of reproduction, oocyte ability to 
generate a functional centrosome, in the absence of the sperm 
contribution, has evolved 221.  
The increased number of centrioles determined with the 
localization of punctuate centrin, was also confirmed by the 
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alterated expression levels of PLK2 and CCNF in our 
parthenogenetic cell lines. In particular, we detected up regulation 
of PLK2, a molecule required for centriole duplication 244, in 
human (15,9-fold) pig (15,7-fold) and sheep (13,9-fold) derived 
lines and a down-regulation of CCNF (6,5 folds) in human cells 
(Figure 32). These results are consistent with the recent finding 
that siRNA mediated depletion of CCNF in HeLa cells induces 
centrosomal and mitotic abnormalities, including multipolar 
spindles and asymmetric, bipolar spindles with lagging 
chromosomes 252, similar to the alterations we found in 
parthenogenetic cell lines and described in this thesis. Altered 
expression levels of mitotic check point molecules were also found 
in human parthenogenetic cells (Figure 33). In particular, the 
comparison of uni-parental pluripotent cells with their bi-parental 
counterpart (HES 7, HES I-3 and HES I-6) indicated a much higher 
level of expression of MAD1, and the related molecules MAX and 
SIN3 in parthenogenetic cells. MAD1 is a central component of the 
spindle assembly checkpoint and recruitment of kinetochores 248-
250 and its de-regulation has been shown to affect cell cycle 
progression with a decrement of cell proliferation and a 
protracted G1 phase 251. The altered levels of such molecules may 
be related to the lack of paternal contribution in spindle assembly. 
A similar explanation could account for the very low transcription 
of BUB1, CENPE and TTK detected in these cells. These two 
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molecules, in fact, are normally involved in kinetochore-
microtubule binding, correct chromosome congression and 
alignment, as well as segregation during mitosis. In particular, 
BUB1 and CENPE disruption usually causes a reduction of 
tension across the centromere and an increased incidence of 
spindle pole fragmentation, resulting in a mixture of aligned and 
unaligned chromosomes 246.  
Since the lack of a paternally derived centriole, able to recruit the 
egg centrosomal material to form a functional centrosome, was 
the common feature in all the three species examined here, we 
suggest that parthenogenetic activation per se, rather than the 
oocyte donor age or the culture method, is responsible for the 
centrosome alterations.  
This hypothesis was definitively validate by the results obtained 
after sperm tail injection in porcine matured oocytes. 
Immunostaining carried out on parthenogenetic activated 
embryos previously injected with tail containing male proximal 
centrioles, displayed a normal centriole number comparable to 
that of the in vitro fertilized embryos. This confirm that the 
presence of male centriole can restore the negative regulatory 
mechanism that suppress de novo centriole assembly.  
Furthermore, since the presence of multipolar spindle is usually 
linked with ploidy alterations, these results may explain the high 
degree of aneuploidy characterizing parthenogenetic cell lines. 
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Generally a high rate of aneuploidy together with multipolar 
centrosome should lead to the inhibition of cell proliferation and 
to a rapid cell death through the activation of the mitotic 
checkpoint 273. Aneuploidy in yeast and mammalian cells leads to 
a stress response caused by the unbalance in cellular protein 
composition 275. Recent results indicate that aneuploidy-related 
stress limits cell proliferation through a p53-dependent 
mechanism 289. 
On the contrary, we observed that human and pig 
parthenogenetic ESC lines undergo unlimited cell divisions and 
maintain the ability to differentiate into normal cell types if 
cultured in the appropriate conditions 67,257. Furthermore, the 
capacity of cell proliferation and differentiation was certainly 
maintained also in the sheep parthenotes developed in utero since 
they showed a normal development and organogenesis with a 
beating heart 159, in the absence of any overt sign of malignant 
transformation. Consistently with these observations the 
apoptotic index of all parthenogenetic cell lines described in this 
thesis is low and not significantly different from their bi-parental 
counterparts (Figure 35). This is made possible thank to a 
significant down regulation of p53 and p21 genes identified in 
parthenogenetic lines of all species (Figure 36). Indeed these gene 
expression alterations may represent the possible way used by 
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these cells to continue their proliferation even in the presence of 
high levels of aneuploidy and centrosome alterations. 
Similar findings were recently described in a Drosophila 
transgenic strain that contains extra centrosomes in around 60% of 
somatic cells but that is morphologically normal, except for a long 
delay in development compared to the wild type 234. Drosophila 
cells, however, did not show an increased incidence of 
aneuploidy, probably because most of the extra centrosomes were 
able to cluster forming a bipolar spindle by metaphase. This is 
different from the cells examined in the current experiments 
which showed a high and steady rate of aneuploidy. Indeed we 
have been unable to detect the clusterization of supernumerary 
centrioles in our cells. 
By contrast we identified through morphological and molecular 
analysis the presence of autophagic activity, an evolutionary 
conserved and strictly regulated lysosomal pathway for cleansing  
aberrant and dysfunctional organelles 276.  
LC3 positivity, in fact, indicates the presence of high amounts of 
lysosomes and autophagosomes in the cytoplasm of 
parthenogenetic cells (Figure 37). This molecule (also known as 
MAP1LC3) assists autophagosome formation and is present in 
sealed autophagosomes 276. Consistent with the morphological 
results, expression levels of autophagy related genes (ATG5, 
SIRT1, EP300 and E2F) were higher in parthenogenetic cells than 
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in bi-parental ones (Figure 38), while MTOR, a well characterized 
autophagy inhibitor 277, showed specific mRNA levels 10 times 
lower in uni-parental cell lines than in bi-parental. In particular, 
ATG5 has a pivotal role in autophagosome formation, through its 
recruitment together with ATG12, ATG16 and LC3 to the 
phagophore. The expression of this autophagic modulator can be 
up-regulated by E2F1 290 and it can be deacetylated by SIRT1 291: 
both mechanisms result in enhanced autophagy, with potential 
positive effects on cell life span 292. It is interesting to note that 
SIRT1, not only promotes autophagy 293 but also inactivates p53 by 
deacetylation 294 therefore reinforcing the down-regulation of p53 
observed in parthenogenetic cell lines.  
This very intense autophagic activity is probably an alternative 
way to re-establish a correct centrosome complement and to 
preserve the diploid status, providing a way to eliminate the 
extranumerary centrioles and chromosomes. This process is likely 
to be used as an active self-protective strategy in order to 
eliminate highly abnormal organelles, thus contributing to cell 
survival and ensuring the maintenance of a “normal” population 
295. Since we have previously shown that centrosome amplification 
is already taking place at the blastocyst stage, when ICM are 
isolated for cell line derivation, it is interesting to note that 
autophagic degradation has recently been described in early 
embryonic development and it was suggested to be used for 
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removal of obsolete maternal factors 296. We hypothesize that 
parthenogenesis-related anomalies prolong and amplify the 
ongoing autophagic processes and therefore result as a preferred 
pathway for counteracting the deleterious effects of centrosome 
amplification, as opposed to other systems where centrosome 
clustering is commonly observed 297.  
Optical and ultrastructural analysis clearly showed the existence 
of intercellular bridges (Figure 39). Injection of fluroscent 10-kDa 
dextran also confirmed the functional activities of this canals 
(Figure 41). Moreover our results demonstrated that 
parthenogenetic cell lines displayed up regulation of molecules 
essential for the stabilization of the intercellular canals containing 
chromosome filaments (AURKB and KLHL3) 278. These 
connections can be considered as a reminiscent of the midbodies 
converted into stable canals and correlated to chromatin bridges 
278. Similar structures have been described in the form of stable 
intercellular bridges between germ cells 298 and provide a mean 
for transfer of mRNAs, proteins, and cell products 299. In 
particular, mRNAs are transported through intercellular bridges 
by a testis-brain-RNA-binding protein called Translin (TSN) 300. 
Arrested cytokinesis is a common process taking place during 
spermatogenesis 299. However gene expression pattern and 
morphological analysis indicated that the communications 
observed between parthenogenetic cells are more similar to the 
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recently described intercellular canals that persists between two 
cells when chromosome segregation is altered for any reason 278, 
as it occurs in about 1% of dividing somatic cells and, at higher 
rate, in transformed cells 301.  
Since the dramatic increase of autophagic activity was insufficient 
to prevent an incidence of aneuploidy, but cell proliferation and 
differentiation was not compromised, we hypothesized that this 
canals may provide a mutual exchange of missing cell products 
between adjacent cells 300,302 and, at the same time, alleviates the 
unbalance in cellular protein composition that would hamper 
normal cell functions. 
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6. CONCLUSIONS 
Our data provides evidence that the lack of paternal centriole in 
the parthenogenetic zygote leads to a centrosome amplification 
due to the lack of appropriate inhibition mechanisms and the 
ensuing multipolar mitosis cause severe chromosomal instability 
(CIN). Despite it is becoming clear that CIN probably plays a 
causative part in a substantial proportion of malignancies 303 we 
found that it is surprisingly compatible with parthenogenetic 
embryonic stem cells in vitro proliferation and differentiation as 
well as with parthenotes post-implantation development in vivo. 
Our data support the view that this is possible through a series of 
compensatory mechanisms that suppress apoptosis and enable 
cells to support each other through wide and stable network of 
intercellular communications.  
Our data lead us to propose that deriving cell lines from human 
parthenotes, and from animal species that share the same 
fertilization model, can help us to understand the mechanisms 
that link parthenogenesis, pluripotency and oncogenesis. We 
think that this has previously gone largely unnoticed because of 
the substantial difference in the fertilization process between the 
mouse and all other mammalian species, of the very limited 
number of human and non-rodent parthenogenetic cell lines 
available and of the absence of obvious phenotypic alterations. 
However the extensive concordance between our observations 
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and a wide amount of experimental data obtained in completely 
different experimental models, support the physiological 
relevance of our data. The findings also indicate that 
parthenogenesis could be an unexpected but very powerful model 
to study the onset of malignant transformation.   
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Abstract Human parthenogenetic embryos have recently
been proposed as an alternative, less controversial source
of embryonic stem cell (ESC) lines; however many
aspects related to the biology of parthenogenetic embryos
and parthenogenetic derived cell lines still need to be
elucidated. We present here results on human cell lines
(HP1 and HP3) derived from blastocysts obtained by
oocyte parthenogenetic activation. Cell lines showed
typical ESC morphology, expressed Oct-4, Nanog, Sox-2,
Rex-1, alkaline phosphatase, SSEA-4, TRA 1-81 and
had high telomerase activity. Expression of genes
specific for different embryonic germ layers was
detected from HP cells differentiated upon embryoid
body (EBs) formation. Furthermore, when cultured in
appropriate conditions, HP cell lines were able to
differentiate into mature cell types of the neural and
hematopoietic lineages. However, the injection of undif-
ferentiated HP cells in immunodeficient mice resulted
either in poor differentiation or in tumour formation
with the morphological characteristics of myofibrosarco-
mas. Further analysis of HP cells indicated aberrant
levels of molecules related to spindle formation as well
as the presence of an abnormal number of centrioles
and autophagic activity. Our results confirm and extend
the notion that human parthenogenetic stem cells can be
derived and can differentiate in mature cell types, but
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also highlight the possibility that, alteration of the
proliferation mechanisms may occur in these cells,
suggesting great caution if a therapeutic use of this
kind of stem cells is considered.
Keywords Human . Parthenogenetic cell lines . Centriole .
Mitotic check-point transcripts
Introduction
Parthenogenesis is the process by which a single egg can
develop without the presence of the male counterpart and is a
form of reproduction common to a variety of organisms such
as fish, ants, flies, honeybees, amphibians, lizards and snakes,
that may routinely reproduce in this manner [1].
Mammals are not spontaneously capable of this form of
reproduction, however, mammalian oocytes can successfully
be activated in vitro, by mimicking the calcium wave induced
by sperm at fertilization and stimulated to divide [2].
Mammalian parthenotes, however, are unable to develop to
term and arrest their development at different stages after
activation, depending on the species [3]. The reason for this
arrest is believed to be due to genomic imprinting which
causes the repression of certain maternally inherited
imprinted genes [4].
Despite these limitations, following the success reported in
mouse [5, 6] and non-human primate models [7, 8], human
parthenogenetic embryos have recently been proposed as an
alternative, less controversial source of embryonic stem cell
lines [2, 9–12]. Parthenotes may also represent a possible
tool for studies on the mechanisms driving early human
embryogenesis and for the pre-clinical test of experimental
protocols in human assisted reproduction (i.e. different
oocytes cryopreservation procedures, oocyte in vitro matu-
ration or polar body genetic screening) [13].
However many aspects related to the biology of
parthenogenetic embryos and parthenogenetic derived cell
lines still need to be elucidated. The decreased extent of
heterozygosis may amplify any negative genetic compo-
nent potentially present in the genotype [14, 15] and has
recently been postulated as a major limitation in partheno-
genetic lines derived from primates [7]. The very high
incidence of chromosome instability and aberrant chromatid
separation in oocytes retrieved from IVF patients, especially
when over 34 year old [16–18] also represents a concern,
given the fact that these correspond to a large part of the
population accessing assisted reproductive therapy and,
hence, are a major potential source of oocytes for parthenote
derivation.
In an attempt to better elucidate some of these aspects,
we present here results on human parthenogenetic cell lines
recently derived in our laboratory; we characterize their
pluripotency and differentiation plasticity, both in vitro and
in vivo, showing many characteristics common to bi-
parental embryonic stem cells; however we report the
presence of abnormal centrosomes and altered expression
levels of specific mitotic spindle check-point proteins,
possibly related to their uniparental origin.
Materials and Methods
Human Oocytes Collection, Activation and Culture
Oocytes were collected at the Infertility Unit of the Depart-
ment of Obstetrics and Gynecology of the “Ospedale
Maggiore Policlinico Mangiagalli e Regina Elena”. In Italy
nomore than three embryos per cycle can be obtained [19, 20]
therefore, in our Unit, patients from whom more than three
good quality oocytes are retrieved, are routinely offered the
opportunity to cryopreserve supernumerary eggs. Patients
refusing this possibility were proposed to participate to the
present study. Approval for the study was obtained by the
local institution review board and all participating women
gave informed consent.
Fresh oocytes were obtained following controlled ovarian
hyperstimulation and transvaginal follicular aspiration for
oocyte retrieval was performed 36 h post-hCG as previously
described [13]. The cell lines described in these experiments
were obtained from twenty oocytes retrieved from four
patients (age range 32–39 years) and activated according to
Paffoni et al. [13].
Isolation of ICM, Establishment and Culture of Cell Lines
from Human Parthenogenetic Embryos
Inner cell masses (ICM) were microsurgically removed
from blastocysts, singly plated and cultured in Dulbecco’s
modified Eagle’s medium, without pyruvate, high glucose
formulation (Gibco, Italy) supplemented with 10%Knock-out
serum replacer (Gibco, Italy), 5% fetal bovine serum (Gibco,
Italy), 1 mM glutamine, 0.1 mM β-mercaptoethanol (Sigma,
Italy), 5 ng/ml human recombinant basic Fibroblast Growth
Factor (R&D System, USA) and 1% nonessential amino acid
stock (Gibco, Italy). Within 3 days, circular colonies with
distinct margins of small, round cells were observed. When a
colony enlarged enough to cover half or more of the well
surface, cells were mechanically removed using a sterile
microloop (Nunc, DK), they were transferred to a 50 μl drop
of fresh medium and pipetted to small cell clumps, avoiding to
obtain single cell suspension. Cells were then passaged on
freshly prepared feeder-layers. Culture medium was changed
every day.
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Gene Expression in HP Cell Lines
Reverse Transcription-Polimerase Chain Reaction
All chemicals were purchased from Invitrogen (Milan,
Italy) unless otherwise indicated.
RNA was extracted using the acid-phenol method
according to Chomczynski and Sacchi and included a
DNase I (1 U/μl) incubation. RNA was then immediately
reverse transcribed, using Superscript-™ II Reverse Tran-
scriptase and following the manufacturer’s instruction.
RNA from bi-parental embryonic stem cells was used as
positive control. Amplifications were carried out in an
automated thermal cycler (iCycler, Biorad), using the con-
ditions appropriate for each set of primers. In particular,
depending on the different experiments, we screened for the
expression of pluripotency related transcripts (Oct-4, Nanog,
Sox-2, Rex-1) and differentiation markers (Bone Morphoge-
netic Protein-4, BMP-4; Neurofilament-H, NF-H; α-amilase).
Expression of β-actin was always examined as an internal
control of the sample quality. Amplification products were
purified in Spin-X centrifuge tube filters (Corning, the
Netherlands), sequenced (SEQLAB, Gottingen, Germany)
and aligned using Clustal W 1.82 (EMBL-EBI service).
Immunocytochemistry
Markers of stem cells and stem cell differentiation were
assessed by immunocytochemistry using the following
primary antibodies: Oct-4 (1:50, Chemicon, USA); Nanog
(1:20, R&D System, USA); SSEA-4 (1:100, Chemicon,
USA); Alcaline phosphatase (1:50, R&D System, USA);
TRA-1-81 (1:100, R&D System, USA); Desmin (1:200,
Chemicon, USA); Keratin 17 (1:200, Chemicon, USA);
Vimentin (1:200, Chemicon, USA); Nestin (1:200, Abcam,
UK); Map2 (1:200, Abcam, UK); CNPase (1:200, Abcam,
UK); beta-tubulin III (1:250, Chemicon, USA). Staining
conditions were as indicated by manufacturers. Incubation
with suitable secondary antibodies (Alexafluor, Invitrogen,
Italy) was carried out for 30 min and nuclei were stained
with 4′,6-diamidino-2-phenylindole (DAPI, Sigma, Italy).
Samples were observed either under a TCS-NT laser
confocal microscope (Leica Microsystems, Germany) or a
Eclipse E600 microscope (Nikon, Japan).
Telomerase Activity
Telomerase activity measurement was performed in
undifferentiated and differentiated HP cells respectively, using
the TRAPeze® Telomerase Detection Kit (Chemicon, USA),
following the manufacturer’s instruction. Reactions were
separated on non-denaturing TBE-based 12% polyacrylamide
gel electrophoresis and visualized with SYBER Green
staining.
Derivation of Embryoid Bodies
To induce the formation of EBs, HP cells were cultured
in 30 μl hanging droplets, as previously described [21].
The medium was refreshed every day and after 7–9 days,
EBs were detectable. Differentiation of EBs was con-
firmed by morphological examination and molecular
analysis that demonstrated the expression of markers
related to mesoderm (BMP-4), ectoderm (NF-H) and
endoderm (α-amilase). Human genomic DNA was used
as a positive control.
Spontaneous Differentiation of HP Cell Lines
Embryoid bodies were mechanically dissociated and cells
were plated directly onto CultureWell Chambered Coverglass
16-well dishes (Molecular Probes, Italy) to encourage ad-
herent culture conditions and spontaneous differentiation as
previously described [22]. After 1 week cells were processed
for RT-PCR amplification or immunocytochemistry.
Neural Differentiation of HP Cell Lines
EBs were prepared as described above and exposed to 10 μM
retinoic acid (Sigma, Italy) and 10 ng/ml Sonic Hedgehog
(R&D System, USA). They were kept 48 h in hanging drops
culture conditions and then they were dissociated and plated
on 0.1% gelatin coated CultureWell Chambered Coverglass
16-well dishes. Differentiation was carried out in Neural
Progenitor Cell Basal Medium (Cambrex Bioscience, USA),
supplemented with Neural Cell Survival Factor-1 (Cambrex
Bioscience, USA) and 25 ng/ml Brain Derived Neurotrophic
Factor (R&D System, USA). After a period from 9 days to
21 days of culture, cells were fixed and stained with specific
antibodies.
Hematopoietic Differentiation of HP Cell Lines
Single-cell suspension was obtained by passaging EBs
through a 21-gauge needle. Cell suspensions were plated
in a serum-free medium (CellGro Medium, Cambrex
Bioscience, USA) supplemented with 10% FBS (Bio-
chrom, Germany) and with the following human recom-
binant cytokines: thrombopoietin (TPO, 10 ng/ml), Flt-3
ligand (FL, 50 ng/ml), stem cell factor (SCF, 50 ng/ml),
interleukin-(IL)-6 (10 ng/ml), (Peprotech EC Ltd., UK).
After 2 weeks cells were harvested and assayed for the
evaluation of colony-forming cells (CFCs) in 2 ml of
complete methylcellulose medium (H4434; StemCell
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Technologies, USA). The medium contained 1% methyl-
cellulose, 30% FBS, 1% Bovine Serum Albumine,
10−4 M 2-mercaptoethanol, 2 mM L-glutamine, 3 IU/ml
erythropoietin, 50 ng/ml SCF, 10 ng/ml granulocyte macro-
phage colony-stimulating factor (GM-CSF), 10 ng/ml
Interleukin-3 (IL-3). After further 21 days of culture,
colonies were scored and then picked up for morphological
or flow cytometric analysis.
Colonies were spotted on Poly-D-lysine coated slides
with a cytocentrifuge (Shandon Cytospin 4, Thermo
Electron Corporation, USA) for 7 min at 200 rpm. Samples
were then fixed and stained with May-Grunwald-Giemsa
for evaluating their hematopoietic differentiation.
Flow Cytometry
To perform flow cytometry analysis on colonies, 2×105 cells
were incubated with the following conjugated mouse-anti
human antibodies: CD45 PE (Beckman Coulter, USA),
CD34 FITC (Becton Dickinson, USA). Isotype immunoglo-
bulins IgG1 PE (Chemicon, USA), IgG1 FITC (Beckman
Coulter, USA) were used as negative controls. For each
sample, at least 50.000 events were acquired with Cytomics
FC500 (Beckman Coulter, USA) and analyzed using the
CXP-analysis software.
“In Vivo” Differentiation
Undifferentiated HP cells of each line were harvested and
injected in the hind limb of 3 Fox Chase SCID (C.B-17/
IcrCrl-scid-BR) and 3 SCID Beige (C.B-17/IcrCrl-scid-
bgBR) mice (Charles Rivers Laboratories, Italy). Each
animal received 3.5×106 cells. The same amount of feeder
cells were injected as a negative control. Tumor formations
were palpable and were retrieved 7–10 weeks after the
injection. They were fixed for 24 h in 10% neutral buffered
formalin, dehydrated and processed using a routine wax-
embedding procedure for histological examination after
hematoxylin/eosin staining. Expression of specific antigens
was determined on serial tissue sections by immunohisto-
chemistry using the indirect avidin-biotin peroxidase
technique (Vector Labs: VECTASTAIN Elite ABC Kit,
Universal; DAB Substrate Kit, 3,3′-diaminobenzidine).
Details about primary antibodies and immunohistochemical
procedures employed are reported in Table 1.
Centrosome Localization
Undifferentiated cells were plated directly on CultureWell
Chambered Coverglass 16-well dishes (Molecular Probes
Europe, Italy) and cultured for 24 h. They were fixed in
100% methanol at −20°C and stained with a primary antibody
specific for human Centrin 1 (1:100, Abcam, UK). Secondary
detection was carried out with the appropriate Alexa Fluor
antibody (Invitrogen, Italy). The results obtainedwere observed
under a Nikon Eclipse E600microscope at 100×magnification.
Electron Microscopy
Samples were fixed for 2 h in 0.1 M cacodylate buffer
pH 7.2, containing 2% glutaraldehyde. Specimens were
then washed in the same buffer and post-fixed for 2 h with
1% osmic acid in cacodylate buffer. After standard serial
ethanol dehydration, specimens were embedded in an
Epon-Araldite 812 mixture. Sections were obtained with a
Reichert Ultracut S ultratome (Leica, Austria). Semi-thin
sections were stained by conventional methods (crystal
violet and basic fuchsin) and subsequently observed under
a light microscope (Olympus, Japan). Thin sections were
stained by uranyl acetate and lead citrate and observed with
a Jeol 1010 EX electron microscope (Jeol, Japan).
Mitotic Spindle Check-Point Molecules
RNAwas extracted from HP cells and from three bi-parental
embryonic stem cell lines, HES 7, HES I-3 and HES I-6 with
the TaqMan®Gene Expression Cells to Ct kit (Applied
Biosystem, CA, USA). Expression of mitotic checkpoint
genes was evaluated using pre-designed gene-specific primer
and probe sets from TaqMan®Gene Expression Assays
(Applied Biosystem, USA) for the following human tran-
scripts: Mitotic arrest deficient 1 (MAD1); Budding uninhib-
ited by benzimidazoles 1 (BUB1); Centromere protein E
(CENPE); TTK kinase (human homologue of the yeast
monopolar spindle 1 kinase); Aurora A Kinase; Myc-
associated factor X (MAX); SWI-Independent 3 (SIN3);
β-actin. Gene expression level was reported as ΔCt value.
For each individual gene the number of amplification cycles
for the fluorescent reporter signal to reach a common
threshold value (Ct) was estimated and then normalized by
subtracting the Ct value obtained for the same sample for a
positive control transcript (Δ-actin), to give ΔCt value.
Results
Three parthenogenetic cell lines (HP1, HP2 and HP3)
were obtained from 20 oocytes. Unfortunately one of the cell
lines was accidentally lost before its full characterization
therefore results for only two lines are reported. These cell
lines could be propagated extensively in vitro and constantly
(67 passages) expressed cell markers that characterize human
embryonic stem cells: Oct-4, Nanog, Rex-1, Sox-2, alkaline
phosphatase, SSEA-4, TRA 1-81 (Fig. 1, panel a and b).
Undifferentiated HP cells expressed high telomerase activity,
while no telomerase activity could be detected once cells
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were induced to differentiate (Fig. 1, panel c), indicating a
physiologically normal control of telomerase activity in these
cells.
When cultured with the hanging drop method, the
formation of EBs was observed regularly after 10–12 days.
Embryoid bodies expressed several tissue-specific markers
including BMP-4, NF-H, α-amilase (Fig. 2, panel a),
keratin 17, vimentin, desmin (Fig. 2, panel b), indicating
that derivatives representative of all three germ layers could
be obtained.
Moreover, when cells were cultured in NPDM Bullet Kit
(Cambrex Bioscience, USA), expression of nestin, β-tubulin
III, CNPase and MAP-2 was observed, demonstrating the
formation of more mature cell types of the neural lineage
(Fig. 3, panel a).
Similarly, exposure of HP cells to specific cytokines and
adequate culture conditions allowed for differentiation of
these cells towards the hematopoietic lineage, with the
generation of CD34/CD45 positive cells (Fig. 3, panel b)
that were able to form colonies in methylcellulose-medium
after a period of 3 weeks (Fig. 3, panel c). Staining of the
differentiated cells with May-Grunwald–Giemsa demon-
strated the presence of lymphoid, erythroid and myeloid
sub-populations (Fig. 3, panel d).
In vivo differentiation ability of HP cells was tested
through intramuscular injection of undifferentiated HP cells
in immunodeficient mice and resulted, for both HP lines,
either in poor differentiation or in tumours that were
classified as myofibrosarcomas (Fig. 4).
Real-time PCR experiments demonstrated aberrant
levels of molecules related to spindle formation in HP
cells, when compared to those of three bi-parental
embryonic stem cell lines (HES 7, HES I-3 and HES I-6). In
particular higher levels of MAD1, MAX and SIN3 were
detected, pointing to the possibility of a deregulation in
the MAD1 dependent pathway. Furthermore, negligible
transcription levels of CENP-E, TTK and Aurora A
kinase, indicated abnormalities at different spindle check
points in HP cells (Fig. 5). Immunohistochemical (Fig. 6,
panel a) and ultrastructural (Fig. 6, panel b-e) analysis of
HP cells demonstrated the presence of groups of multiple
centrosomes showing abnormal shape. These cells were
always accompanied by massive autophagic process
(Fig. 6, panel d). The autophagic cargoes could include
damaged centrioles (Fig. 6, panel e).
Discussion
The development of human parthenotes to the blastocyst
stage was reported only recently [23–25] and not many
data are available because of the limited accessibility of
Table 1 Primary antibodies and procedures used for immunohistochemistry
Antibody Host species
and clonality
Company Clone or
company
code
Antigen
retrieval
Working
dilution
Incubation
time
Secondary
antibody
VIMENTIN Mouse monoclonal DAKO 3B4 EDa 1:1000 40 min at 37°C Biotynilated
anti-mouse
SMA Rabbit monoclonal EPITOMICS E184 HIARb 1:1200 40 min at 37°C Biotinylated
anti-rabbit
DESMIN Rabbit monoclonal EPITOMICS 1184-1 HIAR 1:2000 40 min at 37°C Biotinylated
anti-rabbit
MYOGLOBIN Rabbit polyclonal DAKO L1860 NA 1:10 40 min at 37°C Biotinylated
anti-rabbit
GFAP Rabbit polyclonal DAKO Z334 HIAR 1:10000 40 min at 37°C Biotinylated
anti-rabbit
S100 Rabbit polyclonal DAKO Z311 HIAR 1:15000 40 min at 37°C Biotinylated
anti-rabbit
SYNAPTOPHYSIN Rabbit monoclonal EPITOMICS EP1098Y HIAR 1:500 1 h at room temperature Biotinylated
anti-rabbit
CYTOKERATIN Mouse monoclonal ZYMED AE1/AE3 ED 1:1000 40 min at 37°C Biotynilated
anti-mouse
FVIII Rabbit polyclonal DAKO N1505 ED 1:80 40 min at 37°C Biotinylated
anti-rabbit
LYSOZYME Rabbit polyclonal DAKO A 0099 ED 1:13000 40 min at 37°C Biotinylated
anti-rabbit
a ED: enzymatic digestion with pepsin solution (Digest all™ 3, Zymed)
b HIAR: heat-induced antigen retrieval, pressure cocker, sodium citrate solution pH 6
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unfertilized human oocytes. Even more limited are the
information related to the potential plasticity of the lines
that can be derived from parthenogenetic human embryos,
with specific regards to the potential abnormalities
associated with their origin. The results presented in this
manuscript describe the properties and limits of the cell
lines derived from human parthenogenetic embryos in our
laboratory.
These lines have been growing for over 67 passages and,
in agreement with previous reports on human parthenoge-
netic stem cells [9–12], possess the main features of bi-
parental stem cells, showing stable expression of
pluripotency-related markers, high in vitro differentiation
plasticity and the capability to respond to specific stimuli in
order to give rise to high specification tissue differentiation.
Consistent with these data is their high telomerase activity.
Telomerase activity is indeed correlated with regeneration
and immortality and is typically expressed in germ cells and
embryonic stem cells, while it is absent in most somatic cell
types [26, 27]. In our experiments, undifferentiated HP cells
Fig. 1 Pluripotency of HP cells
is demonstrated by their
positivity to several known
pluripotency-related markers
and by their telomerase activity.
The expression of Oct-4, Nanog,
Rex-1, Sox-2 is shown by
RT-PCR screening of RNA
extracted from HP cells. Beta
actin and RNA from bi-parental
embryonic stem cells were used
as positive control (panel a).
Cytochemical analysis with
specific antibodies demonstrated
immunopositivity of HP cells
for Oct-4, Nanog, alkaline
phosphatase, SSEA-4 and TRA
1-81. Cell nuclei, stained with
DAPI, are coloured in blue
(panel b). Undifferentiated
(Undiff) HP cells displayed high
levels of telomerase activity,
while no telomerase activity
could be detected in
differentiated (Diff) progeny,
indicating a physiologically
normal control of telomerase
activity in these cells (panel c)
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displayed high levels of telomerase activity, while no
activity could be appreciated when cells were differentiated
in vitro through the preparation of EBs. These data indicate
that a physiologically normal control of telomerase activity
is present in HP cells and that, if subjected to differentiation
culture conditions, they respond turning down telomerase
activity, as expected in normal somatic cells. Indeed an
average of 10 days differentiation culture allowed us to
obtain parthenogenetic EBs that actively transcribed RNAs
involved in specification of the three embryonic germ
layers, demonstrating HP cell potential to differentiate in
the main tissue types of the body. HP cell plasticity was
further demonstrated by immunostaining of the monolayers
obtained after EB disaggregation and plating , with
consistent presence of cells belonging to ectoderm, meso-
derm and endoderm lineages.
A crucial point is to assess the possibility to drive
differentiation of human parthenogenetic cells towards a
specific lineage, in controlled culture conditions. In this line
we carried out the sets of experiments presented in this
manuscript aimed at the derivation of mature forms of
neural and hematopoietic cell populations. HP cells were
able to form different cell subtypes belonging to the neural
lineage as well as to differentiate in the complex array of
hematopoietic cells. Although further assays to test the real
extent of cellular functionality are needed, these results
further confirm human parthenogenetic cell lines differen-
tiation potential. In particular our results showed that HP
cells were able not only to give rise to early neural lineages
as previously described [9–12] but also to more mature cell
types expressing nestin, CNPase and MAP2. This is
consistent with the observation that murine androgenetic
Fig. 2 Differentiation ability of
human parthenogenetic cells
after induction of EB formation.
RT-PCR analysis of RNA
extracted from EBs consistently
demonstrated expression of
markers specific for the three
germ layers and, more in details
bone morphogenetic protein-4
(Bmp-4, mesoderm), neurofila-
ment H (NF-H, ectoderm) and
α-amylase (endoderm). Beta
actin and genomic DNA were
used as a positive control
(panel a). Disaggregation and
plating of EBs confirmed HP
cell plasticity, with consistent
presence in the monolayer of cells
displaying immunopositivity for
keratin 17 (endoderm), desmin
(mesoderm) and vimentin
(ectoderm). Cell nuclei, stained
with DAPI, are coloured in blue
(panel b)
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embryonic stem cells are able to differentiate into neuronal
and glial cells [28]. Our results further expand current
knowledge on human parthenogenetic cell in vitro differ-
entiation plasticity, showing the formation of mature
hemopoietic cell lineages. This confirms what has been
previously reported by Mann et al. [31] in mouse
androgenetic and gynogenetic stem cells, that where shown
to be able to generate adult-transplantable hematopoietic
stem cells, that can repopulate the hematopoietic system of
adult transplant recipients [29]. Altogether these findings
indicate that, outside the normal developmental paradigm,
the differentiation potential of uniparental cells may be
much less restricted than that of parthenogenetic cells in
chimeras and that these cells can be an interesting and
relevant model for the study of fundamental mechanisms
involved in human lineage determination.
However, injection of HP cells in immunodeficient
mice gave rise to poor differentiation or in the formation
Fig. 3 Neural and hematopoietic
differentiation of HP cells.
Culture conditions routinely used
to address bi-parental embryonic
stem cells towards neural
differentiation successfully drove
HP cells to form different cell
subtypes belonging to the neural
lineage, with cells displaying
immune-positivity for nestin,
β-tubulin III, CNPase and
MAP-2. Cell nuclei, stained with
DAPI, are coloured in blue
(panel a). Differentiation towards
the hematopoietic lineage was
obtained exposing HP cells to
specific cytokines and adequate
culture conditions. CD34/CD45
positive cells were demonstrated
and separated by cell sorting
(panel b) These cells were able to
form colonies when cultured in
methycellulose-medium (panel c)
and to generate lymphoid,
erythroid and myeloid
subpopulations (panel d,
left to right)
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of myofibrosarcomas [30], depending on animal injected.
This is consistent with the observation that the subcuta-
neous injection of androgenetic mouse embryonic stem
cells in immunodeficient mice generates sarcomas with
muscular differentiation [31] and suggests the possibility
of an intrinsic deregulation of the mechanisms controlling
the choice between proliferation and differentiation in
embryonic stem cells obtained through parthenogenesis
and androgenesis. Interestingly, this deregulated differen-
tiation appears to be modulated by the microenvironment
and, while undetectable, or repressed, when cells were
differentiated in vitro, it became evident once cells were
exposed to the less restrained in vivo milieu.
These results are in contrast to what previously described
in other human parthenogenetic cell lines. We have no
explanation for this differences and we cannot rule out the
possibility that these anomalies simply derive from differ-
ences in the procedures used for the derivation of the cell
lines. In particular while our activation protocol is almost
identical to that described by Revazova et al. [11, 12] it did
not include an electrical activation step as performed by
Mai et al. [10] whereas Lin et al. used spontaneously
activated oocytes [9]. Our cell lines were cultured on
immortalized mouse fibroblasts similarly to Mai et al. [10]
who used mouse embryonic fibroblasts, while in all other
cases human fibroblast feeder layers where used [9, 11, 12].
However, since normal cell lines were obtained with
protocols, in many aspects similar to the one used in our
experiments which, in turn, are described in the literature
for the culture of bi-parental cell lines, we think it is
unlikely that the specific protocol used in our experiment
can be the cause of the observed abnormalities.
Even if specific activation and culture conditions used in
the current experiments cannot be excluded as main cause
Fig. 5 Expression level of molecules related to spindle formation and
chromosome segregation in HP cells and bi-parental cell lines HES 7,
HES I-3 and HES I-6. Bars represent the average ΔCt of HP cells
(solid bars) and bi-parental cells (striped bars) related to the genes
examined. ΔCt value was obtained from the Ct of the target gene
normalized with the Ct value for β-actin of the same sample
Fig. 4 Formation of
myofibrosarcoma-like tumors
following injection of
undifferentiated HP cells in the
hind leg of SCID Beige and Fox
Chase SCID mice. Numerous
multinucleated cells showing
aberrant mitotic figures (a).
Vimentin-positive (b) and
Smooth Muscle Actin-positive
(c) cells dissecting and separating
residual skeletal myofibres.
Scattered, isolated
Desmin-positive (d) cells are
also detectable. HE staining (a)
and indirect avidin-biotin
immunoperoxidase staining with
3,3′-diaminobenzidine
chromogen reaction (c, d, e).
Scale bar 100 μm (A)
and 50 μm (b, c, d)
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of the altered behaviour of our cell lines upon in vivo
transplantation, we hypothesize that the uniparental origin
of HP cells and, in particular, the lack of the centrioles
supplied by the male counterpart, may be a possible
explanation with the use of relatively old donors as a
potential aggravating factor. It has been demonstrated that
centrioles degenerate and are lost during human oogenesis
and while oogonia and growing oocytes display normal
centrioles until pachytene stage, they are absent in the
mature oocytes [32]. With the notable exception of mice
[33] this degenerative process has been described in rhesus
monkeys [34], rabbits [35], cows [36], sea urchins [37],
Xenopus [38], and several other species [39]. Due to the
absence of centrioles, the oocyte centrosomal material does
not aggregate into unified foci and is unable to form astral
microtubules and a correctly oriented spindle, unless
rescued by a spermatozoon. The consequences of the lack
of centrioles on parthenogenetic development have been
studied in detail in lower species, where successful
parthenogenesis largely depends upon the oocyte ability to
generate complete and functional centrosomes in the
absence of the material supplied by a male gamete. In
particular, parthenogenetically activated sea urchin and
insect eggs have been described to form multiple centrioles,
possibly as the result of the lack of a correct control on the
process of spindle formation [40–42]. Indeed, the inability
of parthenogenetic oocytes to organize normal spindles due
to the lack of a functional centrosome has been suggested
as a strict checkpoint control to suppress parthenogenetic
development [43] since it is not an evolutionarily preferred
pathway even in species that are facultative parthenotes
because it leads to genomic homogeneity that, in turn,
results in the accumulation of genetic anomalies in the
population. These observations on the parthenogenetic
process in lower species are in agreement with our findings
in HP cells. Similarly to what reported in sea urchins and
many insects, for instance, we also found that HP cells
display multiple centrioles, suggesting that a decreased
ability to rearrange functional centrosomes is present in
these cells. This is also consistent with the observations by
Marshall [44], indicating that centriole de novo assembly is
normally turned off when a centriole is present. The
absence of sperm centriole in parthenotes may therefore
lead to the lack of a negative regulatory mechanism that
suppress de novo centriole assembly and may explain the
presence of multicentriolar structures as the ones described
in parthenotes and as the ones we detect in HP cells.
Interestingly enough, HP cells can proliferate and divide
and most importantly, they can correctly differentiate,
into a variety of tissues, responding to experimental
conditions that are able to induce differentiation in bi-
parental cells. This ability does not seem to be limited by
the abnormalities described above and suggests that the
requirement of a paternal centrosome described in lower
animals appears to be less stringent in human cells, at
least in in vitro controlled conditions. Indeed, in higher
Fig. 6 Immunohistochemical
(a) and ultrastructural (b-c-d-e)
analysis of human parthenoge-
netic cells. The presence of
amplified centrosomes loosely
dispersed in the cytoplasm can
be appreciated. Supernumerary
centrioles (arrows) and massive
autophagic processes generally
coexist (d). Often the cargo of
autophagic compartments
resemble centrioles partially
damaged (arrowheads)
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mammals, genomic imprinting is thought to be the main
mechanism to ensure bi-parental fertilization [45]. How-
ever these abnormalities in spindle rearrangement may
explain the presence of cells showing misshaped chromo-
somes in our cell lines. On the other hand, these
abnormalities do not seem to be specific of HP cells, and
do not seem to be related to the derivation protocol and/or
the culture conditions used in our experiments, since
spindle rearrangement and multiple chromosome mal-
segregations have been previously described in human
parthenogenetic embryos, that were obtained from oocytes
spontaneously activated and/or induced with puromycin
[46]. Furthermore they do not seem to be confined to
human parthenotes and appear to be common to other
mammalian species. Indeed a high incidence of abnormal
spindle and misshaped chromosomal complements has
been reported in parthenotes derived from bovine as well
as porcine activated oocytes, with abnormalities occurring
as early as completion of the first cell cycle. Each of these
reports linked these phenomena to the absence of a
paternally supplied centrosome [47, 48].
Altered expression levels of mitotic check point mole-
cules were found when in vitro cultured HP cells were
examined by real-time PCR. In particular, the comparison
of HP cells with bi-parental embryonic stem cell lines
indicated a much higher level of expression of Mad-1, and
the related molecules MAX and SIN3 in parthenogenetic
cells. Mad-1 is a central component of the spindle assembly
checkpoint and recruitment of kinetochores [49–51]. The
altered levels of such molecules present in HP cells may be
related to the lack of paternal contribution in spindle
assembly. A similar explanation could account for the very
low transcription for TTK and CENP-E detected in these
cells.
Conclusions
Cell lines derived from human parthenogenetic embryos
have great potentials since these cells possess most of the
main features of bi-parental stem cells, show high plasticity
and give rise to high specification tissue differentiation.
Whereas human parthenogenetic cell lines capable of
normal differentiation, not only in vitro but also in vivo
have been described, we observed malignant in vivo
differentiation accompanied by aberrant centriole distribu-
tion and abnormalities in the control of the mitotic spindle
check point. A series of experimental data, from our and
other laboratories, suggest that these phenomena may be
related to their uniparental origin but do not explain why
these alterations have not been observed in other cell lines.
We have no clear explanation for this but it is interesting to
note that experiments with bovine parthenotes showed that
the ability of maternal centrosomes to organize micro-
tubules differs from oocyte to oocyte, and this may
determine the developmental fate of each parthenote [52]
and, presumably of the resulting cell lines. Indeed differ-
ences in the in vivo differentiation potential between their
two human parthenogenetic cell lines have been described
also by Mai et al. [10]. Further investigations are required
in order to understand how individual variations can impact
the derivation of stable lines from human parthenotes and
how undesirable abnormalities can be prevented, especially
if a therapeutic use of this kind of stem cells is considered.
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Abstract The generation of porcine embryonic stem cells
(pESC) would potentially have great impact in the
biomedical field given the long-standing history of the pig
as a prime animal model for pre-clinical biomedical
applications. These cells would also be beneficial for the
agricultural area, allowing efficient genetic engineering of
this animal, to improve health and production traits. Despite
numerous reports, no conclusive results have been obtained
on the isolation and propagation of pESC lines and the
establishment of pluripotent cells from the pig has remained
an elusive goal. In the present study we performed a
systematic analysis of different culture media for their
ability to support the establishment of homogenous out-
growths from in vitro-produced embryos. Furthermore, we
investigated which molecular networks are responsive to
the factors contained in the most efficient media, since
the identification of dominant signaling pathways that
regulate porcine stem-cell pluripotency is likely to
facilitate the generation of genuine pESC. Finally we
compared IVF blastocysts versus parthenotes as a
possible source for putative pESC in terms of blastocyst
rate, resilience to immunosurgery procedures, ability to
attach to the feeder, to generate outgrowths and to
establish stable cell lines.
Keywords Porcine .Medium formulation .
Pluripotency signalling pathway . IVF. Parthenogenesis
Introduction
The establishment of embryonic stem cells (ESC) in
domestic animals could potentially have great impact both
in agricultural perspective and biomedical fields. In
particular, pig is a desirable species to create pluripotent
cell lines because of its value as a biomedical model, due to
its immunological, morphological, physiological and func-
tional similarities to the human [1–4]. However, despite
numerous reports, no conclusive results have been obtained
on the isolation and propagation of putative porcine ESC
(pESC) lines and no validated pESC lines are available as
yet. Putative pESC established by Notarianni et al. [5] were
poorly defined. In other studies no ESC-like cells survived
passage 10, while epithelial-like lines survived up to
passage 42, but failed to differentiate [6]. Talbot et al. [7]
reported that pluripotency was difficult to maintain in ESC-
like and epithelial-like cell cultures for more than a few
passages. Further studies have been conducted by other
authors [8, 9], however, the general consensus is that none
of these lines were truly ESCs and pluripotent [10, 11] and
a number of technical questions are still to be answered.
The use of conventional protocols for culture of mouse and
human ESC does not appear to sustain extended growth nor
pluripotency of cultured porcine cells. Recently it has been
demonstrated that medium components play a pivotal role
in regulating intrinsic and extrinsic factors involved in the
control of pluripotency and that specific pathways may be
up-regulated, or down-regulated, in response to the addition
of specific molecules [12]. It is evident that one important
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aspect that needs to be addressed is the identification of
appropriate in vitro culture conditions that may encourage
establishment of homogeneous outgrowths, and ensure a
favorable environment, as a preliminary step towards the
isolation of genuine pig pluripotent cells. Here we present
results of experiments designed in order to perform a
systematic study of different media formulations. We
identified ten different medium compositions and tested
them for their ability to promote outgrowth formation.
Furthermore, since the identification of dominant signaling
pathways that regulate stem-cell pluripotency in the pig is
likely to facilitate the generation of genuine pESC, we
studied the expression pattern of molecular networks
known to play a key role in the maintenance of pluri-
potency (LIFR, gp130, STAT3, FGFR-1, FGFR-2, PI3K,
AKT and PTEN) in response to factors contained in the
most efficient media. Finally, given the fact that in the
literature a higher efficiency of ESC derivation is reported
for parthenogenetic activated oocytes compared to biparen-
tal blastocysts [13–15], we compared embryos obtained from
IVF versus parthenogenetic activation, to verify if this occurs
also in pig. Furthermore we tried to identify what mechanism
affects efficiency since it could help the derivation of cell
lines regardless to the source of the embryo.
Material and Methods
Oocyte Collection and In Vitro Maturation (IVM)
Unless otherwise indicated, chemicals were purchased from
Sigma- Aldrich (Milan, Italy).
Ovaries were collected from gilts of approximately
120 Kg at the local abattoir and transported to the
laboratory in physiological saline (9g/l NaCl) at 30–34°C.
Cumulus- oocyte complexes (COCs) were aspirated from
antral follicles with an 18-gauge needle and vacuum
pressure of 50 ml/min.
The follicle aspirate was collected in 15 ml tubes
(Terumo, VenoSafe™) and only COCs with a large,
compact cumulus and homogeneous oocyte cytoplasm
were selected. In vitro maturation (IVM) was performed
as previously described [16] on a total of 2351 oocytes.
Embryo Production
At the end of IVM (46 h), oocytes were denuded by gently
pipetting in TCM-199 HEPES buffered medium, containing
0.1% hyaluronidase at 38.5°C and washed for 10 min in the
same medium supplemented with 20% (v/v) fetal calf serum
(FCS). Subsequently oocytes were fertilized with frozen-
thawed spermatozoa or parthenogenetically activated as
described below.
In Vitro Fertilization (IVF)
Frozen-thawed spermatozoa were purified by centrifugation
through two-layer Percoll gradients. Live sperm cells were
washed in Tyrode’s albumin lactate pyruvate medium
(TALP medium), consisting of 1.25 mM MgCl2.6H2O,
102.7 mM NaCl, 3 mM KCl, , 0.28 mMNaH2PO4, 5 mM
NaHCO3, 3.7 ml/l of Na lactate, 1 mM Na pyruvate,
20 mM HEPES, 1 mg/ml of polyvinylalcohol (PVA) and
antibiotics.
Spermatozoa were then diluited in IVF medium
(2.65 mM CaCl2-2H2O, 0.4 mM MgCl2.6H2O, 106.1 mM
NaCl, 3.08 mM KCl, 26 mM NaHCO3, 0.33 mMNaH2PO4,
1 mM Na pyruvate, 1.86 ml/l of Na lactate, 6 g/l BSA FAF
and antibiotics). A total of 1130 oocytes were divided in
groups of 45–50 and co-cultured with 120000 spermatozoa/
ml in IVF medium at 38.5°C in 5% CO2 atmosphere. After
24 h, oocytes were gently washed to eliminate cumulus
cells and sperm adhering to the zona pellucida. Finally,
embryos were cultured in groups of 25–35 in 50 µl NCSU-
23 drops under mineral oil at 38.5°C in 5% O2, 5% CO2
and 90% N2 atmosphere.
Parthenogenetic Activation
1221 oocytes were denuded and incubated in TALP
medium for 30 min at 38.5°C. Parthenogenetic activation
was performed according to the method described by
Brevini et al. [16] by sequentially exposing the oocytes to
5 mM ionomycin in TALP for 5 min at 38.58C in the dark;
and to 2 mM 6-DMAP in medium NCSU-23 for 3 h at
38.5°C in an atmosphere of 5% CO2, 5% O2, and 90% N2.
Presumptive parthenotes were washed thoroughly in
NCSU-23 and cultured as described above.
On day 5 post-activation or fertilization, half of the
medium was replaced with fresh NCSU-23 containing 20%
(v/v) FCS to reach a final FCS concentration of 10% (v/v) in
the in vitro culture drop.
Preparation of STO Fibroblast Feeder Layers
STO fibroblasts (LGC Promochem-ATCC, Italy) were
routinely cultured in high glucose DMEM (Gibco, Italy),
supplemented with 2 mM glutamine and 10% Foetal
Bovine Serum (FBS; Gibco, Italy). For growth inactivation,
sub-confluent mono-layers were exposed to the medium
above containing 10 μg/ml mitomycin-C (Gibco, Italy) for
3 h. They were re-suspended in culture medium and seeded
at a density of 25×104 cell/well in 4-well dishes, pre-coated
with 0.1% gelatin. Inactivation was carried-out 24 h before
plating of ICMs or passaging of pluripotent cell lines. Two
hours before use, the medium was changed and replaced
with putative pESC medium (see below).
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Immunosurgery and Outgrowth Derivation
Parthenotes and IVF embryos were cultured up to the early
blastocysts stage (6 days for parthenotes and 7 days for IVF
embryos). Blastocysts were incubated in pronase 0.5% (w/v)
in medium TCM199 (Gibco, Italy), supplemented with
6.5 mg/ml HEPES, 1.1 mg/ml sodium bicarbonate and
4 mg/ml bovine serum albumin (BSA). Incubation was
carried out for 8 min to eliminate zona pellucida.
Subsequently, blastocysts were incubated in low glucose
DMEM medium (Gibco, Italy) supplemented with 10%
PVA and 10% monkey anti-porcine serum (supplied by
Istituto Zooprofilattico Sperimentale Lombardia ed Emilia-
Romagna, Brescia) for 15 min. A 30 min incubation in
DMEM medium (Gibco, Italy) containing 10% PVA and
10% Guinea pig complement was then performed. ICMs
were isolated from lysed trophoblast cells by pipetting and
washed through several DMEM drops to avoid culture oil
carry-overs and encourage better attachment.
Outgrowth Culture Conditions
Isolated ICMs, derived from IVF embryos and parthenotes,
were plated on freshly inactivated STO fibroblast feeder
layers. The different culture formulations tested for their ability
to promote outgrowth attachment are described in Table 1.
After 3 days from primary outgrowth establishment,
media were refreshed. When a colony enlarged enough to
cover half or more of the well surface, cells were
mechanically removed using a sterile microloop (Nunc,
DK), they were transferred to a 50 μl drop of fresh medium
and pipetted to small cell clumps of an average of 500–600
cells, avoiding to obtain single cell suspension. Cells were
then passaged on freshly prepared feeder-layers. Culture
medium was changed every day.
Putative pESC Characterization
Gene Expression Analysis of Putative pESC
A small aliquot of the cell suspension was isolated at each
passage and was subjected to Reverse Transcription-
Polimerase Chain Reaction (RT-PCR), screening for the
expression of the genes listed in Table 2. Total RNA was
extracted and cDNA was obtained using Superscript-™ II
Reverse Transcriptase (Invitrogen, Italy). Amplifications
were carried out in an automated thermal cycler (iCycler,
Biorad), using the conditions appropriate for each set of
primers. Accession numbers, sequences of the primers used,
annealing temperatures and fragment sizes are summarized
in Table 2. Amplification products were purified in Spin-X
centrifuge tube filters (Corning, Netherlands), sequenced
(SEQLAB, Gottingen, Germany) and aligned using Clustal
W 1.82 (EMBL-EBI service).
Real-time PCR was performed on 10 parthenotes and 10
IVF ICMs using ABI- Prism 7000 Sequence Detecting
System (Applied Biosystem) and gene-specific primer
(Table 3). Gene expression level was reported as ΔCt
value. For each individual gene the number of amplification
cycles for the fluorescent reporter signal to reach a common
threshold value (Ct) was estimated and then normalized by
subtracting the Ct value obtained for the same sample for a
positive control transcript (β-actin), to give ΔCt value.
Immunocytochemical Analysis
Parthenogenetic and IVF-derived putative pESC were
rinsed with PBS, fixed in 4% paraformaldehyde and
permeabilized with 0.1% Triton X-100. Primary antibodies,
diluted in blocking solution (10% serum in PBS), were
incubated over night at 4°C.
Table 1 Formulation of the culture media tested. * Nutrient mix was composed by 2 mM glutamine, 0.1 mM β-mercaptoethanol, nucleoside mix
and 1% non-essential aminoacid (Gibco, Italy)
DMEM-low
glucose (Gibco,
Italy)
DMEM –
K.O. (Gibco,
Italy)
HAM’S-
F10 (Gibco,
Italy)
NUTRIENT
MIX *
1000IU/ml
ES-GROWTH
(LIF; Chemicon,
USA)
5ng/ml bFGF
(R&D System,
USA)
K.O. SERUM
(Gibco, Italy)
FBS
(Gibco, Italy)
A + + + 15%
B + + + 10% 5%
C + + + 10% 5%
D + + + + + 15%
E + + + + + 10% 5%
F + + + + 15%
G + + + 10% 5%
H + + 10% 5%
I + +
L + + + 10% 5%
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The following markers of pluripotency were analized:
Oct-4 (1:50, Chemicon, USA); Nanog (1:20, R&D System,
USA); SSEA-4 (1:100, Chemicon, USA). The specificity of
these antibodies on pig tissues was previously validated
[17–19]. Incubation with suitable secondary antibodies
(Alexafluor, Invitrogen, Italy) was carried out for 30 min
and nuclei were stained with 4′,6-diamidino-2-phenylindole
(DAPI). Samples were observed either under a TCS-NT
laser confocal microscope (Leica Microsystems, Germany)
or an Eclipse E600 microscope (Nikon, Japan), depending
on the experiment.
Telomerase Activity
Telomerase activity measurement was performed using the
TRAPeze® Telomerase Detection Kit (Chemicon, USA),
following the manufacturer’s instruction. Briefly, lysates
were obtained from IVF and parthenogenetic putative
pESC. Reactions were separated on non-denaturing TBE-
based 12% polyacrylamide gel electrophoresis and visual-
ized with SYBR Green staining. Buffer alone was used as
negative control, telomerase-positive control cells (provided
in the kit) was the positive control.
Table 2 Primers used for RT-PCR
GENE EMBL Accession No. Primer sequence Annealing temperature Fragment size
Oct-4 NM_001113060.1 For 5′- aggtgttcagccaaacgacc-3′ 64°C 335bp
Rev 5′- tgatcgtttgcccttctggc-3′
Nanog DQ447201.1 For 5′- atccagcttgtccccaaag-3′ 60°C 438bp
Rev 5′- atttcattcgctggttctgg-3′
Sox -2 EU503117.1 For 5′ -gccctgcagtacaactccat-3′ 60°C 216bp
Rev 5′- gctgatcatgtcccgtaggt-3′
Rex - 1 AM410991 For 5′-cttcaaggagagcgcaaaac-3′ 56°C 299bp
Rev 5′-tgtccccaatcaaaaatgct-3′
BMP-4 EU549864.1 For 5′-tgagcctttccagcaagttt-3′ 60°C 298bp
Rev 5′- caacgcacagatcaggaaga-3′
NF-H NM_021076.3 For 5′-agagctggaggcactgaaaa-3′ 60°C 248bp
Rev 5′-tccgacactcttcaccttcc-3′
α-amylase AF064742.1 For 5′-cgctccatgattgctgatta-3′ 57°C 196bp
Rev 5′-cctcaccacccaaatcaatc-3′
LIFR SSU97364 For 5′- atcatcagtgtggtggcaaa-3′ 60°C 201bp
Rev 5′- gcagggtccagactgagatg-3′
gp130 NM_001097432 For 5′- aaagctgcctcaacttggaa-3′ 60°C 211bp
Rev 5′- accagaaacttggtgccttg-3′
FGFR-1 AJ577088.1 (Hyttel, 2009) For 5′- actgctggagttaataccaccg-3′ 55°C 125bp
Rev 5′- gcagagtgatgggagagtcc-3′
FGFR-2 NM_001099924 For 5′-cgtgtacacccaccagagtg-3′ 60°C 139bp
Rev 5′- agaggctgactgaggtccaa-3′
STAT-3 DQ470570.1 For 5′- cgcagagttcaaacacctga-3′ 60°C 260bp
Rev 5′- agttcacgttcttggggttg-3′
PTEN FJ436380.1 For 5′-cgacgggaagacaagttcat-3′ 60°C 163bp
Rev 5′-aggtttcctctggtcctggt-3′
PI3K NM_001012956.1 For 5′- atgggggaagcagagaagtt-3′ 60°C 281bp
Rev 5′- ggcagtttcagccattcatt-3′
AKT AB499527.1 For 5′- atcgtgtggcaggatgtgta-3′ 60°C 200bp
Rev 5′- ctggccgagtaggagaactg-3′
Actin NM_007393.3 For 5′- tgaaccctaaggccaaccgtg-3′ 60°C 267bp
Rev 5′- tgtagccacgctcggtcagga-3′
Vitronectin NM_214104.1 For 5′-gagctgctgcactgactacg-3′ 60°C 299bp
Rev 5′-aaccgttcttgaggttggtg-3′
ITGB1 NM_213968.1 For 5′-cgggagaaaatgctccaata-3′ 60°C 227bp
Rev 5′-cacactcaaacgtcccattg-3′
Actin NM_007393.3 For 5′- tgaaccctaaggccaaccgtg-3′ 60°C 267bp
Rev 5′- tgtagccacgctcggtcagga-3′
Table 3 Primers used for Real
Time-PCR
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Differentation Ability of Putative pESC
Derivation of Embryoid Bodies
To induce the formation of embryoid bodies (EBs), cells
were cultured in 30 μl hanging droplets of putative pESC
medium without LIF and bFGF. The medium was refreshed
every day and after 10–12 days, EBs were detectable.
Differentiation of EBs was confirmed, through RT-PCR
screening for the expression of markers related to meso-
derm (Bone Morphogenetic Protein-4, BMP-4), ectoderm
(Neurofilament-H, NF-H) and endoderm (α-amilase) (see
Table 2).
Spontaneous In Vitro Differentiation
EBs were mechanically dissociated and cells were plated
directly onto CultureWell Chambered Coverglass 16-well
dishes (Molecular Probes, Italy) to encourage adherent
culture conditions and spontaneous differentiation. After
one week, cells were processed for immunocytochemical
analisys. They were subjected to the same process
previously described for immunocytochemical analisys
and were screened for the presence of differentiation
markers: Desmin (1:200, Chemicon, USA); Keratin 17
(1:200, Chemicon, USA); Vimentin (1:200, Chemicon,
USA). The ability of Keratin 17 antibody to recognize pig
cells is documented by the manufacturer. Desmin and
Vimentin antibody specificity was previously validated by
other Authors [17, 20].
Statistical Analysis
The Χ 2 test (P<0.05) was used to compare the results
obtained from IVF and parthenogenetic embryos.
Results
Assessment of Different Culture Conditions for Outgrowth
Formation and Cell Line Derivation
In this set of experiments we examined the effect of
different medium formulations (Table 1) through the
evaluation of primary outgrowth formation, outgrowth
expansion and cell line establishment. We tested the
different media using ICMs derived from both parthenoge-
netic and IVF embryos. The results obtained are summa-
rized in Table 4. No primary outgrowths were obtained with
media A, B, C, G, H, I and L. Using these media ICMs did
not attach or adhered loosely to the feeder layer, with no
increase in outgrowth cell number. Intermediate results
were obtained with media D and F. In these two groups, we
could observe attachment of ICMs. However all cells
differentiated after 9–12 days of culture. The best results were
obtained with medium E that allowed the derivation of
homogeneous outgrowths, consisting entirely of cells which
resembled ES cells in their morphology (Figs. 1 and 2, panel
A), both using parthenogenetic and IVF ICMs. The newly
produced outgrowths grew in size and, after 7–8 days of
culture, formed circular colonies of 3–5 mm in diameter,
with distinct margins (Figs. 1 and 2, panel A). At this stage
they were passaged onto a fresh feeder layer to establish cell
lines or were subjected to further characterization. Putative
pESC showed many pluripotency aspects common to mESC
and hESC. They were maintained for many passages (45
passages at present). They presented high telomerase activity,
which disappeared when cells were induced to differentiate
(Fig. 3), indicating a physiologically normal control of
telomerase activity in these cells. They expressed many of
the known pluripotency related transcription factors and
surface markers (Figs. 1 and 2, panel B and C).
Table 4 Effect of different culture media formulation. Total number of parthenogenetic and IVF ICMs plated, outhgrowth attachment and
pluripotent cell lines obtained
Medium Parthenogenetic ICM Parthenogenetic outgrowth IVF ICM IVF outgrowth Note
A 12 0 5 0 No
B 13 0 4 0 No
C 10 0 5 0 No
D 39 7 18 1 Differentiated after 9–12 days
E 36 30 16 2 Homogeneous and ESC-like morphology
F 24 4 10 1 Differentiated after 9–12 days
G 12 0 6 0 No
H 15 0 8 0 No
I 11 0 6 0 No
L 13 0 5 0 No
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Altogether, this result indicates that the use of medium
E, containing a combination of LIF, bFGF and FBS is the
most effective to promote outgrowth attachment and
support cell line expansion.
Characterization of Molecular Networks Involved
in the Inhibition of Differentiation
We analyzed the expression profile of a set of molecules
responsive to LIF and bFGF. The results obtained by RT-
PCR analysis are shown in Fig. 4 and indicate that putative
pESC express STAT-3, but mRNAs for LIF receptor
subunits (LIFR and gp130) are not present. On the contrary
expression of three genes (PI3K, AKT and PTEN),
representative of the PI3K/AKT pathway, a signaling
cascade known to be responsive to LIF, was detected
consistently. Further analysis demonstrated that putative
pESC express FGFR-2, while no positivity was obtained
for FGFR-1.
Derivation of EBs and Differentiation Plasticity of Putative
pESC
Putative pESC lines obtained from IVF embryos and
parthenotes were analyzed for differentiation ability. For-
mation of EBs was observed regularly after 10–12 days of
hanging droplets culture for both types of cell lines (Figs. 5
and 6, panel A). EBs expressed tissue-specific markers like
BMP-4, NF-H, and α-amilase (Figs. 5 and 6, panel B).
Furthermore when EBs were disaggregated and grown in
monolayer conditions, they presented the expression of
keratin 17, vimentin and desmin (Figs. 5 and 6, panel C),
indicating that subpopulations of cells representative of all
three germ layers could be obtained.
IVF-Embryos vs. Parthenotes: Blastocyst Rate,
Immunosurgery Resilience, Outgrowth and Cell Line
Formation
We compared blastocyst rate, immunosurgery resilience,
primary outgrowth formation and cell lines derivation using
IVF blastocysts and parthenotes as a source.
The results for this comparison are shown in Table 5 and
indicate that parthenogentic activation generated a signifi-
cantly higher number of blastocysts than IVF (23.1% vs
8.93%). ICMs were successfully isolated from 83 IVF
blastocysts (82.18%) and 185 parthenotes (65.6%). Parthe-
notes tended to be less resilient than IVF embryos to
immunosurgery, although this difference is not statistically
Fig. 1 Putative pESC derived from parthenotes. Putative pESC were
positive for several known pluripotency-related markers. The figure is
representative of all passages (45 passages at present). The expression
of Oct-4, Nanog, Rex-1, Sox-2 is shown in panel b. Genomic DNA
was used as a positive control; negative control was represented by
differentiated parthenogenetic putative pESC. Cytochemical analysis
with specific antibodies demonstrated immunopositivity of partheno-
genetic cells for Oct-4, Nanog and SSEA-4. Cell nuclei, stained with
DAPI, are coloured in blue (c)
R
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significant. However, parthenogenetic ICMs had a signifi-
cantly higher ability to form outgrowths (22.16% vs 4.82%)
and to generate cell lines that displayed an ESC-like
morphology (39 from parthenotes and only 3 from IVF
embryos). All cell lines (42) were positive for pluripotency
markers at the first passage. Ten of them lost their
expression within two to three passages and then differen-
tiated or degenerated. Only the remaining 32 cell lines, that
maintained pluripotency markers, displayed high telomer-
ase activity and showed differentiation capability, were
considered putative pESC (Figs. 1, 2, 3, 5 and 6). They
represented 2.41% of the plated IVF ICMs and 16.22% of
the parthenogenetic ones.
Fig. 3 IVF and parthenogenetic putative pESC telomerase activity.
Undifferentiated parthenogenetic and IVF putative pESC displayed
high levels of telomerase activity, while no telomerase activity could
be detected in differentiated (Diff) progeny, indicating a physiologi-
cally normal control of telomerase activity in these cells
Fig. 2 Putative pESC derived from IVF blastocysts. Putative pESC
were positive for several known pluripotency-related markers. The
figure is representative of all passages (45 passages at present). The
expression of Oct-4, Nanog, Rex-1, Sox-2 is shown in panel b.
Genomic DNA was used as a positive control; negative control was
represented by differentiated IVF putative pESC. Cytochemical
analysis with specific antibodies demonstrated immunopositivity of
bi-parental cells for Oct-4, Nanog and SSEA-4. Cell nuclei, stained
with DAPI, are coloured in blue (c)

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In order to understand why parthenogenetic ICM had
higher ability to form outgrowths, we compared the
expression level of cell adhesion molecules between
parthenogenetic and bi-parental ICMs. The results indicated
that the expression of beta integrin-1 (ITGB1) and
vitronectin was higher in parthenogenetic than in IVF
ICMs (see Fig. 7).
Discussion
We compared different media formulations using both pig
parthenogenetic and IVF embryos as a source for outgrowth
formation and cell line derivation. We could establish that,
regardless to the different source used, 1000 IU/ml of LIF,
5 ng/ml human recombinant basic Fibroblast Growth Factor
and a minimum concentration of 10% K.O. serum were
required in our medium, in order to ensure ICM attachment
(medium D and F). In our experimental conditions, the
presence of these components allowed 16.8% (45/268) of
the seeded ICMs to adhere to the inactivated feeder layer
and to form outgrowths. However it is interesting to note
that, only when these outgrowths were maintained also in
the presence of FBS and Ham’s F10 (medium E), self
renewal ability was ensured and stable lines were generated
Fig. 4 Gene expression panel of pluripotency pathways related genes.
Parthenogenetic and IVF putative pESC showed consistent expression
of FGFR-2, STAT3, AKT, PI3K and PTEN, while no positivity was
obtained for FGFR-1, LIFR and gp130
Fig. 5 Differentiation ability of parthenogenetic putative pESC after
induction of EB formation. RT-PCR analysis of RNA extracted from
EBs (a) consistently demonstrated expression of markers specific for
the three germ layers and, more in details bone morphogenetic
protein-4 (Bmp-4, mesoderm), neurofilament H (NF-H, ectoderm) and
α-amylase (endoderm). Genomic DNAwas used as a positive control;
negative control was represented by undifferentiated parthenogenetic
putative pESC (b). Disaggregation and plating of EBs confirmed
parthenogenetic cell plasticity, with consistent presence in the
monolayer of cells displaying immunopositivity for vimentin (ecto-
derm), cytokeratin 17 (endoderm) and desmin (mesoderm). Cell
nuclei, stained with DAPI, are coloured in blue (c)
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(32/52). A possible role played by FBS, in combination
with LIF, in the maintenance of pluripotency has recently
been demonstrated in experiments carried out with mouse
ESC, where the use of a medium supplemented with LIF
and FBS was able to preserve the undifferentiated pheno-
type [21]. Consistent with this, the cell lines generated in
our laboratory, displayed undifferentiated morphology,
expressed pluripotency-related markers and showed high
telomerase activity, indicating that the culture conditions
used were adequate to maintain several aspects related to
pluripotency (Figs. 1 and 2). This was further confirmed by
the ability of both IVF and parthenogenetic putative pESC
to give rise to EBs, that were able to differentiate into cell
types belonging to the three embryonic germ layers, as
shown by molecular screening and immunocytochemical
staining (Figs. 4 and 5).
Cell signaling pathways that are known to govern
pluripotency and that are well characterized in other species
are still to be elucidated in the pig and an understanding of
these aspects would indeed help to identify the conditions
adequate to support self-renewal requirements in this
species. Our results clearly indicated that neither LIF nor
bFGF alone are sufficient to establish outgrowths and
generate stable cell lines. Therefore we studied the
signaling pathways responsible for the biological activities
of both these molecules. Our results showed the expression
of STAT3 but the absence of gp130 and LIFR transcripts,
two specific subunits of LIF receptors (Fig. 3). In
agreement with this, a previous report demonstrated
inconsistent expression of LIFR in porcine 24 hr epiblast
cells [22]. The variability among samples was explained in
that study as a result of contaminating endoderm, making it
difficult to ascertain a potential importance of LIF/LIFR in
the porcine. This observation has been further confirmed by
a recent study that could not detect LIFR in the epiblast
cells of early embryos [23]. Altogether, these data would
imply the dispensability of LIF in supporting pluripo-
tency in the porcine species and would seem to disagree
with our results indicating LIF as a key supplement,
supporting both attachment and self renewal. However
we found that putative pESC actively transcribe for
PI3K, AKT (a key effector in the PI3K pathway) and
PTEN (a negative regulator of the same pathway)
(Fig. 3). The PI3K /AKT signaling cascade is known
to be responsive to LIF and has been previously shown
to trigger the expression of Nanog and to facilitate
efficient proliferation and survival of murine ESC [24].
Based on these observations, we hypothesize that LIF is
involved in maintenance of self renewal in porcine cells.
However this cytokine is unlikely to act through the
gp130/LIFR/STAT3 signaling pathway, but, rather via
alternative cascades, one of which could be represented
by the PI3K /AKT system.
Fig. 6 Differentiation ability of IVF putative pESC after induction of
EB formation. RT-PCR analysis of RNA extracted from EBs (a)
consistently demonstrated expression of markers specific for the three
germ layers and, more in details bone morphogenetic protein-4 (Bmp-
4, mesoderm), neurofilament H (NF-H, ectoderm) and α-amylase
(endoderm). Genomic DNA was used as a positive control; negative
control was represented by undifferentiated IVF putative pESC (b).
Disaggregation and plating of EBs confirmed IVF putative pESC
plasticity, with consistent presence in the monolayer of cells
displaying immunopositivity for vimentin (ectoderm), cytokeratin 17
(endoderm) and desmin (mesoderm). Cell nuclei, stained with DAPI,
are coloured in blue (c)
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A further factor that was tested in our experiments and
resulted to be beneficial for pig outgrowth attachment and
colony formation was bFGF. This observation is supported
by previous reports showing that FGF pathway is necessary
for proliferation and pluripotency [25, 26] and can fully
replace LIF for maintenance of hESC self-renewal [27].
Inhibition of the bFGF signaling has been demonstrated to
repress Oct3/4 expression, suppress downstream kinases
and drive ESC into differentiation [28, 29]. bFGF exerts its
effects, binding to one or more of its several specific
receptors [30, 31]. The expression studies carried out in our
experiments demonstrated the presence of FGFR-2 in pESC
(Fig. 3), indicating the ability of porcine cells to bind bFGF
and explaining the beneficial effect exerted by the addition
of this factor to the culture medium. These experimental
data suggest a possible role of the FGF signaling pathway
in self renewal of porcine cells. Furthermore it is notewor-
thy that bFGF can also bind and activate the PI3K /AKT
cascade [32, 33], which is expressed in putative pESC. It
cannot be ruled out that bFGF could exert its pluripotency
related effect through this pathway as well.
Expression of the molecules involved in the signaling
pathways described above was detected both in partheno-
genetic and IVF derived cells, implying the existence of a
number of common regulatory pathways between the two
cell populations. Striking diversities were however evident
in a second set of experiments where differences between
parthenotes and IVF embryos as a source for the establish-
ment of putative pESC were assessed. In these studies we
used the medium formulation previously selected as the one
ensuring the most adequate support for both and scored the
ability to generate stable outgrowths/cell lines from
embryos of different origins.
We observed that parthenogenetic ICMs appeared to be
less resilient than IVF ones to the standard immunosurgery
protocol used (Table 5). We have no clear explanation for
this, however it may be useful to remember that a
significantly higher number of apoptotic cells has been
reported in pig parthenogenetic blastocysts, compared with
fertilized embryos [34]. This may represent a disadvantage
and leads to a decreased ability of these embryos to
withstand the stress related to immunosurgery treatment.
By contrast, isolated parthenogenetic ICMs generated a
significantly higher number of outgrowths than IVF ones
(22.16% vs 4.82%). This observation suggests a better
ability of parthenogenetic embryos to adhere to the feeder
cells and to form outgrowths. Although, further studies are
needed in order to better elucidate this aspect, we think that
one of the possible explanation of this trend may be found
in the higher expression levels of beta integrin-1 and
vitronectin, that we consistently detected in parthenogenetic
ICMs (see Fig. 7). Both these molecules are involved in the
implantation cascade and stabilize cell to cell adhesion [35].
Their increased expression in parthenogenetic ICMs may
therefore be one of the possible factors accounting for the
significantly higher number of outgrowths obtained from
parthenotes. Consistent with these data, previous studies
carried out in mouse ESC have shown that altered
expression of integrins lead to a reduced ability of the cells
to adhere and to maintain stable association with fibroblast
feeder layers [36]. The higher ability of parthenogenetic
Fig. 7 Expression level of adhesion molecules involved in the
implantation cascade. Bars represent the average ΔCt of parthenoge-
netic ICMs (orange) and IVF ICMs (blu) related to vitronectin and
ITGB1 genes. ΔCt value was obtained from the Ct of the target gene
normalized with the Ct value for β-actin of the same sample
IVF Parthenogenetic activation
Oocytes 1130 1221
Blastocysts 101 (8.93%) 282 (23.1%)
Successful Immunosurgery 83 (82.18%) 185 (65.6%)
Outgrowths 4 (4.82%) 41 (22.16%)*
Cell lines 3 (3.61%) 39 (21.08%)*
Putative pESC 2 (2.41%) 30 (16.22%)*
Table 5 Effect of IVF vs.
parthenogenesis on different pa-
rameter leading to the derivation
of putative pESC lines. Total
number (% rate) of ICMs, out-
growths and cell lines obtained
from IVF and parthenogenetic
blastocyst. *(P<0.05)
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ICMs to form outgrowths represents an obvious advantage
for the generation of cell lines. However, it may as well
increase cell ability to improperly colonize a substrate and
needs to be further studied. Several reports in the literature
correlates increased expression of cell adhesion molecules
to the process of invasion and tumor formation [37, 38].
The higher ability of parthenogenetic ICMs to form
outgrowths described in the present report does not appear
to be specific of the pig and is common to many other
species. In the mouse, Kim K. et al. [15] describe an
efficiency of ESC de novo isolation from parthenogenetic
activated oocytes of 65%, compared to the much lower
success (averaging 15%) reported when IVF blastocysts
were used as a source [39]. Consistent with these data, also
in human systems, embryos obtained with parthenogenetic
activation protocols were more effective than those
obtained from regular IVF, with a significantly higher
number of ICMs that attached to MEF feeder layer and
generated stable cell lines [14]. Similarly, in rabbit, while
only 1 line was isolated from ten IVF blastocysts, 3 lines
were recovered from ten parthenogenetic embryos [40].
These observations suggest that similar regulatory path-
ways are likely to exist among different species and
modulate many of the mechanisms involved in the control
of cell adhesion, outgrowth formation and cell line
generation. However species related differences appear to
drive the coupling of these common mechanisms with the
specific timing of embryo development, the distinct
expression and relative concentration of pluripotency-
related molecules and the diverse needs of the cell in its
micro environment. We think that the understanding of
these subtle but meaningful diversities within species may
provide beneficial information towards the isolation of
genuine ESC.
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Embryonic Stem Cells in Domestic Animals
No shortcuts to pig embryonic stem cells
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Abstract
The establishment of embryonic stem cell (ESC) lines in domestic species could have great impact in the agricultural as well
as in the biomedical field. In particular, derivation of pig ESC would find important applications aimed at improving health and
production traits of this species through genetic engineering. Similarly, the immunological, morphological, physiological, and
functional similarities to the human make the pig a very effective and suitable animal model for biomedical studies and pre-clinical
trials. While proven blastocyst-derived mouse and human ESC lines have been established, no validated porcine ESC (pESC) lines
are available. In the present manuscript we briefly discuss some of the factors that make the establishment of ESC lines in the pig,
and in animal species other than mouse and human, a very slow process. The paucity of information related to morphology,
pluripotency markers, differentiation capability hampers a thorough evaluation of the validity of putative lines.
These difficulties are further increased by the lack of reliable antibodies, reagents, and in vitro culture systems that could ensure
reliable results in the pig and allow for the screening and long-term maintenance of pESC.
Data from the literature suggest that similar regulatory pathways are likely to exist among different species. Coupling of these pathways with
their distinct expression patterns, the relative concentrations of pluripotency-related molecules, and timing of embryo development, along with
supportive micro-environmental conditions, would appear to vary in a species-specific manner. We feel that the understanding of these subtle
but meaningful diversities may provide beneficial information about the isolation of genuine porcine embryonic stem cells.
© 2010 Elsevier Inc. All rights reserved.
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1. Introduction
During the past 15 years, many reports of porcine
ESC lines, or what are often presented as “ES-like”
cell lines, have been published. However, validated
pig ESC (pESC) lines still do not exist and no con-
clusive results have been obtained, despite numerous
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reports related to the isolation and propagation of putative
pESC lines (reviewed in Brevini et al, 2007) [1].
Putative pESC established by Evan et al (1990) [2]
and their relative differentiated cells, were poorly de-
fined. In other studies no ESC-like cells proliferated
beyond passage 10, while epithelial-like lines survived
up to passage 42, but failed to differentiate [3]. In other
studies the pluripotent features of both ESC-like and
epithelial-like cells were difficult to maintain for more
than a few passages [4]. The general consensus is that
none of these lines were truly ESCs and pluripotent
[1,5] and a number of technical questions are still to be
answered. None have been successfully used as a bio-
logical reagent in a manner similar to the use of human,
monkey or mouse ES cells, i.e., directed pluripotent in
vitro differentiation [6,7] or as a means of genetically
engineering through embryonic chimera formation [8].
The majority of mouse and monkeys [9] ESC lines
have been established from in vivo-derived embryos,
while human ones originate from in vitro-fertilized
(IVF) and in vitro-cultured (IVC) blastocysts [10–12].
In the peer-reviewed reports on establishment of
porcine ES, ES-like, or ICM cell lines, all used in
vivo-derived blastocysts as their primary culture mate-
rial [2,13–18]. These in vivo blastocysts were acquired
from the reproductive tract, at various stages, but gen-
erally at the early blastocyst stage to the later elongated
or filamentous stage. Only in the last years studies
reported on the isolation of putative pESC using in vitro
produced blastocysts [1,19–21].
Given the high cost and the low efficiencies of ESC
derivation from in vivo derived embryos [22], more
researchers are working with domestic species to gen-
erate greater numbers of in vitro embryos (in vitro
fertilized embryos, parthenotes, somatic cell nuclear
transfer embryos) for use in ESC isolation. However,
difficulties are evident in the production of pESCs in
vitro: while IVF of bovine embryos is well established,
production of porcine embryos in vitro is still challeng-
ing, with low efficiency and quality [23].
2. Different species, different timing
The optimal embryonic developmental stage for the
initiation of ICM cultures for establishing pESC lines is
not known.
At the time of implantation, the mouse blastocyst
contains three cell types: epiblast, trophectoderm, and
primitive endoderm [24]. The epiblast will give rise to
the embryo and it has been shown to be the source for
ESCs [25]. These three early embryonic lineages are
present in all eutherian species. However, compared to
mice and humans, where the epiblast never gets ex-
posed to the uterine environment, blastocysts of ungu-
lates have an extended period of preimplantation de-
velopment, during which exposure takes place (Fig. 1).
In man, formation of the three early lineages takes
approximately 6 d post fertilization [26]. In contrast, in
the pig, sheep, and cow, epiblast formation starts at
hatching and is completed around day 12 [27]. This
implies that no defined epiblast is likely to be present in
pig blastocysts before hatching (day 6 or 7 of develop-
ment in vivo) [28]. During the following days there is
only a modest increase in the number of epiblast cells
in the ICM of the blastocyst compared with the increase
in trophectoderm and visceral endoderm cells.
In pig conceptuses, the thin layer of trophectoderm,
the Rauber’s layer, covering the epiblast and separating
it from the uterine lumen and visceral endoderm,
slowly starts to degenerate by day 9 post-fertilization.
This structure progressively disappears, leaving the epi-
blast directly exposed to the uterine lumen [29]. The
first signs of polarity become evident along with the
formation of a crescent-shaped thickening within
the posterior third. This thickening will differentiate
into the primitive streak. This event accompanies the
appearance of defined mesoderm and endoderm layers
[30]. It follows a gradual downregulation of the pluri-
potency marker OCT-4 with a concurrent upregulation
of -tubulin III expression, a marker of neural differ-
entiation. This suggests that embryos at this stage are
no longer suitable for ESCs derivation.
The question that needs to be answered is: what
point in the preimplantation development is best for the
isolation of stable pESC lines? Examining this prob-
lem, Chen et al [17] found that early hatched in vivo
Fig. 1. Species specific periods of early embryos development.
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blastocysts had a relatively small number of trophecto-
derm cells and a less flattened ICM. The success rate
for the establishment of pig ES-like cell cultures was
decidedly greater (12 cultures (21%) vs. none) from
recently hatched blastocysts than from late-hatched
blastocysts [17]. Another report used in vivo pig blas-
tocysts from day 5–6 to day 10–11 of gestation and
found that while day 10–11 blastocysts yielded ES-like
cell cultures, few or none were propagated from day
5–6 embryos [15]. Our experience confirms the possi-
bility of establishing stable pluripotent cell lines using
day 6–7 blastocysts. This was demonstrated, using both
in vivo and in vitro (parthenogenetic and IVF) derived
embryos, which were treated with pronase for 7 min to
remove the zona pellucida and then subjected to im-
munosurgery, using a custom made pig antiserum.
ICMs were seeded on inactivated SIM mouse embryo-
derived and thioguanine and ouabain resistant (STO)
fibroblast feeder layers and monitored for attachment
and derivation of outgrowths (Fig. 2). Although cell
lines were derived from the different sources, the rate
of success varied and parthenogenetic ICMs displayed
a higher ability to form outgrowths and generate stable
cell lines [1,31].
3. Which culture conditions?
Compared with the large number of studies explor-
ing the appropriate culture conditions for mouse and
human ESCs, there is a minimal amount of data avail-
able for domestic species ESC. That limited informa-
tion is mainly based on mouse ESC culture systems. As
a result, such conditions did not appear to be effective
for maintaining stable undifferentiated ESC lines in
domestic animals. We are convinced that a major goal
at present is to develop better culture formulations in
order to obtain homogenous pluripotent outgrowths
from pig embryos and identify the best in vitro envi-
ronment that would facilitate derivation of stable pESC
culture.
Several authors highlighted the need for a feeder-
layer (STO cells or mouse embryonic fibroblasts) in
order to ensure the survival of pig (and bovine) epiblast
cells in primary culture [32,33]. Without feeder-cell
support, cultures of primary pig epiblast cells failed to
grow, and instead senesced and died over a 10–14 d
period. Similar results were reported with feeder-free,
short-term, primary cultures of pig ICMs, with or with-
out the addition of leukemia inhibitory factor (LIF) to
the medium [34]. It is plausible that ungulate ES cell
line establishment will therefore require feeder cells, at
least in their initial culture, as has been true for the
establishment of most mouse and primate ES cell lines.
The need for a feeder layer does not seem to be
related only to the release of specific factors by the
feeder cell populations, since the use of conditioned
medium did not exert a comparable effect. The pres-
ence of feeder cells appeared to be necessary in order to
ensure good culture conditions. Therefore, at present,
most laboratories use protocols similar to those de-
scribed in the mouse, and ungulates ESCs are grown on
a feeder layer, in medium supplemented with various
other nutrients or components like basic fibroblast
growth factor (bFGF) [35–37], LIF [23,35–38], epider-
mal growth factor (EGF), and stem cell factor (SCF)
[38]. We have found that pig cell lines do not express
LIF receptor, indicating that the addition of this cyto-
kine to the culture medium is not essential for the
maintenance of pluripotency. However, LIF appears to
inhibit the differentiation process [21] since its pres-
ence in the standard medium used for embryoid body
(EB) formation, results in preventing cell commitment
to germ layer specification and inhibited cell aggrega-
tion (see Fig. 3).
Fig. 2. Isolation of ICM from a preimplantation pig blastocyst, plating on feeder cells and derivation of a colony of putative pluripotent cells.
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It is likely that the role of LIF in pluripotency main-
tenance of pESC does not occur through a classical
LR-gp130 and STAT3 activation pathway [39]. In
agreement with this, Blomberg et al demonstrated in-
consistent expression of LIFR in porcine epiblast cells
cultured for 24 h [40]. The variability among samples
that was observed in that study was explained as the
result of contaminating hypoblast, making it difficult to
ascertain a potential importance of LIF/LIFR in the
porcine. This observation has been further confirmed
by a recent study that could not detect LIFR in the
epiblast cells of early porcine embryos [41]. Within this
scenario, we suggest that LIF effect is likely to be
mediated through alternative signaling pathways that
have been shown to participate in maintaining pluripo-
tency. Our data indicate a possible involvement of the
PI3K/AKT signaling cascade [31], which is known to
be responsive to LIF and has been shown to trigger the
expression of NANOG and to facilitate efficient prolif-
eration and survival of murine ESC [42].
Another key aspect in long term cell culture main-
tenance is sensitivity of cell to cell contacts. Indeed, the
inability to withstand dissociation of primate ES cells
into single-cell suspensions is a complicating factor in
their culture. Mouse ESCs are in general dissociated
with trypsin–EDTA and this procedure does not seem
to affect their plating efficiencies [43]. In contrast,
enzymatic and chemical dissociation of human or mon-
key ES cells typically gives re-plating efficiencies of
less than 1% [44] and seems to render the cells more
exposed to chromosome abnormalities [45,46].
This is apparently even more pronounced in ungu-
late epiblast cells. Primary cultures of AP positive,
undifferentiated, ungulate epiblast cells, prepared by
the successive immunodissection, culture, and physical
dissection method, are extremely sensitive to lysis, by
either physical manipulation, withdrawal of calcium, or
exposure to trypsin-EDTA [32,33,47]. Primary cultures
of pig epiblast cells, in particular, will rupture and lyse
after only 5 min exposure to Ca2/Mg2-free PBS,
with cells completely disintegrating in 30–60 min [47].
This inability to withstand dissociation is a critical
point for passaging protocols of porcine epiblast cells.
In line with this requirement, we disaggregate pig ICMs
using mechanical dissociation and passage pig cell line
colonies using micro-loops and mechanical pipetting,
avoiding completely the exposure to enzymatic diges-
tion. Furthermore, while performing these procedures,
we always make sure to keep clumps of cells and never
reach single cell suspension that would result in imme-
diate differentiation.
4. How do we assess pluripotency?
For many years, characterization of ESC in domestic
species was mainly carried out on the basis of morpho-
logical criteria, given the fact that, until recently, no
Fig. 3. Pluripotent cells, cultured in hanging droplets, generate EBs after 9–10 days of co-culture. The addition of LIF to the medium inhibited
differentiation and cell aggregation.
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specific molecular marker has been identified. Al-
though evidence based on the comparison between the
transcriptomes of mouse and human ESC leads to the
conclusion that mouse ESCs are substantially different
from human cell lines, they express the same set of
factors, known to be required for pluripotency in mouse
ESCs, including, for example, the two homeodomain
proteins OCT-4 and NANOG [48].
Furthermore, classic human and mouse ESC mark-
ers such as OCT-4, SSEA-1, SSEA-4 and alkaline
phosphatase are indeed expressed by ungulates ICM
and embryo-derived cell lines; however, the same
genes are also expressed in the trophectoderm and
endoderm [49–52]. The paucity of specific information
available to authenticate appropriate ESC markers ham-
pers thorough evaluation of the validity of putative
pESC lines.
OCT-4 protein expression mode in porcine is con-
troversial. Many authors report data demonstrating that
both ICM and trophectoderm express this marker
[1,40,50,53–58]. Furthermore, recent studies show
OCT-4 gene expression in porcine trophectoderm and
endoderm cell lines [59]. On the other hand, according
to Vejlsted et al, in embryos at the expanding hatched
blastocyst stage, OCT4 is confined to the inner cell
mass [60]. In our studies we find that OCT-4 mRNA is
detectable at the time of porcine ICM plating and dur-
ing the first passages, while, by passage seven to ten,
OCT-4 mRNA expression is completely turned off or,
when expression persists, immune-positivity is com-
mon to the cytoplasmic compartment and not only
restricted to the nucleus [1]. Of course a consistent
limitation in these findings is the lack of reliable anti-
bodies for ungulates that could ensure consistent re-
sults, which makes the interpretation of the data even
more confused. It is interesting to note that, unexpect-
edly, downregulation of OCT-4 does not seem to affect
these cells, which have been cultured for several further
months without showing changes in their morphology
and with no expression of specific differentiation mark-
ers. These observations suggest that, even though OCT-4
is likely to be a marker of stemness also in the pig, it does
not seem to be the only or the key factor playing a role in
the maintenance of pluripotency in this species [39]. It
may be hypothesized that OCT-4 presence plays an indis-
pensable role in plating and early culture of pig epiblasts,
but may then be replaced by other pluripotency factors
like NANOG, which is a well-characterized marker in
human and mouse ESC lines.
NANOG is constantly expressed in the cell lines that
were generated in our laboratory and, in contrast to
OCT-4, it is detectable at every passage [1]. Interest-
ingly, it is also strongly downregulated in caprine tro-
phectoderm, while being strongly expressed in the ICM
[52] and does appear to be a specific marker of pluri-
potency for ruminants because both its mRNA and
protein are found in the ICM and strongly downregu-
lated in the trophectoderm of caprine blastocysts [52].
Altogether, these observations lead us to hypothe-
size that NANOG may be able to maintain pig pluripo-
tent cells in an undifferentiated state, also in the ab-
sence of the simultaneous expression of OCT-4. This is
further supported by recent studies indicating that
NANOG over expression is sufficient to support mouse
ESC self-renewal [61].
On the other hand, it may be hypothesized that
NANOG expression, in the absence of OCT-4, indicates
a “stand-by” mode, where a cell is prevented from
committing to differentiation but, at the same time, is
not fully pluripotent and only the simultaneous expres-
sion of both factors (and, possibly, many others) has to
be present in order to maintain cells in a genuine plu-
ripotent state.
Conflicting data regarding the expression of other
pluripotency markers (SSEA1, SSEA4, Alkaline Phos-
phatase, Sox2, Rex1) further complicates our under-
standing of pESC. Although these factors are consid-
ered characteristic of ESC in other species, they cannot
be regarded as definitive markers in the pig [1,50,59].
5. Perspectives and strategies
Many factors, some of which are briefly discussed in
the present manuscript, make the establishment of ESC
lines in the pig, and in animal species other than mouse
and human, a very slow process. The paucity of con-
clusive information related to morphology, pluripo-
tency markers, differentiation capability that should be
distinctive of pESC, hampers thorough evaluation of
putative lines at present. These difficulties are further
increased by the lack of antibodies, reagents and tools
that ensure reliable screening in the pig and, as a result
of this, misleading assessments are a real hazard.
Further investigation is required to identify the op-
timal time for the initiation of pig ICM cultures and to
set up better in-vitro culture systems for the establish-
ment and long-term maintenance of pESC. The inter-
actions with the feeder layer still need to be fully
understood. It is reasonable to assume that similar reg-
ulatory pathways are likely to exist among different
species and modulate many of the mechanisms in-
volved in the control of cell adhesion, outgrowth for-
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mation and cell line generation. However species re-
lated differences may drive the coupling of these
common mechanisms with the specific timing of em-
bryo development, the distinct expression and relative
concentration of pluripotency-related molecules and
the cell needs in its micro environment. We feel that the
understanding of these subtle but meaningful diversi-
ties in the pig species may provide beneficial informa-
tion towards the isolation of genuine embryonic stem
cells. Possibly, these aspects can be better evaluated if
we concentrate our research on the identification of
porcine specific pathways involved in the control of
self-renewal, focusing on a close re-exam of the mech-
anisms driving pig early embryo development and dif-
ferentiation. This approach should comprise the evalu-
ation of both intrinsic and extrinsic factors that may not
be the same molecules that have been shown to be
effective in other species. There is still a lot of work to
be done and there are no shortcuts.
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Abstract: Human parthenogenetic embryos have been recently proposed as an alternative, less controversial source of 
embryonic stem cells. However many aspects related to the biology of parthenogenetic cell lines are not fully understood 
and still need to be elucidated. These cells have great potentials; they possess most of the main features of bi-parental 
stem cells, show the typical morphology and express most of the pluripotency markers distinctive of ESC. They also have 
high telomerase activity, that disappears upon differentiation, and display great plasticity. When cultured in appropriate 
conditions, they are able to give rise to high specification tissues and to differentiate into mature cell types of the neural 
and hematopoietic lineages. However, their injection in immunodeficient mice has been reported to result in tumour for-
mations. Aberrant levels of molecules related to spindle formation, cell cycle check points and chromosome segregation 
have also been detected in these cells, that are characterized by the presence of an abnormal number of centrioles and 
massive autophagy. All these observations indicate the presence of an intrinsic deregulation of the mechanisms controlling 
proliferation versus differentiation in parthenogenetic stem cells. In this manuscript we summarize data related to these 
aberrant controls and describe experimental evidence indicating their uniparental origin as one of the possible cause. Fi-
nally we propose their use as an intriguing experimental tool where the pathways controlling potency, self renewal and 
cell plasticity are deeply interconnected with cell transformation, in an unstable, although highly controlled, equilibrium 
between pluripotency and malignacy.  
Keywords: Centriole, mitotic spindle, parthenogenesis, pluripotency, tumorigenic. 
INTRODUCTION 
 Parthenogenesis is the process by which an oocyte can 
develop without the intervention of the male counterpart. It 
is a form of reproduction common to a variety of organisms 
such as fish, ants, flies, honeybees, amphibians, lizards and 
snakes, that may routinely reproduce in this manner. 
 Mammals are not spontaneously capable of this form of 
reproduction, but, mammalian oocytes can be successfully 
activated in vitro, mimicking the intracellular calcium wave 
induced by the sperm at fertilization, which triggers cleavage 
divisions and embryonic development [1]. Mammalian 
parthenotes, however, are unable to develop to term and ar-
rest their development at different stages after activation, 
depending on the species [2]. The reason for this arrest is 
believed to be due to genomic imprinting which causes the 
repression of certain genes [3], that are normaly expresse by 
the paternal allele. 
 Because mammalian parthenotes are inherently unable to 
form a new individual, following the success reported in 
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mouse [4, 5] and non-human primate models [6, 7], human 
parthenogenetic embryos have recently been proposed as an 
alternative, less controversial source of embryonic stem cell 
lines [1, 8-11]. Parthenotes may also represent a possible tool 
for studies on the mechanisms driving early human embryo-
genesis and for the pre-clinical test of experimental protocols 
in human assisted reproduction (i.e. different oocytes cryo-
preservation procedures, oocyte in vitro maturation or polar 
body genetic screening). However many aspects related to 
the biology of parthenogenetic embryos and parthenogenetic 
derived cell lines still need to be elucidated. The assembly of 
the new embryonic centrosome in the absence of the sperm 
centriol can lead to aberrant progression of cell cycle and 
spindle formation [12]. The decreased extent of heterozy-
gosis may amplify any negative genetic component poten-
tially present in the genotype [13, 14]. The very high inci-
dence of chromosome instability and aberrant chromatid 
separation in oocytes retrieved from IVF patients, especially 
when over 34 year old [15-18] also represents a concern, 
given the fact that these represent a large part of the popula-
tion accessing assisted reproductive therapy and, hence, are a 
major potential source of oocytes for parthenotes derivation. 
 In an attempt to better elucidate some of these aspects, 
human parthenogenetic (HP) cell lines, recently derived in 
our laboratory [2, 19], were characterized for their pluripo-
tency and differentiation plasticity, both in vitro and in vivo. 
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Here we discuss the characteristics of these cell lines that are 
common to bi-parental embryonic stem cells. However we 
also describe the presence of an intrinsic deregulation of the 
mechanisms controlling proliferation versus differentiation 
and suggest their uniparental origin the possible cause. 
PLURIPOTENCY AND IN VITRO DIFFERENTIA-
TION ABILITY OF HP CELL LINES 
 The development of human parthenotes to the blastocyst 
stage was reported only recently [20-22] and not many data 
are available because of the limited accessibility of unfertil-
ized human oocytes. Even more limited are the information 
related to the potential plasticity of the lines that can be de-
rived from parthenogenetic human embryos. The lines de-
rived in our laboratory have been growing for over two years 
and possess the main features of bi-parental stem cells. They 
are capable of renewing themselves; they can be continu-
ously cultured in an undifferentiated state and can be propa-
gated extensively in vitro. For over 70 passages they con-
stantly expressed markers that characterize and are distinc-
tive of human embryonic stem cells, such as Oct-4, Nanog, 
Rex-1, Sox-2, alkaline phosphatase, SSEA-4, TRA 1-81, 
indicating a pluripotency signature that is not influenced by 
the exclusive presence of the maternal genome. In common 
with biparental cell lines they also display high telomerase 
activity, which is often correlated with self-renewal, regen-
eration and immortality and is typically expressed in germ 
cells and embryonic stem cells [23, 24] (Table 1). In line 
with this, undifferentiated HP cells displayed high levels of 
telomerase activity, while no telomerase activity could be 
detected when cells were subjected to specific stimuli in or-
der to induce tissue differentiation in vitro . These data indi-
cate that a physiologically normal control of telomerase ac-
tivity is present in HP cells and that, if subjected to culture 
conditions that induce differentiation, they turn down their 
telomerase activity. Consistent with this, HP cells were able 
to form embryoid bodies (EBs) that actively transcribed 
RNAs involved in specification of the three embryonic germ 
layers, demonstrating the potential of these cells to differen-
tiate in the main tissue types of the body. Interestingly, very 
low or no expression of trofectoderm-related markers was 
detected, suggesting that human parthenogenetic cells have a 
poor capability to differentiate towards trofectoderm and this 
may reflect parthenote inability to give rise to adequate fetal 
membrane development and to implant correctly. 
 In our opinion a crucial point was to assess the possibility 
to drive differentiation of human parthenogenetic cells to-
wards a specific lineage, in controlled culture conditions. 
Data from our lab demonstrate that cells were able to form 
different cell subtypes belonging to the neural lineage as well 
as to differentiate in the complex array of hematopoietic 
cells. Although further assays to test the real extent of cellu-
lar functionality are needed, these results further confirm 
human parthenogenetic cell lines differentiation potential. In 
particular our experiments showed that HP cells were able, 
not only to give rise to early neural lineages, as previously 
described [8-11], but also to more mature cell types express-
ing nestin, CNPase and MAP2 [19]. This is consistent with 
the observation that murine androgenetic embryonic stem 
cells are able to differentiate into neuronal and glial cells 
[25]. Similarly, exposure of HP cells to specific cytokines 
and adequate culture conditions allowed for differentiation of 
these cells towards the hematopoietic lineage, with the gen-
eration of lymphoid, erythroid and myeloid sub-populations. 
Our results further expanded current knowledge on HP in 
vitro differentiation plasticity showing the formation of ma-
ture hemopoietic cell lineages and confirms what has been 
recently reported in mouse androgenetic and gynogenetic 
stem cells, that where shown to be able to generate adult-
transplantable hematopoietic stem cells that can repopulate 
the hematopoietic system of adult transplant recipients [25]. 
Altogether these findings indicate that, outside the normal 
developmental paradigm, the differentiation potential of uni-
parental cells may be much less restricted than that of 
parthenogenetic cells in chimeras and that these cells can be 
an interesting and relevant model for the study of fundamen-
tal mechanisms involved in human lineage determination. 
Table 1. Comparison of Pluripotency Signature in Biparental 
and Parthenogenetic (HP) Cell Lines 
 
Human Biparental 
ESC 
Human Partheno-
genetic Cell Lines 
(HP) 
Oct-4 + + 
Nanog + + 
Sox-2 + + 
Rex-1 + + 
TRA 1-81 + + 
SSEA-4 + + 
Telomerase activity high high 
EB derivation yes yes 
PARTHENOGENETIC CELLS SHOW A DEREGU-
LATION OF THE MECHANISMS CONTROLLING 
PROLIFERATION VERSUS DIFFERENTIATION 
 Injection of HP cells in immunodeficient mice gave rise 
to the formation of malignant sarcomas with myofibroblastic 
differentiation [26]. This is consistent with the observation 
that the subcutaneous injection of androgenetic mouse em-
bryonic stem cells in immunodeficient mice generates sar-
comas with muscular differentiation [27]. These findings 
suggest the presence of an intrinsic deregulation of the 
mechanisms controlling the choice between proliferation and 
differentiation in embryonic stem cells obtained through 
parthenogenesis and androgenesis. However, it is interesting 
to note that this appeared to be modulated by the microenvi-
ronment and, while it was undetectable when cells were dif-
ferentiated in vitro, it became evident once cells were ex-
posed to the in vivo milieu. 
 These results are in contrast to what previously described 
in other human parthenogenetic cell lines [8-11] and the pos-
sibility exists that these anomalies derive from differences in 
the procedures used for the derivation of the cell lines. We 
think that an important factor to be considered is the age of 
the oocyte donors. This aspect could be important, given the 
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high incidence of chromosome instability and aberrant 
chromatid separation in oocytes retrieved from IVF patients, 
especially when over 34 year old [15-17]. Unfortunately no 
details on donors age were given in the other reports, there-
fore the relevance of this parameter cannot be evaluated. 
 However, based on a series of experiments carried out in 
our lab [19], we hypothesize that the uniparental origin of 
HP cells and, in particular, the lack of the centrioles supplied 
by the male counterpart, may be a possible explanation of the 
altered behaviour of parthenogenetic cell lines upon in vivo 
transplantation, with the use of relatively old donors as a 
potential aggravating factor. 
PARTHENOGENETIC CELLS AND DE-NOVO CEN-
TRIOLE ASSEMBLY 
 It has been demonstrated that centrioles degenerate and 
are lost during human oogenesis and, while oogonia and 
growing oocytes display normal centrioles until pachytene 
stage, they are absent in the mature oocytes [28]. With the 
notable exception of mice [29] this degenerative process has 
been described in rhesus monkeys [30], rabbits [31], cows 
[32], sea urchins [33], Xenopus [34], and several other spe-
cies [35]. Due to the absence of centrioles, the oocyte centro-
somal material does not aggregate into unified foci and is 
unable to form astral microtubules and a correctly oriented 
spindle, unless rescued by a spermatozoon. The conse-
quences of the lack of centrioles on parthenogenetic devel-
opment have been studied in detail in lower species. In Sci-
ara parthenogenetic embryos, the spindles assembled without 
centrosomes are anastral, and the distance between the 
daughter nuclei is greatly reduced [36]. This limitation is 
common to many other species that are obligatory or faculta-
tive parthenotes, where successful parthenogenesis largely 
depends upon the oocyte ability to generate complete and 
functional centrosomes, in the absence of the material sup-
plied by a male gamete. In particular, parthenogenetically 
activated sea urchin and insect eggs have been described to 
form multiple centrioles, possibly as the result of the lack of 
a correct control on the process of spindle formation [37-39]. 
Indeed, the inability of parthenogenetic oocytes to organize 
normal spindles, due to the lack of a functional centrosome, 
has been suggested as a strict checkpoint control to suppress 
parthenogenetic development [40], since it is not an evolu-
tionarily preferred pathway, even in species that are faculta-
tive parthenotes, because it leads to genomic homogeneity 
that, in turn, results in the accumulation of genetic anomalies 
in the population. These observations on the parthenogenetic 
process in lower species are in agreement with our findings 
in HP cells. Similarly to what reported in sea urchins and 
many insects, for instance, also HP cells display multiple 
centrioles Fig. (1) suggesting that the ability to rearrange 
functional centrosomes is altered in these cells. Marshall 
[41], suggested that centriole de novo assembly is normally 
turned off when centrioles are present in a cell. Therefore the 
absence of sperm centriole in parthenotes may lead to the 
lack of the negative regulatory mechanism that normally 
suppress de novo centriole assembly and may explain the 
presence of multicentriolar structures, as the ones described 
in parthenotes and as the ones we detect in HP cells. 
 Interestingly enough, HP cells can proliferate and divide 
and most importantly, they can correctly differentiate, into a 
variety of tissues, responding to experimental conditions that 
are able to induce differentiation in bi-parental cells. This 
ability does not seem to be limited by the abnormalities de-
scribed above and suggests that the requirement of a paternal 
centrosome described in lower animals appears to be less 
stringent in human cells, at least in in vitro controlled condi-
tions. Indeed, in higher mammals, genomic imprinting is 
thought to be the main mechanism to the obligatority of en-
sure biparental fertilization [42]. However these abnormali-
ties in spindle rearrangement may explain the high percent-
age of cells showing misshaped, mal-segregated chromo-
somes in our cell lines. Multiple chromosome malsegrega-
tions have been previously described in human oocytes after 
parthenogenetic activation, either spontaneous or induced by 
puromycin [43]. Consistent with this, a high incidence of 
polyploid and mixoploid chromosomal complements has 
been reported in parthenotes derived from bovine and por-
cine activated oocytes, with abnormal chromosomal com-
plements occurring as early as completion of the first cell 
cycle and, again, it was linked to the absence of a paternally 
supplied centrosome [44, 45]. 
 The patterns of abnormal centrosome reformations ob-
served in HP cells closely resemble those seen in cancer cells 
which argues that structural defects of centrosomes can ac-
count for the formation of abnormal mitosis and multipolar 
cells frequently observed in cancer [46]. Interestingly 
enough these abnormalities do not seem to affect the overall 
proliferation rate and in vitro differentiation plasticity of HP 
cells. Although this needs to be further elucidated, it could 
be partially explained by the massive autophagocitic activity 
present in these cells. This process is likely to be used as an 
active self-protective strategy in order to eliminate highly 
abnormal organelles thus contributing to cell survival and 
ensuring “normal” population [47]. 
PARTHENOGENETIC CELLS AND MITOTIC SPIN-
DLE CHECKPOINT MOLECULES 
 We previously showed that HP cells display altered ex-
pression levels of mitotic check point molecules Fig. (2). In 
particular, the comparison of HP cells with bi-parental em-
bryonic stem cell lines indicated a much higher level of ex-
pression of Mad-1, and the related molecules MAX and 
SIN3 in parthenogenetic cells. Mad-1 is a central component 
of the spindle assembly checkpoint and recruitment of kine-
tochores [48-50]. Increased level of Mad1 has been previ-
ously shown to cause a reduction in the expression of Myc in 
human monoblasts where a decrement of cell proliferation 
with a protracted G1 phase of the cell cycle was observed but 
Mad1 was neither demonstrated to cause spontaneous differ-
entiation nor to enhance
 
induced differentiation but rather 
inhibited differentiation
 
induced by retinoic acid [51]. On the 
other hand Mad1 dimerizes with MAX and, through a spe-
cific association with the SIN3 co-repressor, decreases tran-
scription and, indirectly inhibits cell proliferation [52]. 
Taken together these observations support the hypothesis 
that the altered levels of such molecules present in HP cells 
cause anomalies in their control of proliferation and differen-
tiation.
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Fig. (1). Expression level of molecules related to spindle formation and chromosome segregation in HP cells and biparental cell lines. Bars 
represent the average Ct of HP cells (white)and biparental cells (grey) related to the genes examined. Ct value was obtained from the Ct of 
the target gene normalized with the Ct value for -actin of the same sample. 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Ultrastructural analysis of human parthenogenetic cells. The presence of amplified centrosomes loosely dispersed in the cytoplasm 
can be appreciated. Supernumerary centrioles and massive autophagic processes generally coexist. 
 Disturbances in the control of spindle formation and cell 
division are also consistent with the observation that HP cells 
showed very low transcription for TTK and CENP-E, mole-
cules normally involved in kinetochore-microtubule binding, 
correct chromosome congression and alignment as well as 
segregation, during mitosis. Disruption of CENP-E, in fact, 
has been shown to reduce tension across the centromere, 
increase the incidence of spindle pole fragmentation, and 
result in mono-oriented chromosomes approaching abnor-
mally close to the spindle pole, with a mixture of aligned and 
unaligned chromosomes [53]. Normally the final result of 
CENP-E inhibition is mitotic arrest, initiation of apoptosis 
and cell death and this effect is more likely to affect rapidly 
dividing cancer cells. However redundant mechanisms have 
been described in mammalian cells to enable kinetochore 
microtubule binding and checkpoint monitoring in the ab-
sence of CENP-E, although with poor positioning at the 
spindle poles and chronically monooriented chromosomes 
[54]. 
CELLS IN AN UNSTABLE EQUILIBRIUM BE-
TWEEN PLURIPOTENCY AND MALIGNANT 
TRANSFORMATION 
 The data presented in this review, and many evidence 
available from the literature, demonstrate that cell lines ob-
tained from parthenogenetic embryos display intriguing, 
although somehow contraddictory features. The main path-
ways controlling potency, self renewal and cell plasticity are 
active and functional in these cells and, in line with this, HP 
cells are able to self renew and maintain unaltered stable 
pluripotent cell colonies in vitro. In this highly controlled 
self renewal equilibrium, where symmetric cell division is 
predominant, abnormal centrioles and chromosome mal-
segregations do not result in aberrant growth and/or dediffer-
entiation. Our data suggest that authophagy is one of the 
resources that these cells utilize in order to eliminate super-
numerary centrioles in these conditions. When cultured in 
vitro, they are able to respond to differentiation media and 
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give rise to populations representative of the three germ lay-
ers, switching between symmetric and asymmetric cell divi-
sions in a timely and controlled manner. HP cells can be 
driven though standard protocols to differentiate into hema-
topoietic and neural cells. However this pluripotency/high 
plasticity status seems to be related to a strictly controlled 
environment, such as the one which is recreated in in vitro 
culture conditions, and is lost when cells are transplanted in 
SCID mice. The in vivo milieu appears to interfere with this 
mode and releases cells to aberrant growth, with unrestrained 
expansion of the stem cell compartment that leads to the 
formation of malignant sarcomas. 
 Work from Boveri at the turn of the 20th century postu-
lated that centrosomes play an essential role in the mainte-
nance of genome stability and that defects in centrosome 
biogenesis could lead to aneuploidy and potentially favor 
tumor formation. For over 100 years, however this hypothe-
sis has not been tested. Basto and colleagues [55] recently 
demonstrated that the induction of supernumerary centro-
somes is sufficient to cause transformation in flies, with 
large and invasive tumors as a result. Castellanos and col-
legues [56] used an unbiased approach to study the tumori-
genic potential of panel of Drosophila mutants, defective in 
various aspects of centrosome biogenesis. These authors 
found that most of mutants generated a high frequency of 
tumors but Polo-like kinase and Aurora A mutants gave rise 
to especially large and invasive tumors that could be serially 
re-transpalnted and were able to generate an almost infinite 
tumor mass. Parallel studies from Weaver et al. [57] demon-
strated that reduced levels of centrosome-linker motor pro-
tein CENP-E result in elevated levels of aneuploidy. Al-
though it will be important to determine how specie with 
high numbers of chromosomes that need to be segregate to 
progeny during cell divition respond to centrosome dysfunc-
tion, we think it may be of interest to note that HP cells were 
found to express dramatically decreased levels of Aurora A 
and CENP-E [19], indicating that similar molecular pathway 
are likely to be affected by the presence of supernumerary 
centriols in human cells. 
 Interpreting the results we generated with HP cells, in the 
light of the data mentioned above, we can hypothesize that 
parthenogenetic cells may represent an interesting model 
where the control of asymmetric cell division is lost, due to 
the presence of abnormal centrosome. Since switching be-
tween symmetric and asymmetric cell divisions in a timely 
and controlled manner is crucial for normal tissue homeosta-
sis, deregulation of this process can cause continued expan-
sion of the stem cell compartment, with the activation of the 
tumorigenic process [58], as we detect when HP cells are 
transplanted to SCID mice. 
 In this line, the tumorigenic process detected in HP cells 
may be related to the presence of supernumerary centrioles 
that would create misalignment between the spindle and the 
asymmetric cell determinants, resulting in enforcement of 
the tumorigenic process. We think that further studies on the 
link between supernumerary centriols, multipolar spindles 
and genetic instability leading to cancer in mammalian spe-
cie could provide important information, especially if we 
consider that most of the data available at the present, are 
limited to lower species. In our opinion the use of HP cell 
lines could represent an intriguing and unique experimental 
tool where the pathways controlling potency and self re-
newal vs cell transformation can be investigated in a human 
model, and where the use of different milieaux can activate 
mechanisms that control the switch between pluripotency 
and malignancy. 
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1. Introduction
Stem cells are characterized by their ability to proliferate 
indefinitely and, in adequate conditions, to give rise to 
specialized cell types. Their isolation can be obtained 
using different sources, with different advantages 
and limitations [1]. Embryonic stem cells (ESCs) are 
pluripotent cells derived from the inner cell mass (ICM) of 
pre-implantation blastocysts, as previously demonstrated 
in the mouse [2,3] and humans [4]. These cells present 
unlimited self-renewal and are able to differentiate into 
all cell types of the body [5,6]. These properties are not 
shared by adult stem cells isolated from differentiated 
adult tissues. Adult stem cells, in fact, show a limited 
capacity for self-renewal ex vivo [7] and are very difficult 
to expand in vitro. Consequently ESCs are considered 
to be an unlimited source of transplantation materials 
for the replacement cell therapy. These characteristics 
have resulted in efforts aimed at establishing ESCs in 
species other than the human and the mouse, including 
rabbit, hamster, cattle, sheep, goat and non-human 
primates. However, in order to generate ESCs lines, 
the creation and destruction of an embryo are needed. 
Moving from animals to man, the embryo’s potency to 
develop into a complete human being, represents a 
concern and raises serious ethical, religious, legal and 
political issues. This imposes the necessity to identify 
alternative sources of pluripotent cells for research and 
therapeutic purposes [1]. During recent years different 
methods have been suggested in order to obtain 
pluripotent cells without the generation and destruction 
of a viable human embryo. To this purpose, ESCs 
have been successfully derived, removing a single cell 
(blastomere) from an eight-cell-stage embryo, using a 
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Abstract:  Embryonic stem cells (ESCs) represent a useful tool for cell therapy studies, however the use of embryos for their derivation give rise 
to ethical, religious and legal problems when applied to the human. During the last years parthenogenesis has been proposed as an 
alternative source to obtain ESCs. Based on the fact that parthenotes avoid many concerns surrounding the “ad hoc” in vitro production 
and following destruction of viable human embryos. Unfortunately many aspects related to parthenogenetic cell biology are not fully 
understood and still need to be elucidated. In this review we describe advantages and limits of these cells. We discuss their typical ESC 
morphology and high telomerase activity, which disappears after differentiation. We examine the pluripotency signature that they share 
with bi-parental ESCs. We review their high differentiation plasticity that allow for the derivation of several mature cell type populations 
when we expose these cells to adequate conditions. On the other hand, in-depth analysis demonstrated chromosome mal-segregation 
and altered mechanisms controlling centriole arrangement and mitotic spindle formation in these cells. We hypothesize their mono-
parental origin as one of the possible cause of these anomalies and suggest a great caution if a therapeutic use is considered. 
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biopsy procedure routinely utilized in in vitro fertilization 
clinics, in order to carry out pre-implantation genetic 
screenings [8,9]. Similar results were obtained deriving 
stem cells from growth-arrested embryos. Zhang et al. 
recently used such ‘blocked’ embryos (considered 
non-viable and discarded) to derive human ESCs that 
met all the criteria for pluripotency and had normal 
karyotype [10]. Another approach proposes the use of 
non-embryonic entities obtained through altered nuclear 
transfer (ANT). This technique is conceptually based on 
somatic cell nuclear transfer (SCNT), but the somatic 
cell used is genetically altered before being transferred 
to an enucleated oocyte, obtaining an abnormal 
blastocyst, unable to implant into the uterus but capable 
of generating customized embryonic stem cells [11,12]. 
Most recently, studies suggest the possibility to induce 
the pluripotent status (iPS) in somatic cells by direct 
reprogramming [13], using retroviruses or lentiviruses 
that “force” the expression of factors considered 
essential for pluripotent status maintenance, such as 
Oct3/4 [14,15], Sox2 [16] and Nanog [17,18]. Several 
pioneering studies suggest cellular reprogramming 
also through fusion of somatic cells with embryonic cell 
lysates [19] or loading permeabilized cells with lysates of 
donor cells (somatic or pluripotent) [20] as an alternative 
to the derivation of ESCs from human embryos, and a 
solution to both the ethical and legal problems. 
The use of artificial parthenogenesis has been recently 
proposed as a possible alternative source of ESCs. While 
many features common to ESCs have been identified in 
these lines, several aspects related to parthenogenetic 
cell biology still need to be elucidated [21]. In this review 
we summarize data present in the literature related to 
parthenogenetic cell line derivation in human species. In an 
attempt to better clarify some important biological aspects, 
we discuss characteristics, pluripotency, differentiation 
plasticity, but also evaluate limits of these cell lines, recently 
derived in our laboratory [22]. 
2. Parthenogenesis in mammals
Parthenogenesis is a form of asexual reproduction, by 
which an oocyte can develop without the intervention 
of the male counterpart. This process may routinely 
occur naturally in some animal species such as fish, 
ants, flies, honeybees, amphibians, lizards and snakes. 
By contrast, in mammals this form of reproduction is 
not spontaneous, but oocytes can be successfully 
activated in vitro, using various electric, mechanical 
or chemical stimulations, which mimic the intracellular 
calcium wave induced by sperm at fertilization [23].  This 
phenomenon causes cleavage divisions and embryonic 
development [1]. However, mammalian parthenotes are 
unable to develop to term due to genomic imprinting 
alteration [24] that result in the repression of paternally 
expressed genes [25]. The consequent developmental 
abnormalities cause an arrest of parthenote development 
at different stages after activation - depending on the 
species [26] - giving embryo-like structure unable to form 
a new individual. In this scenario, after the successful 
isolation of  embryonic parthenogenetic cell lines in the 
mouse [27,28] and non-human primate models [29,30], 
human parthenotes have recently been proposed as an 
alternative, less controversial source of stem cell lines 
[1,31-34]. Furthermore it must be noted that they may 
also be used as a new experimental tool for studies 
on the biological mechanisms involved in human early 
embryo development and assisted reproduction [21].
3.  Human parthenogenesis as a 
source of pluripotent cell lines
In recent years the possibility to obtain ESCs after 
parthenogenetic activation in humans has been 
demonstrated [1,31-34], although the success of this 
approaches has been strongly limited by the restricted 
accessibility to unfertilized oocytes. We firstly reported 
the generation of a human parthenogenetic (HP) cell line 
in 2006 [35] and were then able to characterize these 
cells for their pluripotency and differentiation plasticity, 
both in vitro and in vivo [22]. In particular, we were able to 
show their typical ESC morphology and the main features 
of bi-parental stem cells, expressing appropriate stem cell 
markers such as Oct-4, Nanog, Rex-1, Sox-2, alkaline 
phosphatase, SSEA-4, TRA 1-81, and lack of the human 
ESC negative markers (e.g. SSEA-1) [36,37]. Altogether 
these results indicate a pluripotency signature that does 
not appear to be influenced by the exclusive presence 
of the maternal genome. HP cells also possess high 
levels of telomerase activity, which is turned down when 
cells are subjected to culture conditions that induce their 
differentiation, indicating that a physiologically normal 
control of telomerase activity is present.
In vitro differentiation potential of these cells was 
assessed throughout their culture in hanging droplets, 
which induces formation of embryoid bodies (EBs). 
When EBs were plated and grown as a monolayer, both 
gene expression and immunocytochemical analysis 
demonstrated the ability of these cells to differentiate and 
give rise to components belonging to the three embryonic 
germ layers (Figure 1). Interestingly no expression of 
trophectoderm-related markers was detected, possibly 
reflecting parthenote inability to generate adequate fetal 
membrane development and to implant correctly. 
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A crucial point in ESC studies is, in our opinion, to 
assess the possibility to drive cell differentiation towards 
a specific lineage, using controlled culture conditions. 
Data obtained in our laboratory demonstrate that HP 
cells were able to differentiate and to form different cell 
subtypes belonging to the neural lineage [22]. We are 
able to show that, when exposed to the appropriate 
in vitro microenvironment, these cells, not only gave 
rise to early neural population, but also generated 
more mature cell types expressing nestin, CNPase and 
MAP2 [22]. Moreover our experiments  demonstrated 
HP in vitro differentiation capability to form mature 
hemopoietic cell lineages - lymphoid, erythroid and 
myeloid sub-populations [22]. All these data are in 
agreement with the observation that murine uni-
parental ESCs are able to differentiate into neuronal and 
glial cells as well as to generate adult-transplantable 
hematopoietic stem cells that can re-populate the 
hematopoietic system of adult transplant recipients [38]. 
Moreover these findings indicate that uni-parental cells 
may be differentiated and may represent a powerful tool 
in order to study the mechanisms controlling the human 
lineage determination in vitro.
4.  Parthenogenetic pluripotent cell 
and mitotic spindle alteration
It has been demonstrated that centrioles degenerate 
and are lost during mammalian oogenesis. These 
organelles are present in oogonia and growing oocytes 
until pachytene stage, while they disappear in the 
mature oocytes, where they persist as a peri-centriolar 
disaggregated material [39]. They are then replaced at 
fertilization,  when the sperm contributes the centriole that 
joins and re-organize the peri-centriolar material present 
in the oocyte to re-form a fully functional centrosome 
[40,41].This event causes an aberrant progression of 
cell cycle and spindle formation in the newly synthesized 
embryonic centrosome in the absence of the sperm 
centriol [42]. With the notable exception of mice [43], the 
lack of centrioles on parthenogenetic development have 
been described in rhesus monkeys [44], rabbits [45], 
cows [46], sea urchins [47], Xenopus [48], and several 
other species [49]. In these species oocytes are unable 
to form astral microtubules and a correctly oriented 
spindle (Figure 2). These observations are in agreement 
with our findings in HP cells that lack  correct control 
of the spindle formation process. These cells displayed 
multiple centrioles as well as an altered expression level 
of mitotic check point related-molecules, suggesting 
that the ability to rearrange functional centrosomes is 
altered in these cells. In particular HP cells showed a 
higher level of Mad-1 and the related molecules MAX 
and SIN3, when compared with bi-parental cells. These 
molecules represent a central component of the spindle 
assembly checkpoint and recruitment of kinetochores 
[50-52], suggesting the possibility of severe disturbances 
in the control of spindle formation and mitosis in 
these cells. Furthermore HP cells showed very low 
Figure 1.  Pluripotency and differentiation plasticity of HP cell lines. HP cells grow in colonies and show a typical ESC morphology (A). They 
are able to form EBs (B) that differentiate into cells belonging to the three embryonic germ layers: endoderm (C); mesoderm (D) and 
ectoderm (E).
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transcription for TTK and CENP-E, which are involved 
in correct chromosome aggregation and alignment as 
well as segregation, during mitosis. Altogether these 
observations support the hypothesis that the altered 
levels of such molecules in HP cells cause anomalies in 
their control of proliferation and differentiation. 
5.  Parthenogenetic pluripotent cell 
and karyotype alteration
Abnormalities in spindle rearrangement is usually linked 
to a high percentage of cells showing mal-segregated 
chromosomes. Previous studies demonstrated the 
presence of multiple chromosome malsegregations in 
human oocytes after parthenogenetic activation, either 
spontaneous or induced by puromycin [53]. A high 
incidence of polyploid and mixoploid blastomers has also 
been reported in parthenotes derived from bovine and 
porcine, suggesting the absence of a paternally supplied 
centrosome as a possible cause [54,55]. Consistent with 
this, chromosome instability was observed in HP cell 
lines. However, these abnormalities do not seem to affect 
the overall proliferation rate and in vitro differentiation 
plasticity of these cells that, when cultured in vitro, are 
able to respond to specific media, routinely used for 
bi-paretntal ESCs differentiation, and to give rise to 
populations representative of the three germ layers in 
controlled manner. Furthermore it is interesting to note 
that the use of an alternative protocol of activation has 
been shown to better ensure chromosome stability. In 
this line, Fulka et al. recently reported the derivation of 
karyotypically normal cell lines from mouse MI maturing 
oocytes exposed to Butyrolactone I, which converts 
meiotic metaphase I chromosomes into chromosomes 
with mitotic-like morphology [56].
The data available from the literature as well as that 
described in this review indicate that cell lines isolated 
from parthenotes display interesting, even though 
contradictory aspects. Despite the exhibition of abnormal 
centrioles and chromosome mal-segregations, these 
cells are indeed able to proliferate and maintain their 
pluripotent status and respond in a controlled manner to 
specific stimuli, generating a vast array of differentiated 
cell populations. We think they may represent a precious 
model where the pathways controlling self-renewal 
and differentiation plasticity deeply interrelate with cell 
instability and abnormality. 
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